peptide_seq,HLA_type,CDR3a,CDR3b,protein,peptide_source,MHC_class,TRAV,TRBV,TRAJ,TRBJ,TRBD,CDR3b_nt,tcr_source_organism,tissue,category,experiment_type,sequencing,tba_nucleotide_type,tcr_reference,tba_grade
TAAQAAVVRFQEAAN,DRB115:03,CIEHTNSGGSNYKLTF,CASSLEETQYF,CFP10,Tuberculosis,II,,,,2-5,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
TAAQAAVVRFQEAAN,DRB115:03,CIVHTNSGGSNYKLTF,CASSPEETQYF,CFP10,Tuberculosis,II,,,,2-5,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
TAAQAAVVRFQEAAN,DRB115:03,CIVKTNSGGSNYKLTF,CASSFEETQYF,CFP10,Tuberculosis,II,,,,2-5,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
ADTLQSIGATTVASN,DRB115:03,CAGAGGGGFKTIF,CASSVALASGANVLTF,Rv1195,Tuberculosis,II,,,,2-6,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
ADTLQSIGATTVASN,DRB115:03,CAGPTGGSYIPTF,CASSVALATGEQYF,Rv1195,Tuberculosis,II,,,,2-6,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
ADTLQSIGATTVASN,DRB115:03,CAGTNTGNQFYF,CASSVALQGVHTQYF,Rv1195,Tuberculosis,II,,,,2-5,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
ADTLQSIGATTVASN,DRB115:03,CAVGGLSGANKLTF,CASSVALAGAEYF,Rv1195,Tuberculosis,II,,,,2-6,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",NGS,RNA,PMID:28636589,5
LLWNGPMAV,A02:01,CAAADDKIIF,CASSQGTISYEQYF,YFV-17D,YellowFeverVirus,I,12-2,14,30,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAACAEYGNKLVF,CASSVGGVTYNEQFF,YFV-17D,YellowFeverVirus,I,27,9,47,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAIDDKIIF,CASTDGGDSYTQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,30,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAIDDKIIF,CASTDGGDSYTQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,30,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAKDDKIIF,CATGAASSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,15,30,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAALDDKIIF,CASSQEGTPISYEQYF,YFV-17D,YellowFeverVirus,I,12-2,14,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAANDYKLSF,CSATGNRGADTQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,20,2-3,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAPNDMRF,CASSQAGAYEQYF,YFV-17D,YellowFeverVirus,I,13-1,6-2,43,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAPNDMRF,CASSQAGAYEQYF,YFV-17D,YellowFeverVirus,I,13-1,6-3,43,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAARANTDKLIF,CATSRESGNGKLFF,YFV-17D,YellowFeverVirus,I,29/DV5,15,34,1-4,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAARVGSSASKIIF,CASSPTGPAYEQYF,YFV-17D,YellowFeverVirus,I,13-1,7-2,3,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAASGANNLFF,CASSESPGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,10-1,36,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAASGGSYIPTF,CASSSGPAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-5,6,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAASSIQGAQKLVF,CASSPWDRANTGELFF,YFV-17D,YellowFeverVirus,I,23/DV6,4-3,54,2-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAATDSWGKLQF,CASSVGGVPYNEQFF,YFV-17D,YellowFeverVirus,I,25,9,24,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAATGANNLFF,CSASGARGADTQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,36,2-3,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAVASKIIF,CASSIKPDGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,3-1,3,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAVPIQGAQKLVF,CASGTWGARQPQHF,YFV-17D,YellowFeverVirus,I,29/DV5,12-3,54,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAAVPIQGAQKLVF,CASGTWGARQPQHF,YFV-17D,YellowFeverVirus,I,29/DV5,12-4,54,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CADHTGGFKTIF,CASSPGTGGYTEAFF,YFV-17D,YellowFeverVirus,I,13-2,4-2,9,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CADHTGGFKTIF,CASSPGTGGYTEAFF,YFV-17D,YellowFeverVirus,I,13-2,5-4,9,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CADHTGGFKTIF,CASSPGTGGYTEAFF,YFV-17D,YellowFeverVirus,I,13-2,5-6,9,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CADSSYKLIF,CASSYSTEAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-6,12,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAETRGNNRLAF,CASSVGGGREQFF,YFV-17D,YellowFeverVirus,I,5,9,7,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAFSGYALNF,CASSYTGTGSQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-2,41,1-5,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAFSGYALNF,CASSYTGTGSQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-3,41,1-5,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAFTTDSWGKLQF,CASSQGQANEKLFF,YFV-17D,YellowFeverVirus,I,24,3-1,24,1-4,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGANEKLTF,CSAPTSGGPNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,48,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGAPNTGNQFYF,CASSPGQGPYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGAPNTGNQFYF,CASSPGQGPYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-5,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGAPNTGNQFYF,CASSPGQGPYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-6,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGAPNTGNQFYF,CASSPGQGPYEQYF,YFV-17D,YellowFeverVirus,I,27,4-3,49,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGGASKIIF,CASSATGTGGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-5,3,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGGDDKIIF,CASSLPAAGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,5-8,30,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGGDDKIIF,CASSPGLAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,9,30,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGGDSTLTF,CASSQEGTSRPQHF,YFV-17D,YellowFeverVirus,I,12-2,3-1,11,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGNDYKLSF,CATSGGGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,15,20,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGPGT-GKSTF,CASSTRSSYEQYF,YFV-17D,YellowFeverVirus,I,27,19,27,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGPLDSNYQLIW,CATSESRGGGYGYTF,YFV-17D,YellowFeverVirus,I,27,15,33,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGSASKIIF,CASSPGTSGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,5-1,3,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGSASKIIF,CASSYSGGGNQPQHF,YFV-17D,YellowFeverVirus,I,12-2,12-3,3,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGSASKIIF,CASSYSGGGNQPQHF,YFV-17D,YellowFeverVirus,I,12-2,12-4,3,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGS-RLMF,CASSNQGASAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,27,31,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGVPYNNNDMRF,CASGTGTPYNEQFF,YFV-17D,YellowFeverVirus,I,27,9,43,2-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGYMDTGRRALTF,CATSSASSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-3,34,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAGYMDTGRRALTF,CATSSASSYEQYF,YFV-17D,YellowFeverVirus,I,25,15,5,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAKSASKIIF,CASSEALGSTSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,3,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALAPDKLIF,CASSSQGLSTEAFF,YFV-17D,YellowFeverVirus,I,"12-2, 21",12-3,34,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALAPDKLIF,CASSSQGLSTEAFF,YFV-17D,YellowFeverVirus,I,"12-2, 21",12-4,34,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALKDYGQNFVF,CASSLYPGTAEGGYTF,YFV-17D,YellowFeverVirus,I,16,27,26,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALNDDKIIF,CASGTEIFYYEQYF,YFV-17D,YellowFeverVirus,I,9-2,12-3,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALNDDKIIF,CASGTEIFYYEQYF,YFV-17D,YellowFeverVirus,I,9-2,12-4,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALNTGGFKTIF,CASSLFPDNYGYTF,YFV-17D,YellowFeverVirus,I,8-1,27,9,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALSGGYNKLIF,CASSPTGQGAHGYTF,YFV-17D,YellowFeverVirus,I,12-2,4-3,4,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALTGGKLIF,CASSQGGDGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,4-2,23,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALTPDYKLSF,CASSRQGGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,15,20,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALTPDYKLSF,CASSRQGGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,20,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CALWGFQKLVF,CASSPAGQGAGTGELFF,YFV-17D,YellowFeverVirus,I,3,13,8,2-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAMSGGKLIF,CATSRASGSYEQYF,YFV-17D,YellowFeverVirus,I,12-3,15,12,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAPSGGKLIF,CSASGDRGADTQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,23,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CARRGAAGNKLTF,CASSPSAGDYEQYF,YFV-17D,YellowFeverVirus,I,24,4-3,17,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CASEDDKIIF,CSGGLKADTQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CASGDDKIIF,CASSAGQGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-4,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CASSDSRGTEAFF,CASSDSRGTEAFF,YFV-17D,YellowFeverVirus,I,14/DV4,9,42,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDAQTGANNLFF,CASSLYPLGFGYTF,YFV-17D,YellowFeverVirus,I,17,27,36,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDATRDDKIIF,CASSLGGAPYNEQFF,YFV-17D,YellowFeverVirus,I,17,7-2,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDDQGAQKLVF,CASSVGGVPYNEQFF,YFV-17D,YellowFeverVirus,I,17,9,54,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDHQGAQKLVF,CASSVGGVPYNEQFF,YFV-17D,YellowFeverVirus,I,17,9,54,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDPNTGGFKTIF,CASSYPNQPQHF,YFV-17D,YellowFeverVirus,I,17,6-2,9,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDPNTGGFKTIF,CASSYPNQPQHF,YFV-17D,YellowFeverVirus,I,17,6-2,9,1-5,,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDPNTGGFKTIF,CASSYPNQPQHF,YFV-17D,YellowFeverVirus,I,17,6-3,9,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDPNTGGFKTIF,CASSYPNQPQHF,YFV-17D,YellowFeverVirus,I,17,6-3,9,1-5,,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDRWDSNYQLIW,CASSFPNQPQHF,YFV-17D,YellowFeverVirus,I,17,12-3,33,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDRWDSNYQLIW,CASSFPNQPQHF,YFV-17D,YellowFeverVirus,I,17,12-4,33,1-5,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATDSLSYNTDKLIF,CASSAYNEQFF,YFV-17D,YellowFeverVirus,I,17,9,34,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATGDDKIIF,CSVPTSGGSNEQFF,YFV-17D,YellowFeverVirus,I,12-2,29-1,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CATSGTYKYIF,CATSRAGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,15,40,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVAAYKYIF,CASSGGQAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,40,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVDEIKAAGNKLTF,CASSLGAYNSPLHF,YFV-17D,YellowFeverVirus,I,22,5-4,17,1-6,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-DGQKLLF,CASSHGQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,7-2,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-DGQKLLF,CAVGAGATYEQYF,YFV-17D,YellowFeverVirus,I,12-2,10-3,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-DGQKLLF,CAVGAGATYEQYF,YFV-17D,YellowFeverVirus,I,12-2, 6-1,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-DGQKLLF,CAVGAGATYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-4,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-DGQKLLF,CAVGAGATYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-5,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-DGQKLLF,CAVGAGATYEQYF,YFV-17D,YellowFeverVirus,I,12-2, 6-6,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVDMEYGNKLVF,CASSQGGYGYTF,YFV-17D,YellowFeverVirus,I,39,4-3,47,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVDSGNTPLVF,CASSPRQGNDEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-3,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVDSGNTPLVF,CASSPRQGNDEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-4,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVDSTDKLIF,CASSLGGASYEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-3,34,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVDSTDKLIF,CASSLGGASYEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-4,34,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEDDKIIF,CASSVKAGGNEQYF,YFV-17D,YellowFeverVirus,I,12-2,9,30,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEGGKLIF,CSVEGRGTDTQYF,YFV-17D,YellowFeverVirus,I,12-2,29-1,23,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,12-3,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,12-4,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,6-1,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,6-2,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,6-3,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,6-4,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,6-5,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVEPVGGNTPLVF,CASTPGQALNEQYF,YFV-17D,YellowFeverVirus,I,1-1,6-6,29,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGADGLTF,CASSNGQ-YEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-6,45,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGAQKLVF,CAISEVLTGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,10-3,54,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGASKIIF,CASSIAPSGVAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,19,3,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CAISESPSGALGQFF,YFV-17D,YellowFeverVirus,I,12-2,10-3,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CASSPGTGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,27,30,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CASSPQGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-6,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CASSSRTGDTQYF,YFV-17D,YellowFeverVirus,I,12-2,9,30,2-3,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CASSYVRASYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CSAPASGGGNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CSAPLAGGHNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CSAPTSGGHNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGDDKIIF,CSAPTSGGSNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGGGKLIF,CASSEAVLGGNSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,37,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGGGKLIF,CASSTGATGSNNEQFF,YFV-17D,YellowFeverVirus,I,12-2,6-1,23,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGGGKLIF,CASSTGATGSNNEQFF,YFV-17D,YellowFeverVirus,I,12-2,6-5,23,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGGGKLIF,CSAAGDRGADTQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,23,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-GKSTF,CASSPGTVAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-6,27,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGNYQLIW,CASSDLAGGTDTQYF,YFV-17D,YellowFeverVirus,I,12-2,9,33,2-3,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVGTYKYIF,CSATEAGGPGNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,40,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVIAGKSTF,CSVATSGGSNEQFF,YFV-17D,YellowFeverVirus,I,12-2,29-1,27,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVIGDKIIF,CASSLGSTGTYEQYF,YFV-17D,YellowFeverVirus,I,12-2,27,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVKDDKIIF,CASTGTGGFSYNEQFF,YFV-17D,YellowFeverVirus,I,12-2,25-1,30,2-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVKGDDKIIF,CASSFYGREAFF,YFV-17D,YellowFeverVirus,I,12-2,7-2,30,1-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVMDDKIIF,CASSAAGNQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-2,30,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVMDDKIIF,CASSAAGNQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-3 ,30,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVMDDKIIF,CASSQEVAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,3-1,30,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNDYKLSF,CASSPNSAGGTEAFF,YFV-17D,YellowFeverVirus,I,12-2,4-3,20,1-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNEQSSGSARQLTF,CASSYSEQGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,22,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNGDGQKLLF,CAWGYQITGSAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,30,16,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNGDTDKLIF,CASSPSGGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-3,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNGDTDKLIF,CASSPSGGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNGNQFYF,CASSPQTGAVTEAFF,YFV-17D,YellowFeverVirus,I,12-2,9,49,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNPDGKLIF,CSVPSRGYAGELFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,23,2-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNPETSYDKVIF,CSASEAGGSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,50,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNQGGKLIF,CASTPSPSRPPLF,YFV-17D,YellowFeverVirus,I,12-2,12-3,23,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNQGGKLIF,CASTPSPSRPPLF,YFV-17D,YellowFeverVirus,I,12-2,12-4,23,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVN-RLMF,CASSLKGNTEAFF,YFV-17D,YellowFeverVirus,I,12-2,7-6,31,1-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVN-RLMF,CASSLKLNTEAFF,YFV-17D,YellowFeverVirus,I,12-2,7-6,31,1-1,,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVN-RLMF,CASSSTQGAAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,27,31,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNSDGQKLLF,CASSGQGGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNSDGQKLLF,CASSGQGGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNSDGQKLLF,CASSGQGGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNSDGQKLLF,CASSGQGGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-4,16,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNSDKLIF,CSVSGERGTDTQYF,YFV-17D,YellowFeverVirus,I,12-2,29-1,34,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVNTDKLIF,CSVDRRADEQFF,YFV-17D,YellowFeverVirus,I,12-2,29-1,34,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-PTDSWGKLQF,CASSKQGESNSPLHF,YFV-17D,YellowFeverVirus,I,8-1,6-1,24,1-6,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-PTDSWGKLQF,CASSKQGESNSPLHF,YFV-17D,YellowFeverVirus,I,8-1,6-5,24,1-6,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAV-PTDSWGKLQF,CASSKQGESNSPLHF,YFV-17D,YellowFeverVirus,I,8-1,6-6,24,1-6,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVQADYGGATNKLIF,CASSLASGGALYNEQFF,YFV-17D,YellowFeverVirus,I,20,27,32,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRAYYGGSQGNLIF,CASSQEAGGGTGELFF,YFV-17D,YellowFeverVirus,I,1-2,4-3,42,2-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRDDKIIF,CSGGDGNTIYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,1-3,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRTYNYGQNFVF,CASSLEGQGAPGQPQHF,YFV-17D,YellowFeverVirus,I,12-2,12-3,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRTYNYGQNFVF,CASSLEGQGAPGQPQHF,YFV-17D,YellowFeverVirus,I,12-2,12-4,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRTYNYGQNFVF,CASSLEGQGAPGQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-1,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRTYNYGQNFVF,CASSLEGQGAPGQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-4,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVRTYNYGQNFVF,CASSLEGQGAPGQPQHF,YFV-17D,YellowFeverVirus,I,3,7-2,26,1-5,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSASKIIF,CASNTGTDSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,11-2,3,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSASKIIF,CASSDQTGDAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,3,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSDDKIIF,CASSDKFAGNPQPQHF,YFV-17D,YellowFeverVirus,I,12-2,10-1,30,1-5,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSDDKIIF,CASSPAGVSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,18,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSDDKIIF,CASSPGPTSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,7-2,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSDYKLSF,CASSSSGTAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-2,20,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSDYKLSF,CASSSSGTAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-3,20,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSDYKLSF,CSVGGGGAGVETQYF,YFV-17D,YellowFeverVirus,I,12-2,29-1,20,2-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGDDMRF,CASSAGTVSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,43,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGDDMRF,CASSAGTVSYEQYF,YFV-17D,YellowFeverVirus,I,12-2, 6-2,43,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGDDMRF,CASSAGTVSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,43,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGDDMRF,CASSAGTVSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-4,43,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGDKIIF,CASSSGSPGSYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-1,30,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGDKIIF,CASSSGSPGSYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,30,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGGKLIF,CASSPQGFSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-3,37,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGGKLIF,CASSPQGFSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,12-4,37,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGGKSTF,CSVQRRADEQFF,YFV-17D,YellowFeverVirus,I,12-2,29-1,27,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGNKLVF,CASSPAAGGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,5-1,47,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGQKLLF,CSASDNMVGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,20-1,16,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGSARQLTF,CASSVATEGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,9,22,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGSASKIIF,CASSQGPAAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,14,3,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGTYKYIF,CASSQGTSGNEQFF,YFV-17D,YellowFeverVirus,I,12-2,4-3,40,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSGYSTLTF,CASSAQGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,11,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSPDKLIF,CASSPSAGPGYGYTF,YFV-17D,YellowFeverVirus,I,12-2,27,34,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSPHKVIF,CASSSGTVSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,18,50,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVS-RLMF,CATSRATSNQPQHF,YFV-17D,YellowFeverVirus,I,12-2,15,31,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSSDKIIF,CSASLKADEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,30,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSSNDYKLSF,CASSETGQPQHF,YFV-17D,YellowFeverVirus,I,12-2,6-1,20,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSSTDKLIF,CSAPLAGGPNEQFF,YFV-17D,YellowFeverVirus,I,12-2,20-1,34,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSTDKLIF,CASSLKLAGTDTQYF,YFV-17D,YellowFeverVirus,I,12-2,27,34,2-3,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSTDKLIF,CASSPGGVSYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,34,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSTDKLIF,CASSPGGVSYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-6,34,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSTDKLIF,CASSQTGTGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-6,34,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVSTDSGSARQLTF,CASSPGLGTYEQYF,YFV-17D,YellowFeverVirus,I,8-4,4-2,22,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTASKLTF,CASSAGQESYEQYF,YFV-17D,YellowFeverVirus,I,12-2,9,44,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTDDKIIF,CASSETGTQAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASSGQGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,2,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASSPSGGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,7-2,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASSSQGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,7-2,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASTRQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2, 6-2,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASTRQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASTRQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDDKIIF,CASTRQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-6,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDKIIF,CASSGGTSGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-4,23,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDKIIF,CASSGGTSGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,10-2,30,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDKLIF,CALSDLGGSGNTGKLIF,YFV-17D,YellowFeverVirus,I,12-2,12-3,34,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDKLIF,CALSDLGGSGNTGKLIF,YFV-17D,YellowFeverVirus,I,12-2,12-4 ,34,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDKLIF,CALSDLGGSGNTGKLIF,YFV-17D,YellowFeverVirus,I,12-2,12-4,34,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGDQFYF,CASSPGHAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,27,49,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGNEKLTF,CASSYSSSGGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-5,48,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGNTDKLIF,CASSSAGAAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,34,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGNTDKLIF,CASSSAGAAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,34,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGTYKYIF,CASSRSGNYGYTF,YFV-17D,YellowFeverVirus,I,12-2,5-6,40,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGYALNF,CASRPGQGYEQYF,YFV-17D,YellowFeverVirus,I,12-2,19,41,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGYSTLTF,CASSGQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-1,11,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGYSTLTF,CASSGQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,11,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGYSTLTF,CASSGQGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,11,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGYSTLTF,CASSGQGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-1,11,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTGYSTLTF,CASSGQGAYGYTF,YFV-17D,YellowFeverVirus,I,12-2,6-5,11,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTKGLTGGGNKLTF,CASSGRDRQNTEAFF,YFV-17D,YellowFeverVirus,I,8-4,19,10,1-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTPDDKIIF,CASSTGTAAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-2,30,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTPDDKIIF,CASSTGTAAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,6-3,30,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTRNNDMRF,CASSWGGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,5-4,43,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTSARLMF,CASSAQGDSYEQYF,YFV-17D,YellowFeverVirus,I,12-2,4-3,31,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTSDKLIF,CASSAGTGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,9,34,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVTTDKLIF,CASSVAGGAYEQYF,YFV-17D,YellowFeverVirus,I,12-2,9,34,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVVDPSDGYNKLIF,CASSAGGTPDQPQHF,YFV-17D,YellowFeverVirus,I,8-6,9,4,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAVVPNTGNQFYF,CATSGGTSYEQFF,YFV-17D,YellowFeverVirus,I,8-3,15,49,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CAYSTDSWGKLQF,CASSQGQLNQPQHF,YFV-17D,YellowFeverVirus,I,24,3-1,24,1-5,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CILRDGWVTGYKYIF,CANNCGFF,YFV-17D,YellowFeverVirus,I,26-2,5-1,40,1-4,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CIVREWDNYGQNFVF,CASSQVAKMAKDNYGYTF,YFV-17D,YellowFeverVirus,I,26-1,4-3,26,1-2,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CLVGDNLDSSYKLIF,CATTGGSGYEQYF,YFV-17D,YellowFeverVirus,I,4,15,12,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CLVGSPFPTSGTYKYIF,CASSVAPGRDGYTF,YFV-17D,YellowFeverVirus,I,4,12-3,40,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CLVGSPFPTSGTYKYIF,CASSVAPGRDGYTF,YFV-17D,YellowFeverVirus,I,4,12-4,40,1-2,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVGAGSYQLTF,CASSGTGVSPLHF,YFV-17D,YellowFeverVirus,I,12-1,5-1,28,1-6,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVADSKLTF,CSVTGERGTDTQYF,YFV-17D,YellowFeverVirus,I,12-1,29-1,44,2-3,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVEGDKVIF,CASSHSGYEQFF,YFV-17D,YellowFeverVirus,I,12-1,4-1,50,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVGDDKIIF,CASSGGTADTQYF,YFV-17D,YellowFeverVirus,I,12-1,9,30,2-3,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVGDDKIIF,CASSPAGAYGYTF,YFV-17D,YellowFeverVirus,I,12-1,6-1,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVGDDKIIF,CASSPAGAYGYTF,YFV-17D,YellowFeverVirus,I,12-1,6-5,30,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVV-HDMRF,CATSSGTGAYEQYF,YFV-17D,YellowFeverVirus,I,12-1,15,43,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVHQWGNLIF,CSVVLVDRGADTQYF,YFV-17D,YellowFeverVirus,I,12-1,29-1,42,2-3,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVIHDKIIF,CASSPGTAYEQYF,YFV-17D,YellowFeverVirus,I,12-1,9,30,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVNEKEGNMLTF,CSVGEGLAYEQYF,YFV-17D,YellowFeverVirus,I,12-1,29-1,39,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVNTDKLIF,CASSGSSGYEQYF,YFV-17D,YellowFeverVirus,I,12-1,6-5,34,2-7,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVSAESGYSTLTF,CASSQLGNEQFF,YFV-17D,YellowFeverVirus,I,10,7-8,11,2-1,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVSDYKLSF,CASTPGTGAYEQYF,YFV-17D,YellowFeverVirus,I,12-1,6-6,20,2-7,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVSGFKTIF,CASSDTDRGIYGYTF,YFV-17D,YellowFeverVirus,I,12-1,6-2,9,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVSGFKTIF,CASSDTDRGIYGYTF,YFV-17D,YellowFeverVirus,I,12-1,6-3,9,1-2,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVSSVRGSYIPTF,CASSVDGGGGGYNEQFF,YFV-17D,YellowFeverVirus,I,10,9,6,2-1,2,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVSVGVLYSTLTF,CASSSGRTEHNEQFF,YFV-17D,YellowFeverVirus,I,8-2,11-2,11,2-1,1,,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVTDDKIIF,CASNGGLAYEQYF,YFV-17D,YellowFeverVirus,I,12-1,6-2,30,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
LLWNGPMAV,A02:01,CVVTDDKIIF,CASNGGLAYEQYF,YFV-17D,YellowFeverVirus,I,12-1,6-3,30,2-7,"1,2",,human,,pathogen,"SMRT-Seq2,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28103239,4
RPRGEVRFL,B07:02,CAAFQGAQKLVF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,29,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAEGDSWGKLQF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,23,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEADSWGKLQF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAMREAGGFKTIF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,9-2,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CASSEWTVDGYTF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,22,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVNPDSWGKLQF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-2,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGASGAGSYQLTF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,9,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGDKGSSASKIIF,,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-1,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAEGDSWGKLQF,CATSEAASSWTGELF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,23,24-1,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAEGDSWGKLQF,CSALRDNYNSPLHF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,23,20-1,,1-6,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAEIAGGYNKLIF,CAWTETGLSGNTIYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,5-5,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFGRGAQKLVF,CASRPQGANEKLF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,5,30,,1-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFGRGAQKLVF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-2,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFGRGAQKLVF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-2,5-5,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFGRGAQKLVF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-2,5-7,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFMKANSGGSNYKLTF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-1,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFMKHASGGSNYKLTF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-1,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFMKPAGGGGDYKLTF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-1,7-2,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAFMKSGYALNF,CAWTETGLSGNTIYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-1,30,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAGVRGGADGLTF,CASSPYQTGLDGYTF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,24,16,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALDSDGQKLLF,CASSTDSVDEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,14,5-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALDSDGQKLLF,CASSTDSVDEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,5-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALGGDYGGSQGNLIF,CASREWGGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALKISGSGYALNF,CASRKTGGGEAF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,7-3,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALMTTDSWGKLQF,CASRLQGINEKLF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,12-4,12-4,,1-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALMTTDSWGKLQF,CASRLQGINEKLF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,27,12-4,,1-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEADSWGKLQF,CASRMQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEADSWGKLQF,CASRMQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,5-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEADSWGKLQF,CASRRQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEADSWGKLQF,CASRVQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEADSWGKLQF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEAGGDSWGKLQF,CASRRQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEANSWGKLQF,CASRPQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSEASSWGKLQF,CASRVQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSGSGDSWGKLQF,CASRPQGREETQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSGSTDSWGKLQF,CASRPQGRDQPQHF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,12-4,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CALSGTTDSWGKLQF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,12-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CATDPSNTGNQFYF,CASSQEVAGATGELF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,17,4-2,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVKTTDSWGKLQF,CAISDPGDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-2,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CASRRQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,9,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CASSLGGLGDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,12-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CASSVIGATYEQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,6-1,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-2,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,12-4,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVRDTNTGKSTF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAVSGEYGNKLVF,CASSSTPLSTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,6,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CAYSRLGTDQLIF,CASRLTGEKQETQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,38-2,5-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CFLVGPQGSSASKIIF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,10-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CILRGSGTYKYIF,CASRIWGGADTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,26-2,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGASGAGSYQLTF,CASSDSYRGSYNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,6-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGASGAGSYQLTF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,19,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGNGGATNKLIF,CAISDPSGSSYNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,10-3,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGNGGATNKLIF,CASSVWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CLVGSVGAGSYQLTF,CATRIGWGTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,4,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CTLYSKAGSYQLTF,CASRLIGGGTEAF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,26-2,12-3,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CVASGGTGKLIF,CATSEAASSWTGELF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,12-1,24-1,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CVASGGTGKLIF,CATSEAASSWTGELF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,12-1,7-3,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,CVVSGKNTGFQKLVF,CASSVQALLAGDWADTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,1-1,4-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,,CASRKTGGGTEAF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,,7-3,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,,CASRLIGGGTEAF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,,7-2,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,,CASRPQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,,CASRRQGRDNEQF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
RPRGEVRFL,B07:02,,CASSLHLGGVTDTQYF,HSV-2 VP22,Herpes simplex virus 2 (HSV2),I,,7-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:20139278,4
ATDALMTGY,A01:01,,CAAADEEIGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,10-3,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CAISDAGAGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,10-3,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CAISEGAMGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CAISESSIGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,19,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CAISESSSGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASEAGTVNTNTQYF,Genome polyprotein,Hepatitis C virus,I,,9,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASIDRTIGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,19,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASNPAGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASQGGEIGNNEQF,Genome polyprotein,Hepatitis C virus,I,,19,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRAGTSNTGELF,Genome polyprotein,Hepatitis C virus,I,,2,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRGGTINTGELF,Genome polyprotein,Hepatitis C virus,I,,9,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRPSGQLDEQF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRPTGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-2,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRSGTSNTGELF,Genome polyprotein,Hepatitis C virus,I,,10-3,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRSGTSNTGELF,Genome polyprotein,Hepatitis C virus,I,,2,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRTGISNTGELF,Genome polyprotein,Hepatitis C virus,I,,2,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRTGTSNTGELF,Genome polyprotein,Hepatitis C virus,I,,2,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASRWTGQLDEQF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSAGTINTGELF,Genome polyprotein,Hepatitis C virus,I,,9,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSEAGQLNEQF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSEVGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSFSGQLDTIYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSFTTMGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,10-3,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSIRDAGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,10-3,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLLGQLYEQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLSGQLDEQF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLSGQLDEQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLSGQLDTQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLVGQLDEQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLVGQLDEQYF,Genome polyprotein,Hepatitis C virus,I,,7-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLVGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLVGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-2,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLVGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSLVGQLYEQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSPGDTGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSPREIGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,10-3,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSPSGQLDEQF,Genome polyprotein,Hepatitis C virus,I,,7-3,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSPSGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSPSGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSPTGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-3,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSQSGQLDTQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSQTGQLDEQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSGATGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSGTIGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSGTINTGELF,Genome polyprotein,Hepatitis C virus,I,,9,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSGTVNTGELF,Genome polyprotein,Hepatitis C virus,I,,2,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSGVSGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSIATGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSLGQLETQYF,Genome polyprotein,Hepatitis C virus,I,,7-8,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSRGQLDTQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSSGQLDEQF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSSTDTGANVLTF,Genome polyprotein,Hepatitis C virus,I,,27,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSTGTSNTGELF,Genome polyprotein,Hepatitis C virus,I,,2,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSYRGQLNEQF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASSYVGQLDEQF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CASTTGTIGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,19,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
ATDALMTGY,A01:01,,CATTVGVIGNQPQHF,Genome polyprotein,Hepatitis C virus,I,,19,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
CINGVCWTV,A02:01,CAFMITGAGSYQLTF,CASSLQEWDPNYGYTF,Genome polyprotein,Hepatitis C virus,I,,,,1-2,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:26860370,5
CINGVCWTV,A02:01,CALSVVNQAGTALIF,CASSLVENTEAF,Genome polyprotein,Hepatitis C virus,I,,,,1-1,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:26860370,5
CINGVCWTV,A02:01,CAMREHTSGTYKYIF,CASSDSLVRGYQETQYF,Genome polyprotein,Hepatitis C virus,I,,,,1-3,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:26860370,5
CINGVCWTV,A02:01,CAVEDTGGFKTIF,CASSSSMESGNTIYF,Genome polyprotein,Hepatitis C virus,I,,,,1-3,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:26860370,5
HSKKKCDEL,B08:01,,CAIRAGGDEQF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-1,,TGTGCCATTCGAGCAGGGGGAGATGAGCAGTTCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAIRTGGDEQF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-1,,TGTGCCATTCGAACAGGGGGAGATGAGCAGTTCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAIRTRIGETQYF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-5,,TGTGCCATCAGAACAGGATCGGGGAGACCCAGTACTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAIRTRTGESYTF,Genome polyprotein,Hepatitis C virus,I,,10-3,,1-2,,TGTGCCATCAGGACTCGGACAGGGGAAAGCTACACCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISDEGRNTEAF,Genome polyprotein,Hepatitis C virus,I,,10-3,,1-1,,TGTGCCATCAGTGATGAGGGTCGGAACACTGAAGCTTTCTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISERHLTDTQYF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-3,,TGTGCCATCAGTGAGAGACACCTCACAGATACGCAGTATTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISESTGPGGDTQYF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-3,,TGTGCCATCAGTGAGTCAACCGGGCCAGGGGGAGATACGCAGTATTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISETDKLGF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-1,,TGTGCCATCAGTGAGACGGACAAGTTGGGGTTCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISEVQETQYF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-5,,TGTGCCATCAGTGAAGTCCAAGAGACCCAGTACTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISGGSGDNEQF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-1,,TGTGCCATCAGTGGCGGGAGCGGCGACAATGAGCAGTTCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISGGVRSTYNEQF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-1,,TGTGCCATCTCCGGGGGGGTAAGATCCTACAATGAGCAGTTCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISGMGQRDNEQF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-1,,TGTGCCATCAGTGGGATGGGACAACGCGACAATGAGCAGTTCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISSGTKSTEAF,Genome polyprotein,Hepatitis C virus,I,,10-3,,1-1,,TGTGCCATCAGTTCCGGGACGAAAAGCACTGAGGCTTTCTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAISVSGRSTDTQYF,Genome polyprotein,Hepatitis C virus,I,,10-3,,2-3,,TGTGCCATCAGTGTTTCAGGCCGATCCACAGATACGCAGTATTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSHRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGTCATCGACAGGGGGGCACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSHSRGSGNTIYF,Genome polyprotein,Hepatitis C virus,I,,4-1,,1-3,,TGCGCCAGCAGCCATAGCAGGGGCTCTGGAAACACCATATATTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSLRGRGDQPQHF,Genome polyprotein,Hepatitis C virus,I,,11-2,,1-5,,TGTGCCAGCAGCTTGAGGGGACGAGGAGATCAGCCCCAGCATTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSNRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCAATAGACAGGGTGGAACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPGPQRGGLETQYF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-5,,TGCGCCAGCAGCCCCGGCCCCCAGCGGGGGGGCTTAGAGACCCAGTACTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCCCACGACAGGGTGGAACCGGGGAGCTGTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCCCCAGACAGGGCGGCACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCCCCCGACAGGGAGGGACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCCCGAGACAGGGAGGAACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCCCTCGACAGGGAGGCACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSPRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGCCCTCGACAGGGGGGAACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSQGPPGLAQETQYF,Genome polyprotein,Hepatitis C virus,I,,4-1,,2-5,,TGCGCCAGCAGCCAAGGGCCGCCGGGACTAGCTCAAGAGACCCAGTACTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSQGPPGTTRETQYF,Genome polyprotein,Hepatitis C virus,I,,4-1,,2-5,,TGCGCCAGCAGCCAAGGACCTCCGGGAACAACCAGGGAGACCCAGTACTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSQSRGSGNTIYF,Genome polyprotein,Hepatitis C virus,I,,4-1,,1-3,,TGCGCCAGCAGCCAAAGCAGGGGCTCTGGAAACACCATATATTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSRLTVDRSDTGELF,Genome polyprotein,Hepatitis C virus,I,,4-1,,2-2,,TGCGCCAGCAGCCGACTGACCGTGGACAGGTCCGACACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSRRGATTSTDTQYF,Genome polyprotein,Hepatitis C virus,I,,11-2,,2-3,,TGTGCCAGCAGCCGGAGGGGGGCTACAACTAGCACAGATACGCAGTATTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSRRGRDDEKLF,Genome polyprotein,Hepatitis C virus,I,,11-2,,1-4,,TGTGCCAGCAGCCGCCGGGGAAGGGACGATGAAAAACTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSRRQGAMRETQYF,Genome polyprotein,Hepatitis C virus,I,,11-3,,2-5,,TGTGCCAGCAGCCGCCGACAGGGGGCAATGAGAGAGACCCAGTACTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CASSSRQGGTGELF,Genome polyprotein,Hepatitis C virus,I,,5-1,,2-2,,TGCGCCAGCAGTTCCCGACAGGGAGGGACCGGGGAGCTGTTTTTT,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
HSKKKCDEL,B08:01,,CAVRLMENYGYTF,Genome polyprotein,Hepatitis C virus,I,,10-3,,1-2,,TGTGCCGTCCGACTAATGGAGAACTATGGCTACACCTTC,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI,RNA,PMID:21160049,4
KAFSPEVIPMF,B57:01,CAASGGYQKVTF,CASSGQGYGYAF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAASGGYQKVTF,CATTGTYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAAYGGYQKVTF,CASSGQDYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAESGGYQKTVF,CASSGQSYGYAF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAESGGYQKVTF,CASSGQGGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAESGGYQKVTF,CATTGSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,30,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAESPGGKLIF,CASSREVYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAGSGGYQKVTF,CASSGGSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAGSGGYQKVTF,CASTGTAYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CALSGGYQKVTF,CASTGTDYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAMSGGYQKVTF,CASSGQNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAVSGGYQKVTF,CASSLTAPDTDAF,Gag p24,Human immunodeficiency virus (HIV),I,5,5-4,13,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAVSGGYQKVTF,CASTGGGYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,CAVSGTYQKVTF,CATTDTYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CAAGGQFYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CAGTGTAYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CANSSFLSSGETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,28,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASNSREVYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSATYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSGQEYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,6-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSGQLYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSGRNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSLAETSADGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,5-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSLAGTQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSLAGTQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSSFLSSGETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,28,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSSRQNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASSTSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,23,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASTDSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CASTGSGYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CATSDLGAGTSGTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,24,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:01,,CAWTGTNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,30,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAASLNSGGYQKVTF,CASSGTASFDEQF,Gag p24,Human immunodeficiency virus (HIV),I,,9,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAESTGNQF,CASSGQNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,49,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAESTGYQKVTF,CASTGGQYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,5,19,13,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRDPRSKIIF,CATSDLRGGKF,Gag p24,Human immunodeficiency virus (HIV),I,,24-1,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRDSVAAGNKLTF,CASSSLIRGLGNQPQHF,Gag p24,Human immunodeficiency virus (HIV),I,,28,,1-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMREGVNQGGKLIF,CASEAGNTIYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMREGVNQGGKLIF,CASSVGEGFDIQYF,Gag p24,Human immunodeficiency virus (HIV),I,,9,,2-4,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESISSGSARQLTF,CASSGTTSFDEQF,Gag p24,Human immunodeficiency virus (HIV),I,,9,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESISSGSARQLTF,CASSRQGFTF,Gag p24,Human immunodeficiency virus (HIV),I,,28,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESISSGSARQLTF,CSARPQGQTVALHF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,1-6,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESTSSGSARQLTF,CSARPGQGTVALHF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,1-6,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVAGANNLF,CASSESRMGSQANYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,25-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVSGANNLF,CASEDSSDGANYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVSGANNLF,CSARAGTKTYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVSGNNRLAF,CVSEDSSDGANYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVSGVNNLFF,CASSPDRARDGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVSGYNKLIF,CASSLGASISYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,14,7-8,4,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,CAMRESVSSGSARQLTF,CASSSWEGLDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-6,,2-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CAGSLSNGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSFLLDGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,5-4,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSGLGGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSGTSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSLAGGQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSLAGTHETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSLAGTQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSLVSNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,5-8,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSPRDSKETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,14,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSPYAGSEQF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSQLGQSTDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-6,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSQRQDSSYNEQF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSSAGTQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSSDRARDGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSWSGGQRGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASSYSDGNEAF,Gag p24,Human immunodeficiency virus (HIV),I,,6-6,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASTASYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,28,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CASTGGSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CATSGEGQGGPYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,15,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CSARLRDRGYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,29-1,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CSVEDPDRPSYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,29-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CSVKGQGDTELF,Gag p24,Human immunodeficiency virus (HIV),I,,29-1,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CVSSESRMGSQANYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,25-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57:03,,CVSSLAGTQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 3100,RNA,PMID:17121793,4
KAFSPEVIPMF,B57,,CAASTSAVLGKKGSQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CAIGGHDYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,10-3,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CALTGGDYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,6-5,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASEDFKNIQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-8,,2-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASGGEFYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSDGQGRLGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,11-2,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSDGTGVGLGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,11-2,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSELGATIYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSGFRDRVNEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSGPGGEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,28-1,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSLAGGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSLGGGQNGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSLGGGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSLTYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSPGQTNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSPMDLLDEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-6,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSPRDSQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,14,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSSGDETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,6-5,,2-5,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KAFSPEVIPMF,B57,,CASSSLVNTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,6-5,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSSMGGGTDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-6,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSSRTGGYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASSVVGDSRETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,9,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASYNFGQYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,5-1,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CATPGEVLSPNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CATSDRMDNEQF,Gag p24,Human immunodeficiency virus (HIV),I,,24,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CATSEAANTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,24-1,,2-2,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KAFSPEVIPMF,B57,,CSAREKGSQETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CSARGWVSNNRETQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIILGLNK,B27:05,,CASGGGTVYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-6,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASRPGLASNEQF,Gag p24,Human immunodeficiency virus (HIV),I,,4-3,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASRPGQGATEAF,Gag p24,Human immunodeficiency virus (HIV),I,,6-5,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSAGPGQYGNTIYF,Gag p24,Human immunodeficiency virus (HIV),I,,2,,1-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSARTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSEADFEAFF,Gag p24,Human immunodeficiency virus (HIV),I,,25-1,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSEDRDTEAFF,Gag p24,Human immunodeficiency virus (HIV),I,,9,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSGGRRAFF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSGGRRAF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSGGVFYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSGSNLEAF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,1-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLAGGDSYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLDRLEQF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLEGGANLF,Gag p24,Human immunodeficiency virus (HIV),I,,5-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLEGRYSNQPQHF,Gag p24,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLGTGKVEGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,7-6,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLLAGGTDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-4,,2-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLSGRWSTDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSLTNLGEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-4,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPEGPRAIEQF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPGQFSHEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,18,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPGTSTYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,4-3,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPGT-YEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,4-3,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPLGNSGNTIYF,Gag p24,Human immunodeficiency virus (HIV),I,,9,,1-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPLGVRAYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSPRTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSQARASHLIF,Gag p24,Human immunodeficiency virus (HIV),I,,7-8,,1-4,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSQGSGSGNTIYF,Gag p24,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSQRTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSQVLRGVYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,4-3,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSRATGELF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSRDSNEQF,Gag p24,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSRTTGELF,Gag p24,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSSPDRTYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,5-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSSSGGAGDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,28,,2-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASSVVRGNPNEQF,Gag p24,Human immunodeficiency virus (HIV),I,,6-4,,2-1,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CASTNRGSEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,21,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CATLGGFPDGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CATSETGTTLEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,15,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CATSRELTGGPSYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,15,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CSAPTTEVAGSTDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-3,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CSARDGGEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CSARDRGTREVADNYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CSARDRTRANYGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,20,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CSAREGLAGVLYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27:05,,CSAREGVEGYTF,Gag p24,Human immunodeficiency virus (HIV),I,,20-1,,1-2,,,human,PBMC,pathogen,"5'RACE,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:22683743,4
KRWIILGLNK,B27,,CASSFGQGAIEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,18,,2-7,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CASSGLAGLGQF,Gag p24,Human immunodeficiency virus (HIV),I,,12-3,,2-1,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CASSLEGGAALWDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,5-1,,2-3,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CASSLVLATEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CASSQDQTLYFMNTEAF,Gag p24,Human immunodeficiency virus (HIV),I,,4-1,,1-1,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CASSQDRMDRAGEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CASSQGQLGNTLYF,Gag p24,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIILGLNK,B27,,CATSRDGAGSNEKLF,Gag p24,Human immunodeficiency virus (HIV),I,,15,,1-4,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
KRWIIMGLNK,B27,,CASSLYGEYEQYF,Gag p24,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CASSQGTTDTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,6-6,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TPQDLNTML,B42,,CASSMIQGADTQYF,Gag p24,Human immunodeficiency virus (HIV),I,,19,,2-3,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:21752903,5
EIYKRWII,B08,,CAGSQEFLNRRYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASELSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASRLGRLAYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-5,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSADGSFYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,9,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSDNGGDRSPGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSEAGGTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-1,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSEPPGVRGEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,2,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSLGSAKNIQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSLLDGTRDQQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-8,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSLLPDPRSSGGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-2,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSLQQTLGAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,13,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSLSGSGWQETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSLVGQGARQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSPGGGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSPQQTLGAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,13,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSPSFPPDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSQDLRGARGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,14,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSQDSSGRVTGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-2,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSQGLAGDEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,3-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSQGLAGDEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,29,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSQGTGSTDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,14,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSSPGGVTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-6,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSTLGDSREKLF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,9,,1-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSTLRDSREKLF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,9,,1-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSTLTGEDSGPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-5,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSVEGTIHTDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSVEGTILTDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASSYSVVEAAAEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-6,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CASTGGRGSPLHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,13-6,,1-6,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CGSSVVGDSRETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,9,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CSAIVGSAYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,20,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CSALVEGDEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,20-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CSARDRADRVLIPDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,20-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CSASLGGRISGANVLTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,29,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CSASPVGGAYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
EIYKRWII,B08,,CSVDGPTGGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,29,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
GLNKIVRMY,B15,,CAISESGGRVDEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,10-3,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
GLNKIVRMY,B15,,CASSLDSGFLEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,11-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
GLNKIVRMY,B15,,CASSLQGAPEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-3,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
GLNKIVRMY,B15,,CASSPPSSYNEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
GLNKIVRMY,B15,,CTSRLDPGFLEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,11-3,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASRPGQGGYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASRSPLGYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-8,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASRTQRWETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSIQGLRATNEKLF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,1-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSLAQGWKTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSLGLDETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,13-2,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSQDRIHTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-8,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSSGTSGSAGYNEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSSSTGQQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
ISPRTL-W,B57:03,,CASSTNNEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KAFSPEVIPMF,B57,,CASPHPDRPNYGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CASRKGQGDWEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-5,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CASSIAGGGEDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-4,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CASSQWTGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CASTPPGF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,19,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CSARDPLPEASGGAGTDTQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,20-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
KRWIIMGLNK,B27,,CSARGWVSNNQETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,20-1,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
QASQEVKNW,B57,,CASRTQRWETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
QASQEVKNW,B57,,CASSKGRYNEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
QASQEVKNW,B57,,CASSLGYGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,28,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
QASQEVKNW,B57,,CASSQGPGERAGFNYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,3-1,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TPQDLNTML,B42:01,,CAGRASTGSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-5,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CAPTPEGGGQGQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASDKGTGNYGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASGLGANTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASRARRPSNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASRASTGSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-1,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASRDPYEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASRQEGGGDGQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-1,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSFGGTTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSFGLDEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSFSKNTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSHSKNTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLAFGTSGGEQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLATDGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-6,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLDPEKGAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLEGTSGPQETQYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,2-5,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLGANTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLGLNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLGPTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLGVNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLMGASGANVLTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-1,,2-6,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLNGADGYTF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLRHLASDYNSPLHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-1,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLSDVSWNTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-1,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLSFTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLSKNTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSLVFGTAGGQQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-5,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSPGNTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSQEGGGDGQPPHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-1,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSQEGGGDGQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-1,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSQEGGGEGQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,4-1,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSQEGGGGGQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSQGPTEAF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSREGYSNQPQHF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSSAITGMGDSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,27,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSSQTSGLFANTGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSSTITGMGDSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSSTITGMGVSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-1,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSVGPNEQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4 ,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CASSWTETGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,5-5,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CATHAGTGELF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,6-2/3,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CSVRTHQGPTNEKLF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,29-1,,1-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CTSSLVFGTAGGRQF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,12-3/4,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPQDLNTML,B42:01,,CTSSSTITGMGDSGNTIYF,Gag polyprotein,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASGAAMNTEAF,,Human immunodeficiency virus (HIV),I,,9-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASGLAVPVDGYTF,,Human immunodeficiency virus (HIV),I,,12-5,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASGLGPLTGLGPEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASNPVFAAGGETQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASRGADTGELF,,Human immunodeficiency virus (HIV),I,,7-3,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASRGGPLTEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASRPPDTGELF,,Human immunodeficiency virus (HIV),I,,7-3,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASRRDRDMNTEAF,,Human immunodeficiency virus (HIV),I,,7-2,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASRRGSTYNEQF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASRSPDTGELF,,Human immunodeficiency virus (HIV),I,,7-3,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSFDKGYEQYF,,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSFTRQSPYNEQF,,Human immunodeficiency virus (HIV),I,,5-5,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLAGQGNGYTF,,Human immunodeficiency virus (HIV),I,,7-8,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGADQPQHF,,Human immunodeficiency virus (HIV),I,,27-1,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPAAGYTF,,Human immunodeficiency virus (HIV),I,,6-2/3,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPAIPGNTIYF,,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPLTGLGPEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPRYEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPTVPG-IYF,,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPTVPGNTIYF,,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPTVQGNYGYTF,,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLGPVEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSLSRTGFYEQYF,,Human immunodeficiency virus (HIV),I,,5-5,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSQDRTSGNTIYF,,Human immunodeficiency virus (HIV),I,,3-1,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSQEGWDGRYEQYF,,Human immunodeficiency virus (HIV),I,,14,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSQENRQGRYEQYF,,Human immunodeficiency virus (HIV),I,,14,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSRGNTIYF,,Human immunodeficiency virus (HIV),I,,2,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSSFRDGGTDTQYF,,Human immunodeficiency virus (HIV),I,,5-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSSTRQSPYNEQF,,Human immunodeficiency virus (HIV),I,,5-5,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSSTWGTGELF,,Human immunodeficiency virus (HIV),I,,11-3,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASSTTTGNTEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CASTLDRLAF,,Human immunodeficiency virus (HIV),I,,6-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CATRGRGSEETQYF,,Human immunodeficiency virus (HIV),I,,24-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CGASRTSGEETQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSAADRASGIEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSARGGTSIFYTF,,Human immunodeficiency virus (HIV),I,,20-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSARRFPEAF,,Human immunodeficiency virus (HIV),I,,20-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATARQGGMEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATDRASGIEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATDRDGGLEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATDRDGGPEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATGRESGIEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATHRDRGLEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATNRDRGLEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATRRDRGLEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRAGDNEQF,,Human immunodeficiency virus (HIV),I,,20-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRASAIEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRDGDNEQF,,Human immunodeficiency virus (HIV),I,,20-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRDRALEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRDRGLEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRDSALEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRQGGLEQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRQGGREQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
HPKVSSEVHI,B42:01,,CSATSRRGGREQYF,,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CAGSLALRLADQETQYF,,Human immunodeficiency virus (HIV),I,,7-3,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CAIRTSGDYEQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASALEQGGYNEQF,,Human immunodeficiency virus (HIV),I,,9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASGDSGDEQF,,Human immunodeficiency virus (HIV),I,,5-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASGLALRGGDQETQYF,,Human immunodeficiency virus (HIV),I,,2,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASLEGGSYTF,,Human immunodeficiency virus (HIV),I,,7-2,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASRGSGVYEQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASRGTGVHEQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASRTGGEETQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASRTSGDYEQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASRTSGEETQYF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASRTSGGHEQF,,Human immunodeficiency virus (HIV),I,,6-2/3,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSDNPLVGGFTDMQYF,,Human immunodeficiency virus (HIV),I,,29-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSEDKGGADTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSEDKGGGDTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSFLTGARSKNIQYF,,Human immunodeficiency virus (HIV),I,,5-4,,2-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSLALRGGDQETQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSLDPRMNTEAF,,Human immunodeficiency virus (HIV),I,,11-2,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSLVDPTGFGLETQYF,,Human immunodeficiency virus (HIV),I,,5-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSPRDFSPTDTQYF,,Human immunodeficiency virus (HIV),I,,14,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGADEQF,,Human immunodeficiency virus (HIV),I,,9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGADTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGPDTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGTDAQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGTDEQF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGTDTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CASSVDKGGVDEQF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CATSDSYEQYF,,Human immunodeficiency virus (HIV),I,,24-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CRASSSLRGTAADTQYF,,Human immunodeficiency virus (HIV),I,,7-2,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CSAREDEGWGGYTF,,Human immunodeficiency virus (HIV),I,,20-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CSDDGGQEGYGYTF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CSVEEETNYGYF,,Human immunodeficiency virus (HIV),I,,29-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CSVEGMRDYGYTF,,Human immunodeficiency virus (HIV),I,,29-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CSVEGMREYGYTF,,Human immunodeficiency virus (HIV),I,,29-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CTSSEDKGGGDTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
IIKDYGKQM,B42:01,,CVSSVDKGGTDTQYF,,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASEIGNSGQETQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASGHGMGASTSGYTF,,Human immunodeficiency virus (HIV),I,,4-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASIPNLGNEQF,,Human immunodeficiency virus (HIV),I,,5-5,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASRDGQGHEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASRDRQSHEQYF,,Human immunodeficiency virus (HIV),I,,6-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSASVIAGKLF,,Human immunodeficiency virus (HIV),I,,6-1,,1-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSDRQSLVQF,,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSFPQNTEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSFTSGVITGELF,,Human immunodeficiency virus (HIV),I,,7-9,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSGMNTEAF,,Human immunodeficiency virus (HIV),I,,5-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSHGMGASTSGYTF,,Human immunodeficiency virus (HIV),I,,4-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSKPLYEQYF,,Human immunodeficiency virus (HIV),I,,7-8,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSLAQSREQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSLAQSRERYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSLVGPPGEAF,,Human immunodeficiency virus (HIV),I,,5-5,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSLVGPPGELF,,Human immunodeficiency virus (HIV),I,,5-5,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSLVQSREQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSLWGAKMNTEAF,,Human immunodeficiency virus (HIV),I,,7-8,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPGQGQEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPGQGREQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPIQGSEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRDRDFNYGYTF,,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRQGHEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRQGKEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRQGKEQF,,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRQGLEGANVLTF,,Human immunodeficiency virus (HIV),I,,7-9,,2-6,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRQGQEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSPRTGGTEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSRSGLYEQYF,,Human immunodeficiency virus (HIV),I,,5-5,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSKDGQSQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSLGPPGEQYF,,Human immunodeficiency virus (HIV),I,,6-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSRDGQEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSRGGQEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSRQGKEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSRQGKEQYF,,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSRQSKEAF,,Human immunodeficiency virus (HIV),I,,7-9,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSSVGPPGELF,,Human immunodeficiency virus (HIV),I,,5-5,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSVSAIYNEQF,,Human immunodeficiency virus (HIV),I,,6-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CASSWTGPPGEQF,,Human immunodeficiency virus (HIV),I,,5-5,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CATSRSGLAGKDTQYF,,Human immunodeficiency virus (HIV),I,,15,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CSARGLGVNTEAF,,Human immunodeficiency virus (HIV),I,,20-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CTSSDRQSLVQF,,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CVSSDRQSLVQF,,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
LPPIVAKEI,B42:01,,CVSSLVGPPGELF,,Human immunodeficiency virus (HIV),I,,5-5,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
RFPLTFGWCF,A24:02,,CASSAGYNEQF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,27,,2-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSARAGTSGAGELF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,7-9,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSASGQQPYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,25-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSDF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,6-1,,1-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSDIGQGAIEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,6-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSESIGGRDNNQPQHF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,10-2,,1-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSFRPGLAVTGELF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,6-1,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSHTTGLYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLDETGGYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLEQFTDEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,5-5,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLGQGEETQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,12-3,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLIVQGWYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,7-8,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLRDRVPETQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,7-9,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLRDSVPETQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,7-9,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLSTGRGTYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,28,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSLTGETQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,5-4,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSPGQGIYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSPQKGIYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSPTQGIYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSQLAGVYEQF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSQLSGGTYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSQTSGGTYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CASSSYYRSGNTIYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CATSRASGGTYEQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,15,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CATWDMSSYNSPLHF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,21,,1-6,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RFPLTFGWCF,A24:02,,CTSVPAVRSQRDRGQETQYF,Nef138-10(2F),Human immunodeficiency virus (HIV),I,,6-5,,,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CARRTSGRETQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,2,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASGRTSGIYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,20,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASRIDGSSYNEQF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,6-1,,2-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSDFGQGDEAF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,6-1,,1-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSDIGQGAIEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,6-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSDIGRGVHEQF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,6-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSESTGGRDNNQPQHF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,10-2,,1-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSFGSNLYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,5-4,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSFRPGLAVTGELF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,6-1,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSGTGIYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSHTTGLYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLEISTGELF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,5-1,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLEQFTDEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,5-5,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLGGGGTDTQF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLMKAGDGYGYTF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,28,,1-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLRDRVPETQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,7-9,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLSTGRGTYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,28,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLVEGTGWEQF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSPGQGIYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSPQKGIYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSPTAGIYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSPTQGIYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSPTSGGTYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSQGWFAASVQPQHF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,1-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSQLAGVYEQF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSQLSGGTYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSQTSGGTYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSRTSGGSYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,4-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSSDTGTGGLINGYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,11-2,,1-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSSEVLAEAF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,5-5,,1-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSSYYRSGNTIYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSTGAGTGTPTLF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,19,,1-3,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSTGGEQF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,27,,2-1,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSYDRSYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,11-2,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CATSDPDREVEETQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,24,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CATSRASGGTYEQYF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,15,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CATWDMSSYNSPLHF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,21,,1-6,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CAWGNPGLNTGELF,Nef138-10(wt),Human immunodeficiency virus (HIV),I,,30,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLRDSVPETQYF,Nef138-11(wt),Human immunodeficiency virus (HIV),I,,7-9,,2-5,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSSWDTGELF,Nef138-12(wt),Human immunodeficiency virus (HIV),I,,7-9,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSDAQTGTVLNYGYTF,Nef138-13(wt),Human immunodeficiency virus (HIV),I,,6-1,,1-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSASGQQPYEQYF,Nef138-14(wt),Human immunodeficiency virus (HIV),I,,25-1,,2-7,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSLELSTGELF,Nef138-15(wt),Human immunodeficiency virus (HIV),I,,5-1,,2-2,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
RYPLTFGWCF,A24:02,,CASSPPGLNTQYF,Nef138-16(wt),Human immunodeficiency virus (HIV),I,,4-2,,2-3,,,human,PBMC,pathogen,"SMART,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",ABI 377,RNA,PMID:19279440,9
KRWIILGLNK,B27:05,,CAISEYGASPLHF,p24 KK10,Human immunodeficiency virus (HIV),I,,10-3,,1-6,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CARREANYGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,20-1,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASAMTGEGYGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASMGGANTEAF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASRLLGGGQETQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-6,,2-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSEGAYEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSFGQGAIEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,18,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSGGAHTEAF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSGQLLEAF,p24 KK10,Human immunodeficiency virus (HIV),I,,6-1,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLDHLAGVNNEQF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-6,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLDSYEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLEGSRNTEAF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-8,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLGGLDIEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,18,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLGGTNHGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-6,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLGIPGTAQWVYGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,28,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLRGGNTDTQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,28,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLSSDEHGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLVGSYNEQF,p24 KK10,Human immunodeficiency virus (HIV),I,,12-4,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSLVLAIEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSMGQNSNEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSPGQFGNTIYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSPGQLGNTIYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSPGTGKNIQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,9,,2-4,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSPGVFGVTQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSPGVLGNTIYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSPTTYGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQAQGLSNSPLHF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-6,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQDGVYSNQPQHF,p24 KK10,Human immunodeficiency virus (HIV),I,,3-1,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQEGVNTEAF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-1,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQGLSSNEQF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQGQLGNTIYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQGQYGNEQF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSQPPDRGYGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,11-2,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSRTQGPNTDTQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,5-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSSKTGELF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSSRTGELF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSSTRGTEAF,p24 KK10,Human immunodeficiency virus (HIV),I,,7-2,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSTTSGRYEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,12-4,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CASSVLGTSGGAEQF,p24 KK10,Human immunodeficiency virus (HIV),I,,9,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CATSETGELF,p24 KK10,Human immunodeficiency virus (HIV),I,,24-1,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CATSGVTGELF,p24 KK10,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CAWSLTGMNQPQHF,p24 KK10,Human immunodeficiency virus (HIV),I,,30,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CSARDLGLAGDTDTQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,20-1,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CSARDWASGLSSYEQYF,p24 KK10,Human immunodeficiency virus (HIV),I,,20-1,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIILGLNK,B27:05,,CSARREANYGYTF,p24 KK10,Human immunodeficiency virus (HIV),I,,20-1,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIIMGLNK,B27:05,,CASSPGQLGNTIYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
KRWIIMGLNK,B27:05,,CASSQGQLGNTIYF,p24 KK10,Human immunodeficiency virus (HIV),I,,4-3,,1-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,DNA,PMID:21734237,4
FLKEKGGL,B08,,CAIRPFLGQDDNYGYTF,Protein Nef,Human immunodeficiency virus (HIV),I,,10-3,,1-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASKEELSNTGELF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-2,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASRGGSGELF,Protein Nef,Human immunodeficiency virus (HIV),I,,2,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASSELGARVYEQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASSESSREVSYNSPLHF,Protein Nef,Human immunodeficiency virus (HIV),I,,10-1,,1-6,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASSFIPGQGTHYSNQPQHF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-2,,1-5,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASSLRGTGELF,Protein Nef,Human immunodeficiency virus (HIV),I,,28,,2-2,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASSQEMNRVVGNEQF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-1,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CASTRPGQGTYNEFQF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-9,,2-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FLKEKGGL,B08,,CSVGDQGGSEQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,29-1,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TPGPGVRYPL,B42:01,,CASMGLVGGTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,19,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASRKGIQETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,27,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASRLLGPSTFFYGYTF,Protein Nef,Human immunodeficiency virus (HIV),I,,7-9,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASRPIGGAQETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASRRGFHQPQHF,Protein Nef,Human immunodeficiency virus (HIV),I,,27,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSESGRGDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,10-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSGRDTSTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSLASDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,7-9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSLSPTEAF,Protein Nef,Human immunodeficiency virus (HIV),I,,14,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSLSRQGTGELF,Protein Nef,Human immunodeficiency virus (HIV),I,,27,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPNTIANEQF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPPIPGTADTIYF,Protein Nef,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPRETRTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPRGGGETQHF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-4,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPRGGGETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-4,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPRGTRTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSPVGRGTEAF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-3,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQAASGNTIYF,Protein Nef,Human immunodeficiency virus (HIV),I,,14,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQDRATQETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQEGRRDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQEGRRDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-3,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQFTGTQETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-3,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQRGADTEAF,Protein Nef,Human immunodeficiency virus (HIV),I,,14,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSQYRATQETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-3,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSTFGATQEIQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSTFGATQETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSVAGGQVTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSVSGGQVTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSVVGGGAADTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSVWGDPSYEQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSYRVTEAF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-2/3,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSYSRAPKLENIQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-2/3,,2-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSYSRTDLKNIQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-2/3,,2-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSYYSGGSSYNEQF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-2/3,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASSYYSGGTTYNEQF,Protein Nef,Human immunodeficiency virus (HIV),I,,6-2/3,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASTTAADTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,7-9,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CASYRSDRPTEAF,Protein Nef,Human immunodeficiency virus (HIV),I,,14,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CATSERGGMETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,15,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CATSPRGGAVEQF,Protein Nef,Human immunodeficiency virus (HIV),I,,15,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CPSSPRGGGETQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,5-4,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CSAPEPTSGRWSGELF,Protein Nef,Human immunodeficiency virus (HIV),I,,20-1,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TPGPGVRYPL,B42:01,,CSVKLTEFGYTF,Protein Nef,Human immunodeficiency virus (HIV),I,,29-1,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
TQGYFPDWQNY,B57:03,,CAISECAIRGTSGLTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,10-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TQGYFPDWQNY,B57:03,,CAISERAIRGTSGLTDTQYF,Protein Nef,Human immunodeficiency virus (HIV),I,,10-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TQGYFPDWQNY,B57:03,,CAISERAIRGTSGLTDTQYLF,Protein Nef,Human immunodeficiency virus (HIV),I,,10-3,,2-3,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TQGYFPDWQNY,B57:03,,CASSLAPGGIAF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-2,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TQGYFPDWQNY,B57:03,,CASSQAAGGRAF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-2,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TQGYFPDWQNY,B57:03,,CASSQAAGGRAIF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-2,,1-1,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
TQGYFPDWQNY,B57:03,,CASSQAEGGQNHF,Protein Nef,Human immunodeficiency virus (HIV),I,,4-2,,2-7,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,ABI 3130XL,RNA,PMID:21562156,4
FPRPWLHGL,B42:01,,CAGSEGRDQETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,16-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CAGSLWSGIADTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CANSIKGYNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CANSLYTGSDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASKLYTGGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASQLYSGGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASRGTGESPLHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,14-1,,1-6,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASRLYSGGDKEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASRSGRTNEKLF,Protein Vpr,Human immunodeficiency virus (HIV),I,,6-5,,1-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSEGRDQETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,16-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSFRQGLGHTGELF,Protein Vpr,Human immunodeficiency virus (HIV),I,,28,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSFYPTDEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,5-4,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSHLDSGLAVDTEAF,Protein Vpr,Human immunodeficiency virus (HIV),I,,5-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSIKGYNELF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSIKGYNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSIKGYNERF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSIQTGNSPLHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,1-6,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSIQTVNSPLHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,1-6,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSKDRGTDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-3,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLEAPTDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,5-1,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLEGVPVEF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLERSSEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-6,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLFGSPEQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLFGSPGQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLFSGASQTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLFSGGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLFSGGEETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLFSGPSQTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWAGETEAF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWAGGPETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWAGGSNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWAGPSNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWAGVSDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWDQETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGASNEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGDFSQEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGDFSQERF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGGDREQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGGFSQEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGIADTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-9,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGPTNEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWGGSSNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWPGASNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWSGASNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWSGGADTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWSGIADTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWSGRADTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLWSGVGDGYTF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYAGPDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYGGGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYGGGEQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYGGPEQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYGRGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYGSPDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYHSPTDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYLAPNEKLF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-4,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGADQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGAEQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGGDKEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGGGQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGLDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGPDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYSGYDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYTGGDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSLYTGSDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSPARGTDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-7,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSPISDRSGNTIYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-9,,1-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSQDHGGGTEAF,Protein Vpr,Human immunodeficiency virus (HIV),I,,4-1,,1-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSQDMKGGSFTGELF,Protein Vpr,Human immunodeficiency virus (HIV),I,,4-1,,2-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSQDRGPDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,4-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSQDRREQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,14,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSQEGGPAEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,4-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSQGQSSYEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,3-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSSVDRNSYEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-9,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSSVDRSSYEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CASSVFGGPDQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CATRDRDRENQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,24-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CATSRDRETGGDYGYTF,Protein Vpr,Human immunodeficiency virus (HIV),I,,15,,1-2,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CSAGDWANNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,29-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CSARGGQLQETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,20-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CSARTYAGGTDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,20-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CSGGGYGSGTYEQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,29-1,,2-7,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CSVAGTGMTDTQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,29-1,,2-3,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CSVEDSLVNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,29-1,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CTSSEGRDQETQYF,Protein Vpr,Human immunodeficiency virus (HIV),I,,16-1,,2-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CTSSIKGYNEQF,Protein Vpr,Human immunodeficiency virus (HIV),I,,19,,2-1,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
FPRPWLHGL,B42:01,,CVSSLFGSPEQPQHF,Protein Vpr,Human immunodeficiency virus (HIV),I,,7-2,,1-5,,,human,PBMC,pathogen,"anchored RT-PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25911754,4
RYPLTFGWCF ,A24:02,CAALNDYKLSF,,RF10,Human immunodeficiency virus (HIV),I,13-1*02,,20*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CAEVSTGGGNKLTF,,RF10,Human immunodeficiency virus (HIV),I,13-2*01,,10*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CALGELLRGGSNYKLTF,,RF10,Human immunodeficiency virus (HIV),I,,,53*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CALGELSGTGGFKTIF,,RF10,Human immunodeficiency virus (HIV),I,,,9*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CAVSCLRNNAGNMLTF,,RF10,Human immunodeficiency virus (HIV),I,8-6*02,,39*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CAVWYYGNNRLAF,,RF10,Human immunodeficiency virus (HIV),I,21*02,,7*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CFLGSYGGATTKLIF,,RF10,Human immunodeficiency virus (HIV),I,40*01,,32*02,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CIVYGGSQGNLIF,,RF10,Human immunodeficiency virus (HIV),I,26-1*01,,42*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CPFYNQGGKLIF,,RF10,Human immunodeficiency virus (HIV),I,25*01,,23*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,CVVNSGAGSYQLTF,,RF10,Human immunodeficiency virus (HIV),I,26-1*01,,,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF ,A24:02,,CASKGTVTGELFF,RF10,Human immunodeficiency virus (HIV),I,,19*01,,2-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASLPSVGKGAYEQYF, RF10,Human immunodeficiency virus (HIV),I,,28*01,,2-7*01 ,2*02 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF ,A24:02,,CASSAPRETQYF,RF10,Human immunodeficiency virus (HIV),I,,25-1*01,,2-5*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF ,A24:02,,CASSDFSKGTDTQYF,RF10,Human immunodeficiency virus (HIV),I,,6-1*01,,2-3*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF ,A24:02,,CASSDVGQGSSNYGYTF,RF10,Human immunodeficiency virus (HIV),I,,6-1*01,,1-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF ,A24:02,,CASSEGF,RF10,Human immunodeficiency virus (HIV),I,,6-1*01,,2-1*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSETGGTYEQYF,RF10,Human immunodeficiency virus (HIV),I,,6-1*01,,2-7*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSIDPPGLADNEQFF,RF10,Human immunodeficiency virus (HIV),I,,19*01,,2-1*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSISAGEGVPEQYF,RF10,Human immunodeficiency virus (HIV),I,,19*01,,2-7*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSLESLGLASVDEQFF,RF10,Human immunodeficiency virus (HIV),I,,28*01,,2-1*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSLGRDRPTPYEQYF,RF10,Human immunodeficiency virus (HIV),I,,11-2*01,,2-7*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSLMGLAGVPGELF,RF10,Human immunodeficiency virus (HIV),I,,28*01,,2-2*01 ,2*02 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF ,A24:02,,CASSLRPGRANTGELFF,RF10,Human immunodeficiency virus (HIV),I,,28*01,,2-2*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSLVSGRGNEQFF,RF10,Human immunodeficiency virus (HIV),I,,7-9*03,,2-1*01 ,2*02 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSPGSGELGAGELFF,RF10,Human immunodeficiency virus (HIV),I,,7-9*03,,2-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSPSTGKGNQPQHF,RF10,Human immunodeficiency virus (HIV),I,,28*01,,1-5*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSPVAGVYEQYF,RF10,Human immunodeficiency virus (HIV),I,,4-1*01,,2-7*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSQRDRGTDTEAFF,RF10,Human immunodeficiency virus (HIV),I,,4-1*01,,1-1*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSQSPGQGVGEQFF,RF10,Human immunodeficiency virus (HIV),I,,4-1*01,,2-1*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSQSRQGAQPQHF,RF10,Human immunodeficiency virus (HIV),I,,23-1*01,,1-5*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSSLGQGAPEAFF,RF10,Human immunodeficiency virus (HIV),I,,3-1*01,,1-1*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSSPGQGYGYTF,RF10,Human immunodeficiency virus (HIV),I,,28*01,,1-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSTALRTGNYGYTF,RF10,Human immunodeficiency virus (HIV),I,,19*01,,1-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSYDRGYEQYF,RF10,Human immunodeficiency virus (HIV),I,,11-2*03,,2-7*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSYDRSYEQYF,RF10,Human immunodeficiency virus (HIV),I,,11-2*01,,2-7*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSYSHRLGLHEQYF,RF10,Human immunodeficiency virus (HIV),I,,6-2*01,,2-7*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASSYSIGTGVNNYGYTF,RF10,Human immunodeficiency virus (HIV),I,,6-6*01,,1-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGWCF,A24:02,,CASTSF,RF10,Human immunodeficiency virus (HIV),I,,28*01,,2-1*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,CALFLDGQKLLF,,RW8,Human immunodeficiency virus (HIV),I,9-2*01,,16*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,CAVIFTGGGNKLTF,,RW8,Human immunodeficiency virus (HIV),I,8-1*01,,10*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,CAVPVPGTYKYIF,,RW8,Human immunodeficiency virus (HIV),I,12-2*02,,40*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,CAVSDEVIF,,RW8,Human immunodeficiency virus (HIV),I,8-4*03,,30*01,,,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW ,A24:02,,CASSDTSGANTGELFF,RW8,Human immunodeficiency virus (HIV),I,,7-9*07,,2-2*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CASSIRDRVPETQYF,RW8,Human immunodeficiency virus (HIV),I,,7-9*07,,2-5*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CASSLAVRGLSGDPFF,RW8,Human immunodeficiency virus (HIV),I,,11-3*01,,2-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CASSLTSGANTGELFF,RW8,Human immunodeficiency virus (HIV),I,,7-9*03,,2-2*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CASSPRDKPNYGYTF,RW8,Human immunodeficiency virus (HIV),I,,7-9*03,,1-2*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CASSQPTGREQYF,RW8,Human immunodeficiency virus (HIV),I,,3-1*01,,2-7*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CASSQRDSQETQYF,RW8,Human immunodeficiency virus (HIV),I,,7-9*03,,2-5*01 ,1*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CSARDPIRLISYEQYF,RW8,Human immunodeficiency virus (HIV),I,,20-1*02,,2-7*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
RYPLTFGW,A24:02,,CSARDPVSTYEQYF,RW8,Human immunodeficiency virus (HIV),I,,20-1*01,,2-7*01 ,2*01 ,,human,PBMC,pathogen,"5'RACE,Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",HKL2000,RNA,PMID:24899498,9
CVETMCNEY,A-B18,,CASGGADMKTEAFF,IE1,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
CVETMCNEY,A-B18,,CASSLARNQPQHF,IE1,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
DEEDAIAAY,A-B18,,CASSPGGGKETQYF,IE1,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ELKRKMIYM,A-B18,,CASSDGTAYEQYF,IE1,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ELKRKMIYM,A-B18,,CASSLLMATNEKLFF,IE1,CMV,I,,28*01,,1-4*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ELKRKMIYM,A-B18,,CASSQAVASGGGRSEQFF,IE1,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ELKRKMIYM,A-B18,,CASSYRANYEQYF,IE1,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ELKRKMIYM,A-B18,,CASVTGSTDTQYF,IE1,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ELRRKMMYM,A-B08:01,,CAISEFGLAGSDEQFF,IE1,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
ELRRKMMYM,A-B08:01,,CASSFNGPNTEAFF,IE1,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
ELRRKMMYM,A-B08:01,,CASSLFDGTGSTEAFF,IE1,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
ELRRKMMYM,A-B08:01,,CASSLTQGANTEAFF,IE1,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
ELRRKMMYM,A-B08:01,,CASSLYEEVLLSYNEQFF,IE1,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
ELRRKMMYM,A-B08:01,,CASSQGGSYNEQFF,IE1,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
ELRRKMMYM,A-B08,,CAENMGYGNKLVF,IE1,CMV,I,,TRAV13-2*01,,TRAJ47*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
ELRRKMMYM,A-B08,,CAVNKGYGQNFVF,IE1,CMV,I,,TRAV12-2*01,,TRAJ26*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
ELRRKMMYM,A-B08,,CASSPAGISYNSPLHF,IE1,CMV,I,,7-9*03,,1-6*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
ELRRKMMYM,A-B08,,CASSYSGQGSAAGETQYF,IE1,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
LSEFCRVLCCYVLEE,A02:01,,CASSFATGTAYGYTF,IE1,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,DNA,PMID:19776383,5
LSEFCRVLCCYVLEE,A02:01,,CASSNPQGAKYEQFF,IE1,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,DNA,PMID:19776383,5
LSEFCRVLCCYVLEE,A-A02:01,,CASSFATGTAYGYTF,IE1,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
LSEFCRVLCCYVLEE,A-A02:01,,CASSNPQGAKYEQFF,IE1,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
QIKVRVDMV,A-B08:01,,CASSGVEGITVNTEAFF,IE1,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CASSLKPGLSIDTQYF,IE1,CMV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CASSLKPGLSIDTQYF,IE1,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CASSPTPGQRNGYTF,IE1,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CASSRAGAYNEQFF,IE1,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CASSRLAGADTQYF,IE1,CMV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CASSRLAGADTQYF,IE1,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08:01,,CATSVPSGRSYNEQFF,IE1,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
QIKVRVDMV,A-B08,,CAASSYGQNFVF,IE1,CMV,I,,TRAV23/DV6*01,,TRAJ26*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CAFMTLRGNTGTASKLTF,IE1,CMV,I,,TRAV38-1*01,,TRAJ44*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CATAQVYSGGGADGLTF,IE1,CMV,I,,TRAV17*01,,TRAJ45*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CAVNDYGQNFVF,IE1,CMV,I,,TRAV1-1*01,,TRAJ26*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CAVRDSSYSGAGSYQLTF,IE1,CMV,I,,TRAV3*01,,TRAJ28*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CAVSDYGQNFVF,IE1,CMV,I,,TRAV21*01,,TRAJ26*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CVGNSYGQNFVF,IE1,CMV,I,,TRAV12-1*01,,TRAJ26*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSGEGAKTTNTEAFF,IE1,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:19776383,4
QIKVRVDMV,A-B08,,CASSLRVNTEAFF,IE1,CMV,I,,7-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSRLAANTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSRLAASTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSRLAGASTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSRLAGGTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSRLAGNTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSRLSSNTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
QIKVRVDMV,A-B08,,CASSSTQGKVYEQYF,IE1,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:19776383,4
QIKVRVKMV,A-B08:01,,CARNATGNYGYTF,IE1,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASKWTSGGPNTGELFF,IE1,CMV,I,,10-1*01,,2-2*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASKWTSGGPNTGELFF,IE1,CMV,I,,10-1*01,,2-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASRRRESHAYEQYF,IE1,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSESEQGYTGELFF,IE1,CMV,I,,6-1*01,,2-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSGGQGRTMNTEAFF,IE1,CMV,I,,10-1*01,,1-1*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSLEGFTDTQYF,IE1,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSLGVSEPQHF,IE1,CMV,I,,18*01,,1-5*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSLGWEYNEQFF,IE1,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSLSRGAYEQYF,IE1,CMV,I,,6-5*01,,2-7*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSLTQGLAGVEQYF,IE1,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSLWGALYEQYF,IE1,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSPGGQGGQPQHF,IE1,CMV,I,,4-2*01,,1-5*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSRLAGGTGELFF,IE1,CMV,I,,7-3*01,,2-2*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSRLAGGTGELFF,IE1,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSRLAGGTGELFF,IE1,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23267020,4
QIKVRVKMV,A-B08:01,,CASSRLAGSTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSRLAGSTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSRLAGSTDTQYF,IE1,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23267020,4
QIKVRVKMV,A-B08:01,,CASSSGTSGYEQYF,IE1,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSSREVTGELFF,IE1,CMV,I,,5-1*01,,2-2*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSSREVTGELFF,IE1,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CASSYGPVETEAFF,IE1,CMV,I,,6-6*01,,1-1*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CSGVVGRGAYNEQFF,IE1,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CSGWGGTRDHGYTF,IE1,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CSVDRHSYNEQFF,IE1,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CSVEESGLAGNTGELFF,IE1,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
QIKVRVKMV,A-B08:01,,CSVGRDRDHGYTF,IE1,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
VLEETSVML,A-A02:01,,CASKWGRDLWQPQHF,IE1,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VLEETSVML,A-A02:01,,CASSLDSIASGNTIYF,IE1,CMV,I,,5-1*01,,1-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
VLEETSVML,A-A02:01,,CASSLDSQSSGNTIYF,IE1,CMV,I,,5-1*01,,1-3*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VLEETSVML,A-A02:01,,CASSLDSQSSGNTIYF,IE1,CMV,I,,5-1*01,,1-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
VLEETSVML,A-A02:01,,CASSLQRGRTDTQYF,IE1,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23637823,4
VLEETSVML,A-A02:01,,CASSLQRGRTDTQYF,IE1,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23028307,4
VLEETSVML,A-A02:01,,CASSLVSGGWTEAFF,IE1,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VLEETSVML,A-A02:01,,CASSPVGGSMAKNIQYF,IE1,CMV,I,,3-1*01,,2-4*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VLEETSVML,A-A02:01,,CASSPVGGSMAKNIQYF,IE1,CMV,I,,3-1*01,,2-4*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:23267020,4
VLEETSVML,A-A02:01,,CASSQETDLRSQPQHF,IE1,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VLEETSVML,A-A02:01,,CASSVRQEPYNEQFF,IE1,CMV,I,,7-8*01,,2-1*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
VLEETSVML,A-A02:01,,CASSVRQEPYNEQFF,IE1,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
VLEETSVML,A-A02:01,,CSVGQGATEQYF,IE1,CMV,I,,29-1*01,,2-7*01,,,human,LN,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
VLEETSVML,A-A02:01,,CSVGQGATEQYF,IE1,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"RACE,selection of antigen- specific t cells using peptide-mhc multimers ",Roche 454,RNA,PMID:25339770,4
YILEETSVM,A-A02:01,,CASSLVGGTGSVSYQFF,IE1,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
YILEETSVM,A-A02:01,,CASSVDGTGGALGNTIYF,IE1,CMV,I,,9*01,,1-3*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
YILEETSVM,A-A02:01,,CAWSWGDSTNSPLHF,IE1,CMV,I,,30*01,,1-6*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:10756006,5
ARNLVPMVATVQGQN,A02:01,,CASSYNSAGYNEQFF,p65,CMV,I,,6-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,DNA,PMID:19776383,5
ARNLVPMVATVQGQN,A02:01,,CASTDGQKNSPLHF,p65,CMV,I,,6-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,DNA,PMID:19776383,5
ARNLVPMVATVQGQN,A02:01,,CATESTGIGGYTF,p65,CMV,I,,25-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,DNA,PMID:19776383,5
CPSQEPMSIYVY,B35:08,CAVRPSGGSYIPTF,,p65,CMV,I,8-6*02,,6*01,,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,CAVSANYGGSQGNLIF,,p65,CMV,I,8-6*02,,42*01,,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,CAVSAPYNTDKLIF,,p65,CMV,I,8-6*02,,34*01,,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,CAVSDKNRDDKIIF,,p65,CMV,I,8-6*02,,30*01,,,,human,clone,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,CAVSDKNRDDKIIF,,p65,CMV,I,8-6*02,,30*01,,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,,CASRPGTASYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,clone,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,,CASRPGTASYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,,CASRPGTSSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
CPSQEPMSIYVY,B35:08,,CASRPGTSSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
EDVPSGKLFMHVTLG,A02:01,,CASAGETQYF,p65,CMV,I,,11-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,DNA,PMID:19776383,5
FPTKDVAL,B35:08,,CASSLVAGYGSYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,clone,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CASSLVAGYGSYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CASSQDRASPLHEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CASSQDWGDGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CASSQVGHEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSEPGLDQPQHF,p65,CMV,I,,30*01,,1-5*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSEPQNLPSLYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSLASGGTDNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSPTGDQPQHF,p65,CMV,I,,30*01,,1-5*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSVAAGILEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSVAAGILEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,Polyclonal T-cell line,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
FPTKDVAL,B35:08,,CAWSVASGANNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:18270323,4
IPSINVHHY,B35:01,CAERGWDNDMRF,,p65,CMV,I,5*01,,43*01,,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
IPSINVHHY,B35:01,,CASSADSNGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
NLVPMVATV,A02:01,CAARSNFGNEKLTF,,p65,CMV,I,19*01,,48*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAEISPSGGSYIPTF,,p65,CMV,I,13-2*01,,6*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAERLQTGANNLFF,,p65,CMV,I,5*01,,36*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAEYTGTASKLTF,,p65,CMV,I,13-2*01,,44*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAFIAGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAFPYNNNDMRF,,p65,CMV,I,18*01,,43*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAFPYNNNDMRF,,p65,CMV,I,18*01,,43*01,,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAGNTGNQFYF,,p65,CMV,I,1-1*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAGPEKTSYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAGPMKTSYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAGPMKTSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
NLVPMVATV,A02:01,CAGPRKTSYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAGPRQTSYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAKNTGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAKNTGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAMNTGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAMRVPRAQGGSEKLVF,,p65,CMV,I,14/DV4*01,,57*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAPPSNTGFQKLVF,,p65,CMV,I,16*01,,8*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAPYTGTASKLTF,,p65,CMV,I,16*01,,44*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAPYTGTASKLTF,,p65,CMV,I,16*01,,44*01,,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CARNTGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CARNTGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CARQDGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CATDAPGGYQKVTF,,p65,CMV,I,17*01,,3*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CATKNTGNQFYF,,p65,CMV,I,9-2*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAVAFGNQFYF,,p65,CMV,I,1-1*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAVDIETSGSRLTF,,p65,CMV,I,39*01,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAVFF,,p65,CMV,I,3*01,,,,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
NLVPMVATV,A02:01,CAVRIDYKLSF,,p65,CMV,I,1-1*01,,20*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAVYFGNVLHC,,p65,CMV,I,16*01,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAVYGTASKLTF,,p65,CMV,I,1-1*01,,44*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAVYYGQNFVF,,p65,CMV,I,16*01,,26*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CAYPYNNNDMRF,,p65,CMV,I,18*01,,43*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CILDNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CILLGTGANNLFF,,p65,CMV,I,26-2*01,,36*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CILPLWLTF,,p65,CMV,I,26-2*01,,53*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,CILSPNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CAASREGPNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CAGSKQSGTGYYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CAGSQVWGSDEKLFF,p65,CMV,I,,3-1*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASRALAGGQVEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASRDQTAYYGYTF,p65,CMV,I,,10-1*01,,1-2*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASRGLAGGLGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASRSAQRGFTETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSAVAGAPLEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSAWDRSSGANVLTF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSCQTGAACGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSDGIQGAWANVLTF,p65,CMV,I,,6-4*01,,2-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11756174,4
NLVPMVATV,A02:01,,CASSEALLGRANYGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSEEPSGGAYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSELGGAGTGELFF,p65,CMV,I,,10-1*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSETGATNYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSETGATNYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSFLQVTEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSFQGYTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSFQGYTEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSFQTGASYGYTF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSIGETGGIPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSIGGTGGIPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSKQSGTGYYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSLAASVNPAYGQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSLAPGATNEKLFF,p65,CMV,I,,6-1*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSLAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSLAPGTTNEKLFF,p65,CMV,I,,7-3*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11756174,4
NLVPMVATV,A02:01,,CASSLAPGTTNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSLEGYTEAFF,p65,CMV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSLEGYTEAFF,p65,CMV,I,,14*01,,1-1*01,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSLEGYTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSLFGGGTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSLFVGGPGNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSLGGGGFYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSLGGGSYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSLQAGANEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11756174,4
NLVPMVATV,A02:01,,CASSLQTGAGGFGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSLQTGATFNYGYTF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSLQTGVRSYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSLSGGGEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11756174,4
NLVPMVATV,A02:01,,CASSLTSGSPYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSLVASGQETQYF,p65,CMV,I,,7-3*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11756174,4
NLVPMVATV,A02:01,,CASSLVASVNPAYGQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSPGTEETQYF,p65,CMV,I,,5-4*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSPHQADTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSPHQAGTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSPKLQGAWAEKLFF,p65,CMV,I,,7-2*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPLTGTGVYGYTF,p65,CMV,I,,6-6*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSPPAGSYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPQTGTIYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPQTGTIYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPTGGGTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSPTGGSPSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
NLVPMVATV,A02:01,,CASSPVAGAPHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSPVAGGAYNEQFF,p65,CMV,I,,13*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPVTGGIYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPVTGGIYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSPVTGQGFYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSPWTGTLNTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSQDPFAVLNTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSQLGPSAYEQYF,p65,CMV,I,,16*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSQVWGSGEKLFF,p65,CMV,I,,3-1*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSSAFYGYTF,p65,CMV,I,,11-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSSAHYGYTF,p65,CMV,I,,11-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSSAHYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSSANYGYTF,p65,CMV,I,,11-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSSANYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSSANYGYTF,p65,CMV,I,,12-4*01,,1-2*01,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
NLVPMVATV,A02:01,,CASSSSFPGGGNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSSSTGTGRCLLPNNTEAFF,p65,CMV,I,,11-3*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSVGLPYEQYF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSYATGASYGYTF,p65,CMV,I,,6-3*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSYGGGEDYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSYGGGEDYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSYQTGAAYGYTF,p65,CMV,I,,6-3*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSYQTGAAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSYQTGAAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CASSYQTGAGGYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSYQTGAIYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSYQTGASYGYTF,p65,CMV,I,,6-3*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,amplicon-seq,RNA,PMID:24069285,4
NLVPMVATV,A02:01,,CASSYQTGTIYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CASSYSTGAGETQYF,p65,CMV,I,,13*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASSYVTGTGSYGYTGF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASTGTSGALYNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CASTLLGGAGYNEQFF,p65,CMV,I,,13*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:24069285,5
NLVPMVATV,A02:01,,CATSDLKVHSGNYGYTF,p65,CMV,I,,24-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CATSREGPNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CATSSSWDLNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CAWSSRDSMTDTQYF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CAWSSRGQMTDTQYFG,p65,CMV,I,,30*01,,2-1*01,,,human,sinovial_fluid,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CAWSSRGQMTDTQYF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CAWSVSDLAKNIQYF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CSAFSGAAFVTDTQYF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CSAKILAGAGSEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CSARDQRGLAGGIEDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CSARDQRGLAGGIGDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CSGGTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CSLRSQGTDTQYF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16237109,4
NLVPMVATV,A02:01,,CSTRDQRGLAGGIGDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02:01,,CSVGGTLDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
NLVPMVATV,A02:01,,CSVQRGGFETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:21135165,4
NLVPMVATV,A02,CAAAGDNNRKLIW,,p65,CMV,I,13-1*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAALMDSNYQLIW,,p65,CMV,I,29/DV5*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAACQGGSEKLVF,,p65,CMV,I,41*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAADKGNRDDKIIF,,p65,CMV,I,17*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAADRGSTLGRLYF,,p65,CMV,I,13-1*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAEDDGANNLFF,,p65,CMV,I,13-1*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAERGSTLGRLYF,,p65,CMV,I,23/DV6*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAESGGSYIPTF,,p65,CMV,I,22*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAESNSGYALNF,,p65,CMV,I,13-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAEYYGQNFVF,,p65,CMV,I,1-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAFDSGNTGKLIF,,p65,CMV,I,36/DV7*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAFHSGSARQLTF,,p65,CMV,I,13-1*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAFNQAGTALIF,,p65,CMV,I,1-1*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAGDAMDSNYQLIW,,p65,CMV,I,23/DV6*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAGEGNKLVF,,p65,CMV,I,13-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAGFLSGGYNKLIF,,p65,CMV,I,13-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAGGDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAGSSSGGYNKLIF,,p65,CMV,I,13-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAHGNQGGKLIF,,p65,CMV,I,29/DV5*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAHILTGGGNKLTF,,p65,CMV,I,13-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAIGSTLGRLYF,,p65,CMV,I,23/DV6*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAILIGKLIF,,p65,CMV,I,29/DV5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAILKNNNARLMF,,p65,CMV,I,23/DV6*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAILLGDYKLSF,,p65,CMV,I,23/DV6*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAINAGGTSYGKLTF,,p65,CMV,I,13-1*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAINDMRF,,p65,CMV,I,8-3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAINQAGTALIF,,p65,CMV,I,1-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAIQRDDYKLSF,,p65,CMV,I,13-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAIYPPGNQFYF,,p65,CMV,I,29/DV5*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAIYSGGGADGLTF,,p65,CMV,I,13-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAIYSGGYNKLIF,,p65,CMV,I,13-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKETSGSRLTF,,p65,CMV,I,13-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKGVYGGATNKLIF,,p65,CMV,I,13-1*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKNTGANSKLTF,,p65,CMV,I,29/DV5*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKRRNDYKLSF,,p65,CMV,I,29/DV5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKSRFYNQGGKLIF,,p65,CMV,I,29/DV5*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKTERVTF,,p65,CMV,I,13-1*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAKYNFNKFYF,,p65,CMV,I,13-1*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALAF,,p65,CMV,I,8-4*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALDGNQFYF,,p65,CMV,I,29/DV5*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALGSNDYKLSF,,p65,CMV,I,29/DV5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALIKAAGNKLTF,,p65,CMV,I,23/DV6*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALLGAGGTSYGKLTF,,p65,CMV,I,21*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALQGGSEKLVF,,p65,CMV,I,20*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALRDDKIIF,,p65,CMV,I,12-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALRNNNARLMF,,p65,CMV,I,1-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALRRRSNDYKLSF,,p65,CMV,I,13-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALRTASKLTF,,p65,CMV,I,13-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALSGTSYGKLTF,,p65,CMV,I,27*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAALYNTDKLIF,,p65,CMV,I,13-1*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAMDDKIIF,,p65,CMV,I,13-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAMSGSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANAGSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANDLMDSNYQLIW,,p65,CMV,I,13-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANFGNEKLTF,,p65,CMV,I,13-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANKAAGNKLTF,,p65,CMV,I,21*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANQAGTASKLTF,,p65,CMV,I,29/DV5*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANQRGARLMF,,p65,CMV,I,13-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANSGNTPLVF,,p65,CMV,I,29/DV5*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAANTGGFKTIF,,p65,CMV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPAGGTSYGKLTF,,p65,CMV,I,12-3*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPASGGSYIPTF,,p65,CMV,I,13-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPEGSARQLTF,,p65,CMV,I,36/DV7*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPFNRLAF,,p65,CMV,I,13-1*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPGADSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPGSEKLVF,,p65,CMV,I,29/DV5*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPIIQGAQKLVF,,p65,CMV,I,29/DV5*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPLGSRLTF,,p65,CMV,I,39*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPLSGGSYIPTF,,p65,CMV,I,13-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPNNAGNMLTF,,p65,CMV,I,1-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPNYGGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPPGYNRLIF,,p65,CMV,I,1-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPRDSGTSYGKLTF,,p65,CMV,I,36/DV7*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPRGLMF,,p65,CMV,I,13-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPSGSARQLTF,,p65,CMV,I,12-2*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPVAPSGAGSYQLTF,,p65,CMV,I,13-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPVKTSYDKVIF,,p65,CMV,I,8-3*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPVRVNKFYF,,p65,CMV,I,13-1*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPVSGGYQKVTF,,p65,CMV,I,13-1*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPYAGANNLFF,,p65,CMV,I,21*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAPYNTDKLIF,,p65,CMV,I,21*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAQPDSSYKLIF,,p65,CMV,I,21*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAQRGNTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAQRIGAGSYQLTF,,p65,CMV,I,29/DV5*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAQRNRDDKIIF,,p65,CMV,I,23/DV6*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAQRSQGNLIF,,p65,CMV,I,13-1*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAQTGANNLFF,,p65,CMV,I,20*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARAGNMLTF,,p65,CMV,I,12-3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARASGGSYIPTF,,p65,CMV,I,13-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARDARLMF,,p65,CMV,I,29/DV5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAREDSGAGSYQLTF,,p65,CMV,I,29/DV5*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARGGYSGTYKYIF,,p65,CMV,I,13-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARHNARLMF,,p65,CMV,I,2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARIKAAGNKLTF,,p65,CMV,I,13-1*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARNARLMF,,p65,CMV,I,29/DV5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARPVMDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARRAETDKLIF,,p65,CMV,I,13-1*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARSNDYKLSF,,p65,CMV,I,20*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARTFGGADGLTF,,p65,CMV,I,13-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARVMEYGNKLVF,,p65,CMV,I,23/DV6*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARVSSYNTDKLIF,,p65,CMV,I,23/DV6*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARWTGFQKLVF,,p65,CMV,I,13-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAARYGGSQGNLIF,,p65,CMV,I,29/DV5*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASAFGNEKLTF,,p65,CMV,I,13-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASAGPSNTGKLIF,,p65,CMV,I,29/DV5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASAIGTASKLTF,,p65,CMV,I,29/DV5*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASALTGNQFYF,,p65,CMV,I,29/DV5*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASAQAGSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASARETSGSRLTF,,p65,CMV,I,29/DV5*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASARYGGSQGNLIF,,p65,CMV,I,23/DV6*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASASFKTIF,,p65,CMV,I,29/DV5*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASASHYQLIW,,p65,CMV,I,29/DV5*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASATGTASKLTF,,p65,CMV,I,29/DV5*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASATQGGSEKLVF,,p65,CMV,I,29/DV5*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASAVDGFQKLVF,,p65,CMV,I,29/DV5*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASAVMDSNYQLIW,,p65,CMV,I,29/DV5*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDGGSGGGADGLTF,,p65,CMV,I,29/DV5*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDNTDKLIF,,p65,CMV,I,29/DV5*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDQGGANSKLTF,,p65,CMV,I,29/DV5*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDRAAGNKLTF,,p65,CMV,I,29/DV5*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDRDDKIIF,,p65,CMV,I,29/DV5*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDSNYQLIW,,p65,CMV,I,29/DV5*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASDTGRRALTF,,p65,CMV,I,13-1*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEAAGNNRKLIW,,p65,CMV,I,29/DV5*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEGGSARQLTF,,p65,CMV,I,13-1*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEGKLIF,,p65,CMV,I,13-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEGNKLVF,,p65,CMV,I,29/DV5*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEGNYGQNFVF,,p65,CMV,I,29/DV5*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEGQFYF,,p65,CMV,I,29/DV5*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEHAGNMLTF,,p65,CMV,I,29/DV5*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEKEAGTASKLTF,,p65,CMV,I,29/DV5*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASEPGGGADGLTF,,p65,CMV,I,29/DV5*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASERGGGNKLTF,,p65,CMV,I,29/DV5*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASERRGSNYKLTF,,p65,CMV,I,29/DV5*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASFLGAGNNRKLIW,,p65,CMV,I,23/DV6*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASFSGTYKYIF,,p65,CMV,I,29/DV5*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGDDKIIF,,p65,CMV,I,13-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGGSSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGISNFGNEKLTF,,p65,CMV,I,13-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGNNDMRF,,p65,CMV,I,29/DV5*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGRDDKIIF,,p65,CMV,I,29/DV5*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGRDSSYKLIF,,p65,CMV,I,29/DV5*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGRSSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGTYKYIF,,p65,CMV,I,29/DV5*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASGVGSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASHNNARLMF,,p65,CMV,I,29/DV5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASIAEGGADGLTF,,p65,CMV,I,13-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASIGGQNFVF,,p65,CMV,I,13-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASINQAGTALIF,,p65,CMV,I,13-1*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASINTGFQKLVF,,p65,CMV,I,13-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASIQNTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASIRTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASISNFGNEKLTF,,p65,CMV,I,13-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASITGANNLFF,,p65,CMV,I,13-1*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASKKAAGNKLTF,,p65,CMV,I,29/DV5*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASLDFTGFQKLVF,,p65,CMV,I,13-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASLFYSGAGSYQLTF,,p65,CMV,I,29/DV5*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASLNTGGFKTIF,,p65,CMV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASLRDNQGGKLIF,,p65,CMV,I,13-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASMGGFKTIF,,p65,CMV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASMYSGGGADGLTF,,p65,CMV,I,13-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNDYKLSF,,p65,CMV,I,29/DV5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNGYKLSF,,p65,CMV,I,13-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNPAGSQGNLIF,,p65,CMV,I,13-1*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNPANDYKLSF,,p65,CMV,I,13-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNPSSGYSTLTF,,p65,CMV,I,13-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNRAGTASKLTF,,p65,CMV,I,13-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNRSWDSGGGNKLTF,,p65,CMV,I,23/DV6*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASNSGYALNF,,p65,CMV,I,29/DV5*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPAGNMLTF,,p65,CMV,I,29/DV5*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPLLSGGYNKLIF,,p65,CMV,I,13-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPNTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPPGYSTLTF,,p65,CMV,I,13-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPPLGTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPPNEFSGGYNKLIF,,p65,CMV,I,29/DV5*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASPRDNYGQNFVF,,p65,CMV,I,13-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASQQRQLTF,,p65,CMV,I,13-1*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRAASKLTF,,p65,CMV,I,13-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRGNNARLMF,,p65,CMV,I,13-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRGTAGNKLTF,,p65,CMV,I,13-1*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRGTSYGKLTF,,p65,CMV,I,13-1*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRMDSNYQLIW,,p65,CMV,I,29/DV5*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRPNSGGSNYKLTF,,p65,CMV,I,29/DV5*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASRPQAGTALIF,,p65,CMV,I,13-1*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSNRGSTLGRLYF,,p65,CMV,I,13-1*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSNTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSQGGKLIF,,p65,CMV,I,13-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSRNAGNMLTF,,p65,CMV,I,13-1*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSRSNSGYALNF,,p65,CMV,I,29/DV5*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSSGAGSYQLTF,,p65,CMV,I,13-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSSGGTSYGKLTF,,p65,CMV,I,29/DV5*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSSGSARQLTF,,p65,CMV,I,29/DV5*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSSRDDKIIF,,p65,CMV,I,13-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSSSEYGNKLVF,,p65,CMV,I,29/DV5*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSWGTYKYIF,,p65,CMV,I,13-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSYNNNDMRF,,p65,CMV,I,29/DV5*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASSYNTDKLIF,,p65,CMV,I,13-1*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASTDGKLTF,,p65,CMV,I,13-1*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASTGGFKTIF,,p65,CMV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASTRGYNKLIF,,p65,CMV,I,13-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASVENSGYALNF,,p65,CMV,I,29/DV5*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASVTGANNLFF,,p65,CMV,I,29/DV5*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASWRDNFNKFYF,,p65,CMV,I,13-1*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASYDTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASYKNSGYALNF,,p65,CMV,I,13-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASYNARLMF,,p65,CMV,I,29/DV5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASYNNNDMRF,,p65,CMV,I,13-1*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASYYKLSF,,p65,CMV,I,13-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAASYYTGGFKTIF,,p65,CMV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATAIIQGAQKLVF,,p65,CMV,I,29/DV5*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATDSNYQLIW,,p65,CMV,I,29/DV5*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATEEEYGNKLVF,,p65,CMV,I,35*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATFSNQFYF,,p65,CMV,I,41*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATGGSYIPTF,,p65,CMV,I,13-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATLSYTGANSKLTF,,p65,CMV,I,22*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATNSGGSNYKLTF,,p65,CMV,I,41*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATPLLTGGFKTIF,,p65,CMV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATRGANNLFF,,p65,CMV,I,13-1*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATRGNARLMF,,p65,CMV,I,13-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATSGTYKYIF,,p65,CMV,I,29/DV5*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATTGNQFYF,,p65,CMV,I,13-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAATYSGGGADGLTF,,p65,CMV,I,13-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAVDSNYQLIW,,p65,CMV,I,12-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAVEQAGTALIF,,p65,CMV,I,29/DV5*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAWAAGNKLTF,,p65,CMV,I,29/DV5*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAWSNYQLIW,,p65,CMV,I,13-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYGQNFVF,,p65,CMV,I,20*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYNAGNNRKLIW,,p65,CMV,I,24*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYNQGGKLIF,,p65,CMV,I,21*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYNTNAGKSTF,,p65,CMV,I,1-2*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYSGAGSYQLTF,,p65,CMV,I,13-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYSGYSTLTF,,p65,CMV,I,13-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYSSASKIIF,,p65,CMV,I,8-4*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYTEYGNKLVF,,p65,CMV,I,13-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAAYTGGFKTIF,,p65,CMV,I,17*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CACYSGGGADGLTF,,p65,CMV,I,38-2/DV8*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADFTGGGNKLTF,,p65,CMV,I,5*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADLNRDDKIIF,,p65,CMV,I,25*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADLRRALTF,,p65,CMV,I,13-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADPLGTYKYIF,,p65,CMV,I,13-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADQTGANNLFF,,p65,CMV,I,5*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADRFRDDKIIF,,p65,CMV,I,1-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CADYYGQNFVF,,p65,CMV,I,16*01,,26*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,CADYYGQNFVF,,p65,CMV,I,3*01,,26*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CAEADDKIIF,,p65,CMV,I,29/DV5*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEAVGGSYIPTF,,p65,CMV,I,5*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEDDPANDYKLSF,,p65,CMV,I,5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEDRGSYIPTF,,p65,CMV,I,5*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEDTGGYNKLIF,,p65,CMV,I,5*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEEQGDSNYQLIW,,p65,CMV,I,13-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEGEGANNLFF,,p65,CMV,I,5*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEGTMDSSYKLIF,,p65,CMV,I,13-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEGVGTYKYIF,,p65,CMV,I,5*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEIEAGTALIF,,p65,CMV,I,5*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEIGGQNFVF,,p65,CMV,I,13-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEIIPAQGGSEKLVF,,p65,CMV,I,13-2*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEINARLMF,,p65,CMV,I,5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEIPNYGGSQGNLIF,,p65,CMV,I,5*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEIPSNDYKLSF,,p65,CMV,I,5*01,,20*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CAEIPYNQGGKLIF,,p65,CMV,I,13-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEISNAGNMLTF,,p65,CMV,I,13-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEISNTGKLIF,,p65,CMV,I,5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEIYFNARLMF,,p65,CMV,I,13-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEKGNGDARLMF,,p65,CMV,I,13-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEKNKNRLAF,,p65,CMV,I,13-2*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEKPGGYQKVTF,,p65,CMV,I,13-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEKTSYDKVIF,,p65,CMV,I,13-2*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEKVDKIIF,,p65,CMV,I,13-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAELTGGFKTIF,,p65,CMV,I,13-2*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEMAPSGNTPLVF,,p65,CMV,I,5*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEMIRDDKIIF,,p65,CMV,I,5*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEMPMDSSYKLIF,,p65,CMV,I,13-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENAGNNRKLIW,,p65,CMV,I,5*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENDMRF,,p65,CMV,I,13-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENDPFSGGYNKLIF,,p65,CMV,I,13-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENFNDYKLSF,,p65,CMV,I,13-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENGAGGYNKLIF,,p65,CMV,I,13-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENGAKAAGNKLTF,,p65,CMV,I,13-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENGNTGKLIF,,p65,CMV,I,13-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENIANQGGKLIF,,p65,CMV,I,13-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENKETSGSRLTF,,p65,CMV,I,13-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENMDSSYKLIF,,p65,CMV,I,13-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENPDDKIIF,,p65,CMV,I,13-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENPYGQNFVF,,p65,CMV,I,13-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENQAGTALIF,,p65,CMV,I,13-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENQRTGGQNFVF,,p65,CMV,I,13-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENQVKAAGNKLTF,,p65,CMV,I,13-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENRNDYKLSF,,p65,CMV,I,13-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENRNGAYGQNFVF,,p65,CMV,I,13-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENRNSGGSNYKLTF,,p65,CMV,I,13-2*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENSAYNQGGKLIF,,p65,CMV,I,13-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENSRSNDYKLSF,,p65,CMV,I,13-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENSYNQGGKLIF,,p65,CMV,I,13-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAENTIGNTDKLIF,,p65,CMV,I,13-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEPGKTSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEPNSGYSTLTF,,p65,CMV,I,5*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERARRDDKIIF,,p65,CMV,I,5*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERDNAGNMLTF,,p65,CMV,I,5*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERELTGGGNKLTF,,p65,CMV,I,5*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERGVDSSYKLIF,,p65,CMV,I,5*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERNNDMRF,,p65,CMV,I,23/DV6*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERPYGNNRLAF,,p65,CMV,I,13-2*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERRANAGGTSYGKLTF,,p65,CMV,I,13-2*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERRDNFNKFYF,,p65,CMV,I,13-2*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERRSSASKIIF,,p65,CMV,I,5*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAERVDQGGKLIF,,p65,CMV,I,13-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESIGKLIF,,p65,CMV,I,5*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESIIKAAGNKLTF,,p65,CMV,I,5*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESILDYGQNFVF,,p65,CMV,I,5*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESINGGSQGNLIF,,p65,CMV,I,5*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESIRGSGGGADGLTF,,p65,CMV,I,5*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESISSNTGKLIF,,p65,CMV,I,5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESIVDSSYKLIF,,p65,CMV,I,5*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESLNQAGTALIF,,p65,CMV,I,13-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESMNSGYALNF,,p65,CMV,I,5*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESNWYGGSQGNLIF,,p65,CMV,I,13-2*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESPGTYKYIF,,p65,CMV,I,13-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESPNARLMF,,p65,CMV,I,5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESPSGNTGKLIF,,p65,CMV,I,5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESWGDSSYKLIF,,p65,CMV,I,13-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAESYDNYGQNFVF,,p65,CMV,I,5*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETANSGYALNF,,p65,CMV,I,5*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETDNYGQNFVF,,p65,CMV,I,5*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETFNDYKLSF,,p65,CMV,I,13-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETLSGNTGKLIF,,p65,CMV,I,13-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETLTRHASGGSYIPTF,,p65,CMV,I,5*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETLTYNTDKLIF,,p65,CMV,I,13-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETNAGKSTF,,p65,CMV,I,13-2*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETNQAGTALIF,,p65,CMV,I,13-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETPRVDIF,,p65,CMV,I,5*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETPTNDYKLSF,,p65,CMV,I,5*01,,20*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CAETRRSDYKLSF,,p65,CMV,I,5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETRSPDYKLSF,,p65,CMV,I,5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETVNSGNTPLVF,,p65,CMV,I,5*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETYNFNKFYF,,p65,CMV,I,13-2*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAETYSKIIF,,p65,CMV,I,13-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEVGTDKLIF,,p65,CMV,I,5*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEVSGNTGKLIF,,p65,CMV,I,5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEWVEYGNKLVF,,p65,CMV,I,13-2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAEYNTDKLIF,,p65,CMV,I,5*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFAHGSSNTGKLIF,,p65,CMV,I,1-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFDAPFGNEKLTF,,p65,CMV,I,38-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFDNYGQNFVF,,p65,CMV,I,1-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFDRGSTLGRLYF,,p65,CMV,I,38-1*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFEAGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFEGAQKLVF,,p65,CMV,I,24*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFEGPNFGNEKLTF,,p65,CMV,I,38-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFETQGGSEKLVF,,p65,CMV,I,24*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFGDAGGTSYGKLTF,,p65,CMV,I,36/DV7*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFGDYKLSF,,p65,CMV,I,24*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFGSNYQLIW,,p65,CMV,I,24*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFGYGNTPLVF,,p65,CMV,I,38-1*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFIHPGNNRLAF,,p65,CMV,I,38-1*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFIHPLYNQGGKLIF,,p65,CMV,I,38-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFIQGAQKLVF,,p65,CMV,I,38-1*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFISYNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFITGIQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFITGNQFYFGTGTSLTVIPRGSYIPTF,,p65,CMV,I,24*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFITGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFITIGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFITSNMLTF,,p65,CMV,I,24*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFITSNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFKDSNYQLIW,,p65,CMV,I,38-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFKGYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFLAGNFNKFYF,,p65,CMV,I,24*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFLGAGSYQLTF,,p65,CMV,I,38-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFLTGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMAGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMEGDSNYQLIW,,p65,CMV,I,38-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMGYGGSQGNLIF,,p65,CMV,I,24*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMKHANVDSNYQLIW,,p65,CMV,I,38-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMKHGDSSNTGKLIF,,p65,CMV,I,38-1*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMKQTTSGTYKYIF,,p65,CMV,I,38-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMKRYGGSQGNLIF,,p65,CMV,I,38-1*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMKTRPSTGTASKLTF,,p65,CMV,I,38-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMNPRGSNYKLTF,,p65,CMV,I,38-1*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMNYEGGADGLTF,,p65,CMV,I,38-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMSTNFGDEKLTF,,p65,CMV,I,38-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMTGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMTKQGGSEKLVF,,p65,CMV,I,38-1*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFMTSVSNQFYF,,p65,CMV,I,38-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFNPPGSQGNLIF,,p65,CMV,I,38-2/DV8*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFNQAGTALIF,,p65,CMV,I,12-3*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPLDSSYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPMDSSYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPMNRDDKIIF,,p65,CMV,I,24*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPNNNAGNMLTF,,p65,CMV,I,38-2/DV8*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPSGGGADGLTF,,p65,CMV,I,24*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPSGYSTLTF,,p65,CMV,I,24*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPSSGTYKYIF,,p65,CMV,I,24*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPSSGYNKLIF,,p65,CMV,I,1-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPTGANNLFF,,p65,CMV,I,24*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPTGTASKLTF,,p65,CMV,I,24*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPYGGSQGNLIF,,p65,CMV,I,38-1*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFPYNNNDMRF,,p65,CMV,I,24*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFRGSNYQLIW,,p65,CMV,I,24*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFRLRSGATNKLIF,,p65,CMV,I,38-1*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFRTGDKVIF,,p65,CMV,I,38-2/DV8*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFRTGGATNKLIF,,p65,CMV,I,38-2/DV8*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFSFGSDSRLTF,,p65,CMV,I,38-1*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFSISNFGNEKLTF,,p65,CMV,I,38-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFSLGDDKIIF,,p65,CMV,I,38-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFSLSSYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFTGGGNKLTF,,p65,CMV,I,2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFTRGYGNKLVF,,p65,CMV,I,38-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFTRSNDYKLSF,,p65,CMV,I,24*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFWDTGRRALTF,,p65,CMV,I,24*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAFYDGDGLTF,,p65,CMV,I,24*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAAASKLTF,,p65,CMV,I,27*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAAGGGADGLTF,,p65,CMV,I,27*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGADNAGNMLTF,,p65,CMV,I,27*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGADSNYQLIW,,p65,CMV,I,27*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAEKVSMDSSYKLIF,,p65,CMV,I,27*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAGAGKSTF,,p65,CMV,I,27*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAGEAGGTSYGKLTF,,p65,CMV,I,27*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAGGGNKLTF,,p65,CMV,I,25*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAGLDSNYQLIW,,p65,CMV,I,27*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAHEKLTF,,p65,CMV,I,27*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAIFVGNDKIIF,,p65,CMV,I,27*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAKSAGNNRKLIW,,p65,CMV,I,27*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAPAYRDDKIIF,,p65,CMV,I,27*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAPIIQGAQKLVF,,p65,CMV,I,27*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAPITGANNLFF,,p65,CMV,I,27*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGARVNKFYF,,p65,CMV,I,27*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGASAAGNKLTF,,p65,CMV,I,27*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGASGAGSYQLTF,,p65,CMV,I,27*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGASNTGKLIF,,p65,CMV,I,27*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGASNTGNQFYF,,p65,CMV,I,27*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGASPRRSGGGADGLTF,,p65,CMV,I,20*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGATNAGNMLTF,,p65,CMV,I,27*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAVVTGANNLFF,,p65,CMV,I,27*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAYLTQGGSEKLVF,,p65,CMV,I,27*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGAYNNTGKLIF,,p65,CMV,I,27*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGDFGNQFYF,,p65,CMV,I,27*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGDNYGQNFVF,,p65,CMV,I,12-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGDPENNAGNMLTF,,p65,CMV,I,27*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGDTTSGTYKYIF,,p65,CMV,I,27*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEAYNTNAGKSTF,,p65,CMV,I,27*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEDDKIIF,,p65,CMV,I,27*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEESTGNQFYF,,p65,CMV,I,27*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEGDDKIIF,,p65,CMV,I,1-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEGRADSNYQLIW,,p65,CMV,I,27*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEKGGRGSTLGRLYF,,p65,CMV,I,27*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGEVVRGAQKLVF,,p65,CMV,I,27*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGAGGTSYGKLTF,,p65,CMV,I,27*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGDKIIF,,p65,CMV,I,27*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGDYNTDKLIF,,p65,CMV,I,35*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGESNFGNEKLTF,,p65,CMV,I,27*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGFQKLVF,,p65,CMV,I,12-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGGGTASKLTF,,p65,CMV,I,27*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGGYSTLTF,,p65,CMV,I,12-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGIQGGSEKLVF,,p65,CMV,I,27*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGKGDSNYQLIW,,p65,CMV,I,27*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGLGGYQKVTF,,p65,CMV,I,25*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGSGANNLFF,,p65,CMV,I,27*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGSGGYNKLIF,,p65,CMV,I,27*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGSNTGKLIF,,p65,CMV,I,25*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGGTGNQFYF,,p65,CMV,I,41*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGHGSSNTGKLIF,,p65,CMV,I,8-3*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGHHNAGNMLTF,,p65,CMV,I,25*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGHLYNFNKFYF,,p65,CMV,I,35*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGHMSYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGHNNNDMRF,,p65,CMV,I,35*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGHWDSNYQLIW,,p65,CMV,I,25*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGIGAASYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGILAYKLSF,,p65,CMV,I,25*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLDNYGQNFVF,,p65,CMV,I,35*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLGANYGGSQGNLIF,,p65,CMV,I,35*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLGYGGATNKLIF,,p65,CMV,I,35*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLHSGYSTLTF,,p65,CMV,I,21*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLKYGNKLVF,,p65,CMV,I,25*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLLGNEKLTF,,p65,CMV,I,39*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLLVDSNYQLIW,,p65,CMV,I,25*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLSIQGAQKLVF,,p65,CMV,I,25*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGLTTDSWGKFQF,,p65,CMV,I,25*01,,24*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CAGLWDRGSTLGRLYF,,p65,CMV,I,35*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGNFGNEKLTF,,p65,CMV,I,29/DV5*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGNNNAGNMLTF,,p65,CMV,I,25*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGNTNAGKSTF,,p65,CMV,I,35*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPDSDLINNDMRF,,p65,CMV,I,35*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPGGVQGAQKLVF,,p65,CMV,I,35*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPGKTSYNKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPGMVTGGGNKLTF,,p65,CMV,I,25*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPGYSTLTF,,p65,CMV,I,25*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPIGGGADGLTF,,p65,CMV,I,25*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPIGGSQGNLIF,,p65,CMV,I,25*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPIKTSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPKVKAAGNKLTF,,p65,CMV,I,25*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPLRKLTF,,p65,CMV,I,21*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPMKTSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPNFGNEKLTF,,p65,CMV,I,35*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPPENYGQNFVF,,p65,CMV,I,35*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPRAGGTSYGKLTF,,p65,CMV,I,25*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPSETSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPSKTSYDKVIF,,p65,CMV,I,25*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPSKTSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPTKTSYDKVIF,,p65,CMV,I,35*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPTYSGAGSYQLTF,,p65,CMV,I,27*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPWYSGTYKYIF,,p65,CMV,I,35*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPYGQNFVF,,p65,CMV,I,25*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGPYNNARLMF,,p65,CMV,I,25*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQAGNDMRF,,p65,CMV,I,35*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQANAGNNRKLIW,,p65,CMV,I,35*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQGATSGTYKYIF,,p65,CMV,I,35*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQGDGGATNKLIF,,p65,CMV,I,35*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQGNQFYF,,p65,CMV,I,35*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQGYGGATNKLIF,,p65,CMV,I,35*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQIYSGAGSYQLTF,,p65,CMV,I,35*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQLDAGNMLTF,,p65,CMV,I,35*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQLGAGGTSYGKLTF,,p65,CMV,I,35*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQLGGTSYGKLTF,,p65,CMV,I,35*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQNNAGNMLTF,,p65,CMV,I,35*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQNNNARLMF,,p65,CMV,I,35*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQPPISSGSARQLTF,,p65,CMV,I,35*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQPSRHDDKIIF,,p65,CMV,I,35*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQSDLGYGGSQGNLIF,,p65,CMV,I,35*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGQWELVF,,p65,CMV,I,35*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRDNYGQNFVF,,p65,CMV,I,35*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRDSGNTGKLIF,,p65,CMV,I,25*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRGDDKIIF,,p65,CMV,I,25*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRGTNAGKSTF,,p65,CMV,I,12-2*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRKAQTGANNLFF,,p65,CMV,I,27*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRLWTDKLIF,,p65,CMV,I,27*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRMDSSYKLIF,,p65,CMV,I,21*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRPDSGTYKYIF,,p65,CMV,I,35*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRPLSGGYNKLIF,,p65,CMV,I,27*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRQSVDMRF,,p65,CMV,I,35*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRRSGNTGKLIF,,p65,CMV,I,25*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRRTDKLIF,,p65,CMV,I,35*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRSNTDKLIF,,p65,CMV,I,25*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRSNTGNQFYF,,p65,CMV,I,25*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRTLNDYKLSF,,p65,CMV,I,25*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGRTPGGATNKLIF,,p65,CMV,I,27*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSDNFNKFYF,,p65,CMV,I,3*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSEAGGYNKLIF,,p65,CMV,I,25*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSFGGYNKLIF,,p65,CMV,I,22*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSGGGADGLTF,,p65,CMV,I,29/DV5*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSGNTPLVF,,p65,CMV,I,17*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSIPPGSARQLTF,,p65,CMV,I,13-2*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSIYNQGGKLIF,,p65,CMV,I,27*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSLKTSYDKVIF,,p65,CMV,I,12-2*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSNYKLTF,,p65,CMV,I,23/DV6*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGSVSNYQLIW,,p65,CMV,I,25*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGTRYNFNKFYF,,p65,CMV,I,27*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGTTTGTASKLTF,,p65,CMV,I,25*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVDNYGQNFVF,,p65,CMV,I,27*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVFSNTGKLIF,,p65,CMV,I,27*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVGDSSYKLIF,,p65,CMV,I,1-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVGSYFGNEKLTF,,p65,CMV,I,27*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVKAAGNKLTF,,p65,CMV,I,25*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVPGGADGLTF,,p65,CMV,I,25*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVPQTGANNLFF,,p65,CMV,I,35*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVSGGYNKLIF,,p65,CMV,I,1-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVSTNAGKSTF,,p65,CMV,I,27*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGVWGGGSNYKLTF,,p65,CMV,I,27*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGWSVSAGKSTF,,p65,CMV,I,25*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGYGNKLVF,,p65,CMV,I,8-3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGYMDSNYQLIW,,p65,CMV,I,27*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGYMYSGGGADGLTF,,p65,CMV,I,27*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAGYSSNTGKLIF,,p65,CMV,I,27*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHASGGSYIPTF,,p65,CMV,I,24*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHAYGNNRLAF,,p65,CMV,I,24*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHENTGFQKLVF,,p65,CMV,I,24*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHGDNAGNMLTF,,p65,CMV,I,25*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHGGTSYGKLTF,,p65,CMV,I,38-2/DV8*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHLADDKIIF,,p65,CMV,I,16*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHLPDSSYKLIF,,p65,CMV,I,9-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHSGGYNKLIF,,p65,CMV,I,6*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAHTGRRALTF,,p65,CMV,I,16*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIFF,,p65,CMV,I,20*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIGEGGGKLIF,,p65,CMV,I,12-3*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIGNNDMRF,,p65,CMV,I,12-3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIGTSYGKLTF,,p65,CMV,I,12-3*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIHEANNLFF,,p65,CMV,I,12-3*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIHSMDSNYQLIW,,p65,CMV,I,12-3*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIISSNTGKLIF,,p65,CMV,I,12-3*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAILAGNQFYF,,p65,CMV,I,9-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAILDDKIIF,,p65,CMV,I,12-3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAILTGGGNKLTF,,p65,CMV,I,12-3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIPRGAQKLVF,,p65,CMV,I,12-3*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIPRHPTGGGADGLTF,,p65,CMV,I,14/DV4*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIPSTGAGSYQLTF,,p65,CMV,I,38-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIQEQGNTPLVF,,p65,CMV,I,14/DV4*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAIRAGGTSYGKLTF,,p65,CMV,I,13-2*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAISGSARQLTF,,p65,CMV,I,17*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAITNSGYSTLTF,,p65,CMV,I,12-3*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAKSLDGANNLFF,,p65,CMV,I,1-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALAGGATNKLIF,,p65,CMV,I,39*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALAYSSASKIIF,,p65,CMV,I,6*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALCQVGGSYIPTF,,p65,CMV,I,16*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDIGTNAGKSTF,,p65,CMV,I,6*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDIHGENGANNLFF,,p65,CMV,I,6*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDLPWGGNTPLVF,,p65,CMV,I,6*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDNAGNMLTF,,p65,CMV,I,6*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDSGGGADGLTF,,p65,CMV,I,6*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDTDNQFYF,,p65,CMV,I,6*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALDTGNQFYF,,p65,CMV,I,6*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALEDFQKLVF,,p65,CMV,I,24*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALEEGNYGGSQGNLIF,,p65,CMV,I,19*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALEGEYGNKLVF,,p65,CMV,I,6*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALFKGGADGLTF,,p65,CMV,I,38-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALFTGGGNKLTF,,p65,CMV,I,9-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALFYGNNRLAF,,p65,CMV,I,19*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGAVIYNQGGKLIF,,p65,CMV,I,19*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGDFTGNQFYF,,p65,CMV,I,19*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGDLRSGYALNF,,p65,CMV,I,19*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGDLTSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGDNNARLMF,,p65,CMV,I,6*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGDPSSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGEILFAGGTSYGKLTF,,p65,CMV,I,19*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELDTGGFKTIF,,p65,CMV,I,19*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELELRISSGSARQLTF,,p65,CMV,I,19*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELEPSGSRLTF,,p65,CMV,I,19*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELEPSGSRLTF,,p65,CMV,I,9-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELGAGGTSYGKLTF,,p65,CMV,I,19*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELGGSYIPTF,,p65,CMV,I,19*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELGTGGFKTIF,,p65,CMV,I,19*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELKGNFNKFYF,,p65,CMV,I,19*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELNYGQNFVF,,p65,CMV,I,19*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGELSTSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGEPAGGTSYGKLTF,,p65,CMV,I,19*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGEPTPSTGANSKLTF,,p65,CMV,I,19*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGEQDSSNTGKLIF,,p65,CMV,I,19*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGERSSYDKVIF,,p65,CMV,I,19*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGEVATNKLIF,,p65,CMV,I,19*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGEVERYSTLTF,,p65,CMV,I,19*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGGHNTGGFKTIF,,p65,CMV,I,19*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGGNKLVF,,p65,CMV,I,24*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGGPPSSASKIIF,,p65,CMV,I,19*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGNRDDKIIF,,p65,CMV,I,19*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGRGSTLGRLYF,,p65,CMV,I,19*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGRGTGNQFYF,,p65,CMV,I,19*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALGWANNLFF,,p65,CMV,I,16*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALHPGNQFYF,,p65,CMV,I,25*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALIPLSGGYNKLIF,,p65,CMV,I,19*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALIQSSGGYNKLIF,,p65,CMV,I,16*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALITWGAGGTSYGKLTF,,p65,CMV,I,19*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALIVPTSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALKGGGGNKLTF,,p65,CMV,I,8-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALKSRGGSEKLVF,,p65,CMV,I,9-2*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLAGNQFYF,,p65,CMV,I,19*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLAGNQFYF,,p65,CMV,I,41*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLAGNQFYF,,p65,CMV,I,9-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLAGNQFYF,,p65,CMV,I,9-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLGMDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLIYNQGGKLIF,,p65,CMV,I,20*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLSEGGGADGLTF,,p65,CMV,I,38-2/DV8*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLVSSNTGKLIF,,p65,CMV,I,6*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALLYNNNDMRF,,p65,CMV,I,6*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALMDYGNNRLAF,,p65,CMV,I,9-2*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALMEYGNKLVF,,p65,CMV,I,38-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALMGYSTDKLIF,,p65,CMV,I,21*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALNAGNMLTF,,p65,CMV,I,9-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALNGNQFYF,,p65,CMV,I,9-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALNGRSQGNLIF,,p65,CMV,I,16*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALNRDTGRRALTF,,p65,CMV,I,9-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALNTGGFKTIF,,p65,CMV,I,16*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALNTGGFKTIF,,p65,CMV,I,6*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALPITGANNLFF,,p65,CMV,I,24*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALPPPTSGSRLTF,,p65,CMV,I,16*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALPSGGSYIPTF,,p65,CMV,I,6*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALPVRTGANNLFF,,p65,CMV,I,19*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALQGAQKLVF,,p65,CMV,I,16*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALQSWGGNNARLMF,,p65,CMV,I,14/DV4*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRDTNAGKSTF,,p65,CMV,I,9-2*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALREGGGSQGNLIF,,p65,CMV,I,18*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALREGTGKLIF,,p65,CMV,I,16*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRENNAGNMLTF,,p65,CMV,I,19*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRGEDSNYQLIW,,p65,CMV,I,19*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRGGGANSKLTF,,p65,CMV,I,19*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRGTGRRALTF,,p65,CMV,I,19*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRGTSGSRLTF,,p65,CMV,I,18*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRKMDSNYKLIF,,p65,CMV,I,19*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRLAPDSNYQLIW,,p65,CMV,I,19*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRPGANNLFF,,p65,CMV,I,9-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRPGGYNKLIF,,p65,CMV,I,19*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRPRDYGQNFVF,,p65,CMV,I,9-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRQTGANNLFF,,p65,CMV,I,18*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALRTTSGTYKYIF,,p65,CMV,I,18*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSAGFQKLVF,,p65,CMV,I,19*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSALESGSARQLTF,,p65,CMV,I,16*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSAPVIIQGAQKLVF,,p65,CMV,I,19*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSATDTGFQKLVF,,p65,CMV,I,19*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDNYGQNFVF,,p65,CMV,I,19*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDPIGRVNRKLTF,,p65,CMV,I,9-2*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDPPPYTGANSKLTF,,p65,CMV,I,9-2*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDPTSGGYQKVTF,,p65,CMV,I,9-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDRGSGGSYIPTF,,p65,CMV,I,9-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDRYGGSQGNLIF,,p65,CMV,I,16*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSDWNSGGSNYKLTF,,p65,CMV,I,9-2*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAEDAGNMLTF,,p65,CMV,I,19*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAFPQGGSEKLVF,,p65,CMV,I,19*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAGDDKIIF,,p65,CMV,I,19*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAGETSGSRLTF,,p65,CMV,I,19*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAGFSGGYNKLIF,,p65,CMV,I,19*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAINQAGTALIF,,p65,CMV,I,19*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEALGKGSRGSTLGRLYF,,p65,CMV,I,19*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAMVEYGNKLVF,,p65,CMV,I,19*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEARMDSSYKLIF,,p65,CMV,I,19*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEARSGANNLFF,,p65,CMV,I,19*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEARSGSARQLTF,,p65,CMV,I,19*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEASGYSTLTF,,p65,CMV,I,19*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEASYGDYKLSF,,p65,CMV,I,19*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEATGGSYIPTF,,p65,CMV,I,19*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEATTGYSTLTF,,p65,CMV,I,19*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEAYGNNRLAF,,p65,CMV,I,19*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEEDYGQNFVF,,p65,CMV,I,19*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEESNFGNEKLTF,,p65,CMV,I,19*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEETSGSRLTF,,p65,CMV,I,9-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEGGGSYIPTF,,p65,CMV,I,19*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEGPLTSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEIDSNYQLIW,,p65,CMV,I,19*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEISNFGNEKLTF,,p65,CMV,I,19*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSELDSNYQLIW,,p65,CMV,I,19*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSELDYGQNFVF,,p65,CMV,I,19*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSENHDYKLSF,,p65,CMV,I,19*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEPGGGGYNKLIF,,p65,CMV,I,19*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEQGGSEKLVF,,p65,CMV,I,16*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEQGGSKKLVF,,p65,CMV,I,16*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSESEGSTLGRLYF,,p65,CMV,I,19*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSESPLSEEDYKLSF,,p65,CMV,I,19*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSESPSNTGKLIF,,p65,CMV,I,9-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSESPTGANNLFF,,p65,CMV,I,19*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSESRNTGTASKLTF,,p65,CMV,I,19*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSESVSSGSARQLTF,,p65,CMV,I,9-2*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEVDSNYQLIW,,p65,CMV,I,19*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEWEYGNKLVF,,p65,CMV,I,19*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSEYSSASKIIF,,p65,CMV,I,9-2*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSFAGGYQKVTF,,p65,CMV,I,9-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGFMDSNYQLIW,,p65,CMV,I,19*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGGSGGTSYGKLTF,,p65,CMV,I,19*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGGSNYKLTF,,p65,CMV,I,19*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGHSGNTPLVF,,p65,CMV,I,19*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGPNAGGTSYGKLTF,,p65,CMV,I,16*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGPNSGYSTLTF,,p65,CMV,I,9-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGSGGSNYKLTF,,p65,CMV,I,16*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGSGGYNKLIF,,p65,CMV,I,19*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGSKLIF,,p65,CMV,I,9-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGTYKYIF,,p65,CMV,I,19*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSGYYGQNFVF,,p65,CMV,I,19*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSISSGSARQLTF,,p65,CMV,I,19*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSLFSGNTPLVF,,p65,CMV,I,9-2*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSLGGANSKLTF,,p65,CMV,I,16*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSNSGYALNF,,p65,CMV,I,16*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSPGTASKLTF,,p65,CMV,I,19*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSPYSYNTDKLIF,,p65,CMV,I,9-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSQGGGFKTIF,,p65,CMV,I,9-2*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSSSNTGNQFYF,,p65,CMV,I,16*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSYAGNNRKLIW,,p65,CMV,I,19*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALSYNTDKLIF,,p65,CMV,I,19*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTFNTNAGKSTF,,p65,CMV,I,16*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTGAGSYQLTF,,p65,CMV,I,38-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTGTASKLTF,,p65,CMV,I,21*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTGTASKLTF,,p65,CMV,I,38-2/DV8*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTLPQTGANNLFF,,p65,CMV,I,19*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTPSNTGKLIF,,p65,CMV,I,12-3*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTSGGGADGLTF,,p65,CMV,I,9-2*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALTYTGGFKTIF,,p65,CMV,I,38-2/DV8*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALVDARLMF,,p65,CMV,I,19*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALVRSNDYKLSF,,p65,CMV,I,9-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALVTGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALWGAGNMLTF,,p65,CMV,I,5*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALWNNARLMF,,p65,CMV,I,38-2/DV8*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALYGNKLVF,,p65,CMV,I,17*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALYPGIQGAQKLVF,,p65,CMV,I,12-2*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CALYSFSGGYNKLIF,,p65,CMV,I,12-3*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMFSGGYNKLIF,,p65,CMV,I,12-3*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMGALDYKLSF,,p65,CMV,I,12-3*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMGESNQFYF,,p65,CMV,I,8-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMGLTGGGNKLTF,,p65,CMV,I,14/DV4*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMGSNYKLTF,,p65,CMV,I,12-3*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMGVTGGGNKLTF,,p65,CMV,I,14/DV4*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMGYIPTF,,p65,CMV,I,12-3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMIGSGAGSYQLTF,,p65,CMV,I,12-3*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMKALSMDSSYKLIF,,p65,CMV,I,14/DV4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMKGSARQLTF,,p65,CMV,I,12-3*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMKGWTGTALIF,,p65,CMV,I,12-3*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMKHNYGQNFVF,,p65,CMV,I,14/DV4*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMKVNSGGYQKVTF,,p65,CMV,I,14/DV4*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMLNSGGYQKVTF,,p65,CMV,I,12-3*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMMDTGRRALTF,,p65,CMV,I,12-3*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMMGGNTGKLIF,,p65,CMV,I,14/DV4*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMNNTDKLIF,,p65,CMV,I,12-3*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMNRDDKIIF,,p65,CMV,I,12-3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMNTGFQKLVF,,p65,CMV,I,8-6*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMPLNDYKLSF,,p65,CMV,I,12-3*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRALSMDSSYKLIF,,p65,CMV,I,14/DV4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRALTF,,p65,CMV,I,14/DV4*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRAPLNFNKFYF,,p65,CMV,I,14/DV4*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRAYAGGTSYGKLTF,,p65,CMV,I,14/DV4*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRDDYGQNFVF,,p65,CMV,I,14/DV4*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRDEGRDDKIIF,,p65,CMV,I,14/DV4*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRDKVLSGGSNYKLTF,,p65,CMV,I,14/DV4*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRDNPGGTSYGKLTF,,p65,CMV,I,14/DV4*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRDSGTYKYIF,,p65,CMV,I,14/DV4*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREANDNYGQNFVF,,p65,CMV,I,14/DV4*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREFASGGSYIPTF,,p65,CMV,I,14/DV4*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREFSNDYKLSF,,p65,CMV,I,14/DV4*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGEDSSYKLIF,,p65,CMV,I,14/DV4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGGGSNYKLTF,,p65,CMV,I,14/DV4*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGGMDSSYKLIF,,p65,CMV,I,14/DV4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGGRNSGYSTLTF,,p65,CMV,I,14/DV4*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGLFSGGYNKLIF,,p65,CMV,I,14/DV4*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGMNSGYSTLTF,,p65,CMV,I,14/DV4*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGNNTNAGKSTF,,p65,CMV,I,14/DV4*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGQDFGNEKLTF,,p65,CMV,I,14/DV4*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGQWGGSQGNLIF,,p65,CMV,I,14/DV4*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGRDDKIIF,,p65,CMV,I,14/DV4*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGRGTDKLIF,,p65,CMV,I,14/DV4*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGSGGSYIPTF,,p65,CMV,I,14/DV4*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGSSGNTGKLIF,,p65,CMV,I,14/DV4*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREGVPDTPLVF,,p65,CMV,I,14/DV4*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRELTNAGGTSYGKLTF,,p65,CMV,I,14/DV4*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRENDTGGFKTIF,,p65,CMV,I,14/DV4*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRERNYGQNFVF,,p65,CMV,I,14/DV4*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRERVDGNEKLTF,,p65,CMV,I,14/DV4*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRESANQAGTALIF,,p65,CMV,I,14/DV4*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRESLGGGYQKVTF,,p65,CMV,I,14/DV4*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREVLNRLAF,,p65,CMV,I,14/DV4*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREVVGDSSYKLIF,,p65,CMV,I,14/DV4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREWDAGNMLTF,,p65,CMV,I,14/DV4*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMREYQAGTALIF,,p65,CMV,I,14/DV4*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRGFLASGGSYIPTF,,p65,CMV,I,12-3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRGLLQGAQKLVF,,p65,CMV,I,14/DV4*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRGNQAGTALIF,,p65,CMV,I,14/DV4*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRGSNYKLTF,,p65,CMV,I,14/DV4*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRGTLFGNEKLTF,,p65,CMV,I,14/DV4*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRGWETSGSRLTF,,p65,CMV,I,14/DV4*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRLTDSNYQLIW,,p65,CMV,I,14/DV4*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRPGFGNEKLTF,,p65,CMV,I,14/DV4*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRPTGGFKTIF,,p65,CMV,I,14/DV4*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRPYNFNKFYF,,p65,CMV,I,14/DV4*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRPYYGNNRLAF,,p65,CMV,I,14/DV4*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRSSFSGGYNKLIF,,p65,CMV,I,14/DV4*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRVLSGNTGKLIF,,p65,CMV,I,14/DV4*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRVLTGRRALTF,,p65,CMV,I,14/DV4*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMRYDTGGFKTIF,,p65,CMV,I,14/DV4*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSADSGGGADGLTF,,p65,CMV,I,12-3*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSANFGNEKLTF,,p65,CMV,I,12-3*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSANSNYQLIW,,p65,CMV,I,12-3*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAPGGSYIPTF,,p65,CMV,I,12-3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAPGGYQKVTF,,p65,CMV,I,12-3*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAPNFGNEKLTF,,p65,CMV,I,12-3*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAQRDDKIIF,,p65,CMV,I,12-3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAWTGTASKLTF,,p65,CMV,I,12-3*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAYAGGTSYGKLTF,,p65,CMV,I,12-3*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAYAGNMLTF,,p65,CMV,I,12-3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAYGGGGADGLTF,,p65,CMV,I,12-3*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSAYTGRRALTF,,p65,CMV,I,12-3*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSDGYSSASKIIF,,p65,CMV,I,12-3*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSDRGSTLGRLYF,,p65,CMV,I,12-3*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSDSNTGKLIF,,p65,CMV,I,12-3*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSDTNTGNQFYF,,p65,CMV,I,12-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSDYKLSF,,p65,CMV,I,12-3*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSEDNNARLMF,,p65,CMV,I,12-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSEGDDKIIF,,p65,CMV,I,12-3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSGADTGFQKLVF,,p65,CMV,I,12-3*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSGDNQGGKLIF,,p65,CMV,I,12-3*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSGGGADGLTF,,p65,CMV,I,12-3*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSGSARQLTF,,p65,CMV,I,12-3*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSHQTGANNLFF,,p65,CMV,I,12-3*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSIGGSNYKLTF,,p65,CMV,I,12-3*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSLDYGQNFVF,,p65,CMV,I,12-3*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSLSNFGNEKLTF,,p65,CMV,I,12-3*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSPAWHSTLTF,,p65,CMV,I,12-3*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSPGRDSNYQLIW,,p65,CMV,I,14/DV4*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSPPTGANSKLTF,,p65,CMV,I,14/DV4*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSPYNQAGTALIF,,p65,CMV,I,12-3*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSTAAYKYIF,,p65,CMV,I,12-3*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSTEDSSYKLIF,,p65,CMV,I,12-3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSTGGFKTIF,,p65,CMV,I,12-3*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSTGGGNKLTF,,p65,CMV,I,12-3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSTTNAGKSTF,,p65,CMV,I,12-3*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSVDNAGNMLTF,,p65,CMV,I,12-3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSVEEYGNKLVF,,p65,CMV,I,12-3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSVIYNNNDMRF,,p65,CMV,I,12-3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSVSNSGYALNF,,p65,CMV,I,12-3*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSVVDSSYKLIF,,p65,CMV,I,12-3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSVVNSGYALNF,,p65,CMV,I,12-3*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSYNAGNNRKLIW,,p65,CMV,I,12-3*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMSYNQGGKLIF,,p65,CMV,I,14/DV4*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMTASGTYKYIF,,p65,CMV,I,14/DV4*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMTQRDFGNEKLTF,,p65,CMV,I,14/DV4*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAMTRNARLMF,,p65,CMV,I,12-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CANAGNMLTF,,p65,CMV,I,12-3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CANFNGGNQFYF,,p65,CMV,I,22*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPAGGNNARLMF,,p65,CMV,I,12-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPARETGGGADGLTF,,p65,CMV,I,16*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPCGYGDATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPCGYGGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPCSNDYKLSF,,p65,CMV,I,20*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPDNYGQNFVF,,p65,CMV,I,17*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPDSNYQLIW,,p65,CMV,I,2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPDTGANSKLTF,,p65,CMV,I,29/DV5*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPFSGTYKYIF,,p65,CMV,I,38-2/DV8*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPGAGSYQLTF,,p65,CMV,I,38-2/DV8*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPGDARLMF,,p65,CMV,I,12-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPHNNAGNMLTF,,p65,CMV,I,16*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPHNNFGNEKLTF,,p65,CMV,I,35*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPHQEGNAGNMLTF,,p65,CMV,I,12-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPIQTGANNLFF,,p65,CMV,I,9-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPLAGNQFYF,,p65,CMV,I,9-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPLQDSNYQLIW,,p65,CMV,I,27*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPLTYGNNRLAF,,p65,CMV,I,9-2*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPNAGNNRKLIW,,p65,CMV,I,16*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPPGDRGSTLGRLYF,,p65,CMV,I,16*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPPISGTYKYIF,,p65,CMV,I,9-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPPPFYNQGGKLIF,,p65,CMV,I,17*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPQGDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPQGDTGRRALTF,,p65,CMV,I,16*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPQGLDGTASKLTF,,p65,CMV,I,6*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPQTGGFKTIF,,p65,CMV,I,17*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPRGDNYGQNFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPRGGNDYKLSF,,p65,CMV,I,5*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPRIQRNNNARLMF,,p65,CMV,I,13-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPRLSSGSARQLTF,,p65,CMV,I,24*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPSFYSGGGADGLTF,,p65,CMV,I,19*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPSGNTGKLIF,,p65,CMV,I,21*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPSNSNSGYALNF,,p65,CMV,I,2*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPSRGYQKVTF,,p65,CMV,I,23/DV6*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPTRGGYTGRRALTF,,p65,CMV,I,12-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPTSYNTDKLIF,,p65,CMV,I,16*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAPYNNDMRF,,p65,CMV,I,20*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAQASGGSYIPTF,,p65,CMV,I,17*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAQEGAGNNRKLIW,,p65,CMV,I,21*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAQNRDDKIIF,,p65,CMV,I,19*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAQWDNYGQNFVF,,p65,CMV,I,13-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARATYDKIIF,,p65,CMV,I,19*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARFNNAGNMLTF,,p65,CMV,I,38-2/DV8*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARGFQKLVF,,p65,CMV,I,12-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARGSGGGADGLTF,,p65,CMV,I,20*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARGVGNTGKLIF,,p65,CMV,I,38-1*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARISGAGSYQLTF,,p65,CMV,I,1-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARNTGKLIF,,p65,CMV,I,39*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARNTGNQFYF,,p65,CMV,I,12-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARNTGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARQGAQKLVF,,p65,CMV,I,38-2/DV8*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARRGSTLGRLYF,,p65,CMV,I,12-3*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARSRGYSTLTF,,p65,CMV,I,24*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARTAGGYQKVTF,,p65,CMV,I,12-3*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CARTNQAGTALIF,,p65,CMV,I,20*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASALNNAGNMLTF,,p65,CMV,I,22*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASEGYGQNFVF,,p65,CMV,I,3*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASFLQGAQKLVF,,p65,CMV,I,38-2/DV8*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASFQGGSEKLVF,,p65,CMV,I,38-2/DV8*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASFSGAQKLVF,,p65,CMV,I,16*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASGEGNKLVF,,p65,CMV,I,13-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASGGSYIPTF,,p65,CMV,I,8-6*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASGNNAGLMF,,p65,CMV,I,24*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASGNNARLMF,,p65,CMV,I,24*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASGSQGNLIF,,p65,CMV,I,3*01,,42*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CASGSSNTGKLIF,,p65,CMV,I,12-3*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASGTGNQFYF,,p65,CMV,I,8-6*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASKSGYSTLTF,,p65,CMV,I,24*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASLGRGSTLGRLYF,,p65,CMV,I,12-3*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASMNYGGSQGNLIF,,p65,CMV,I,29/DV5*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASNAGGTSYGKLTF,,p65,CMV,I,38-1*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASNTDKLIF,,p65,CMV,I,38-2/DV8*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASNTGNQFYF,,p65,CMV,I,18*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,CASNTGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPDSNYQLIW,,p65,CMV,I,24*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPKGGSYIPTF,,p65,CMV,I,17*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPLDSSYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPMDSNYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPMDSSYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPNSGGYQKVTF,,p65,CMV,I,24*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPRPQTGANNLFF,,p65,CMV,I,38-2/DV8*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASPTGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CASPTYNNNDMRF,,p65,CMV,I,38-1*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASQGAGNMLTF,,p65,CMV,I,24*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASQGYGQNFVF,,p65,CMV,I,12-3*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASRGGGGADGLTF,,p65,CMV,I,23/DV6*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASSGGYQKVTF,,p65,CMV,I,21*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASSIGPEGGSYIPTF,,p65,CMV,I,13-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASSNAGGTSYGKLTF,,p65,CMV,I,38-2/DV8*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASSTTSGTYKYIF,,p65,CMV,I,13-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASTMDSSYKLIF,,p65,CMV,I,24*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASTNSNSGYALNF,,p65,CMV,I,24*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASTSNTSKLIF,,p65,CMV,I,8-6*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASYAGNNRKLIW,,p65,CMV,I,1-2*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASYNDYKLSF,,p65,CMV,I,24*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASYNFNKFYF,,p65,CMV,I,6*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASYSSASKIIF,,p65,CMV,I,8-3*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASYTNAGKSTF,,p65,CMV,I,13-1*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CASYYGGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATAALGSSNTGKLIF,,p65,CMV,I,17*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATADRGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATALNTGFQKLVF,,p65,CMV,I,17*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATAPSRGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATASSNSGYALNF,,p65,CMV,I,17*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATAVYSGGGADGLTF,,p65,CMV,I,17*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATAYVDSSYKLIF,,p65,CMV,I,17*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAAGNQFYF,,p65,CMV,I,17*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAALNDYKLSF,,p65,CMV,I,17*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAAQGGSEKLVF,,p65,CMV,I,17*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAAVGETSGSRLTF,,p65,CMV,I,17*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDADRGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDADSGYSTLTF,,p65,CMV,I,17*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAEGYSTLTF,,p65,CMV,I,17*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAGAGTALIF,,p65,CMV,I,17*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAMGRGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDARLGGSEKLVF,,p65,CMV,I,17*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDARSGNTPLVF,,p65,CMV,I,17*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDATGGSYIPTF,,p65,CMV,I,17*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAWETSGSRLTF,,p65,CMV,I,17*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDAYTNQAGTALIF,,p65,CMV,I,17*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDDMDFGNEKLTF,,p65,CMV,I,17*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDEREYGNKLVF,,p65,CMV,I,17*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDESGSRLTF,,p65,CMV,I,17*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDESSDYKLSF,,p65,CMV,I,17*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDETGANNLFF,,p65,CMV,I,17*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDEVDNQGGKLIF,,p65,CMV,I,17*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDFNARLMF,,p65,CMV,I,17*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDGNTGKLIF,,p65,CMV,I,17*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDKGNRDDKIIF,,p65,CMV,I,17*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDKNRGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDNFNKFYF,,p65,CMV,I,17*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDNGNKLVF,,p65,CMV,I,17*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDPDSNYQLIW,,p65,CMV,I,17*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDRAQTGANNLFF,,p65,CMV,I,17*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDRDDYKLSF,,p65,CMV,I,17*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDRMNSGYSTLTF,,p65,CMV,I,17*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDRNDYKLSF,,p65,CMV,I,17*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDSFPTTSGTYKYIF,,p65,CMV,I,17*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDSNAGNNRKLIW,,p65,CMV,I,17*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDSSGYSTLTF,,p65,CMV,I,17*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDSVHKLSF,,p65,CMV,I,17*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDVAGGSYIPTF,,p65,CMV,I,17*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDVGNTGKLIF,,p65,CMV,I,17*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDVWGDNYGQNFVF,,p65,CMV,I,17*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATDYDRGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATEDDKIIF,,p65,CMV,I,17*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGAGGSYIPTF,,p65,CMV,I,17*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGANSKLTF,,p65,CMV,I,17*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGGGKLIF,,p65,CMV,I,17*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGLSNFGNEKLTF,,p65,CMV,I,17*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGSEDMRF,,p65,CMV,I,17*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGSNYQLIW,,p65,CMV,I,9-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGSTNTGNQFYF,,p65,CMV,I,17*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATGTGANNLFF,,p65,CMV,I,17*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATIRTGNQFYF,,p65,CMV,I,17*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATKNTGNQFYF,,p65,CMV,I,12-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATMAGGSYIPTF,,p65,CMV,I,17*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATMDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATNPLDTGRRALTF,,p65,CMV,I,22*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATPGGSYIPTF,,p65,CMV,I,12-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATPLNRETSGSRLTF,,p65,CMV,I,17*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATPNGGGSTLGRLYF,,p65,CMV,I,17*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATPPFSGGYNKLIF,,p65,CMV,I,12-3*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATSRGNQFYF,,p65,CMV,I,24*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATSSGGYNKLIF,,p65,CMV,I,12-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATSTGANNLFF,,p65,CMV,I,17*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATTDTTSGTYKYIF,,p65,CMV,I,20*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVDNYGQNFVF,,p65,CMV,I,17*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVDTGRRALTF,,p65,CMV,I,12-3*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVFDKIIF,,p65,CMV,I,17*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVGAGNMLTF,,p65,CMV,I,17*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVNSGYSTLTF,,p65,CMV,I,17*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVPMDSSYKLIF,,p65,CMV,I,17*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATVTNAGKSTF,,p65,CMV,I,17*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CATYLTGNQFYF,,p65,CMV,I,12-3*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CAVAANNNARLMF,,p65,CMV,I,8-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVADSGGGADGLTF,,p65,CMV,I,8-6*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAFGNQFYF,,p65,CMV,I,8-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAGDSSYKLIF,,p65,CMV,I,22*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAGQAGTALIF,,p65,CMV,I,39*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAPGQNFVF,,p65,CMV,I,12-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAPMMDSSYKLIF,,p65,CMV,I,8-3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAPYSGGSNYKLTF,,p65,CMV,I,36/DV7*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVARNSGNTPLVF,,p65,CMV,I,21*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVASDYKLSF,,p65,CMV,I,36/DV7*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVASGYSTLTF,,p65,CMV,I,12-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVATYYGGSQGNLIF,,p65,CMV,I,22*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAVGGGNKLTF,,p65,CMV,I,22*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAVGNQFYF,,p65,CMV,I,8-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVAWYSSASKIIF,,p65,CMV,I,8-3*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVCMNRDDKIIF,,p65,CMV,I,22*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVCNFNKFYF,,p65,CMV,I,24*01,,21*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,CAVDDNNAGNMLTF,,p65,CMV,I,21*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDDSANDYKLSF,,p65,CMV,I,21*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDEETSGSRLTF,,p65,CMV,I,39*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDEGGGADGLTF,,p65,CMV,I,39*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDIETSGSRLTF,,p65,CMV,I,39*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDIMDSNYQLIW,,p65,CMV,I,8-3*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDKDNTDKLIF,,p65,CMV,I,39*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDMDSTRDDKIIF,,p65,CMV,I,39*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDMPGSDSNYQLIW,,p65,CMV,I,39*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDMRF,,p65,CMV,I,12-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDMWPYNYQLIW,,p65,CMV,I,39*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDNFGNEKLTF,,p65,CMV,I,36/DV7*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDNTNAGKSTF,,p65,CMV,I,36/DV7*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDNYGQNFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDPIKAAGNKLTF,,p65,CMV,I,22*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDPPFSGGYNKLIF,,p65,CMV,I,22*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDQTGNQFYF,,p65,CMV,I,39*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDRDDKIIF,,p65,CMV,I,21*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDRGSTLGRLYF,,p65,CMV,I,12-2*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDRTTSGTYKYIF,,p65,CMV,I,39*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDSAGEYGNKLVF,,p65,CMV,I,39*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDSGNKLVF,,p65,CMV,I,12-2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDTGRGALTF,,p65,CMV,I,12-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDTGRRALTF,,p65,CMV,I,21*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVDVETSGSRLTF,,p65,CMV,I,39*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEAGTGANNLFF,,p65,CMV,I,36/DV7*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEALWDDKIIF,,p65,CMV,I,36/DV7*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEAPGGGTSYGKLTF,,p65,CMV,I,36/DV7*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEASGAGNNRKLIW,,p65,CMV,I,36/DV7*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEDAGKSTF,,p65,CMV,I,22*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEDYNQGGKLIF,,p65,CMV,I,22*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEGDTGGGNKLTF,,p65,CMV,I,8-3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEGTGNQFYF,,p65,CMV,I,22*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEHQTGANNLFF,,p65,CMV,I,22*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVELDTGTASKLTF,,p65,CMV,I,22*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVELIWGGNTGKLIF,,p65,CMV,I,22*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVENWVTGGGNKLTF,,p65,CMV,I,22*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVENYGQNFVF,,p65,CMV,I,22*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVERGTGGFKTIF,,p65,CMV,I,22*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVERLGSNYKLTF,,p65,CMV,I,22*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVERLTGGGNKLTF,,p65,CMV,I,22*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEYGNKLVF,,p65,CMV,I,2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEYGNKLVF,,p65,CMV,I,8-3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEYQAGTALIF,,p65,CMV,I,21*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEYRNKLVF,,p65,CMV,I,3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVEYSGAGSYQLTF,,p65,CMV,I,12-2*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVFHSGGGADGLTF,,p65,CMV,I,41*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVFLFTSVDNDMRF,,p65,CMV,I,8-1*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVFRDDKIIF,,p65,CMV,I,25*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVFSGRRALTF,,p65,CMV,I,12-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVFTGANSKLTF,,p65,CMV,I,21*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVFYGGSQGNLIF,,p65,CMV,I,22*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAAGNKLTF,,p65,CMV,I,12-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGADDYKLSF,,p65,CMV,I,8-3*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGADGGATNKLIF,,p65,CMV,I,8-3*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAEIGNEKLTF,,p65,CMV,I,8-3*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAFMEYGNKLVF,,p65,CMV,I,8-3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAFNGNKLVF,,p65,CMV,I,8-3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAGTGTASKLTF,,p65,CMV,I,8-3*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGANSGYSTLTF,,p65,CMV,I,8-3*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAQTGRRALTF,,p65,CMV,I,8-3*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAREDSSYKLIF,,p65,CMV,I,8-3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGAREGNKLVF,,p65,CMV,I,8-3*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGATTSGTYKYIF,,p65,CMV,I,8-3*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGDDPGGFKTIF,,p65,CMV,I,8-3*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGDMNYGGSQGNLIF,,p65,CMV,I,8-3*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGDRSDMRF,,p65,CMV,I,8-3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGEGTSYGKLTF,,p65,CMV,I,8-3*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGESNQFYF,,p65,CMV,I,8-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGFTSGTYKYIF,,p65,CMV,I,8-3*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGGFKTIF,,p65,CMV,I,20*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGGGADGLTF,,p65,CMV,I,41*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGGGSNYKLTF,,p65,CMV,I,41*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGGVTGGGNKLTF,,p65,CMV,I,21*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGHNTDKLIF,,p65,CMV,I,21*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGLDYGGSQGNLIF,,p65,CMV,I,8-3*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGMDSSYKLIF,,p65,CMV,I,1-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGPGYSSASKIIF,,p65,CMV,I,8-3*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGPHNRDDKIIF,,p65,CMV,I,8-3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGPLRRYSTLTF,,p65,CMV,I,8-3*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGPLYNAGNNRKLIW,,p65,CMV,I,2*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGPNDYKLSF,,p65,CMV,I,22*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGPYNNARLMF,,p65,CMV,I,41*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGQDFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGQGAQKLVF,,p65,CMV,I,12-2*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGQGSTGNQFYF,,p65,CMV,I,8-3*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGQNFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGRLNNNARLMF,,p65,CMV,I,8-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGSETGANNLFF,,p65,CMV,I,21*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGSNDYKLSF,,p65,CMV,I,8-4*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGSNFGNEKLTF,,p65,CMV,I,8-3*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGSNSGYALNF,,p65,CMV,I,8-3*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGSSYKLIF,,p65,CMV,I,8-3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGSYNAGNMLTF,,p65,CMV,I,8-3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGTNQAGTALIF,,p65,CMV,I,8-3*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGTSGTYKYIF,,p65,CMV,I,41*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGTTSGTYKYIF,,p65,CMV,I,8-3*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGWGNNDMRF,,p65,CMV,I,22*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGYAGGTSYGKLTF,,p65,CMV,I,8-3*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGYARLMF,,p65,CMV,I,8-3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGYGSGYSTLTF,,p65,CMV,I,1-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVGYSGYSTLTF,,p65,CMV,I,12-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVHDDKLIF,,p65,CMV,I,21*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVHPFSGGYNKLIF,,p65,CMV,I,20*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVHSGNTPLVF,,p65,CMV,I,21*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVHSSNTGKLIF,,p65,CMV,I,23/DV6*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVHTNAGKSTF,,p65,CMV,I,1-1*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVHTPYGQNFVF,,p65,CMV,I,20*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIAGGTSYGKLTF,,p65,CMV,I,22*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIFQAGNNRKLIW,,p65,CMV,I,1-1*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIGVNNFNKFYF,,p65,CMV,I,21*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIIISNFGNEKLTF,,p65,CMV,I,12-2*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIKAAGNKLTF,,p65,CMV,I,1-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVILHGSSNTGKLIF,,p65,CMV,I,8-6*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVILNDMRF,,p65,CMV,I,12-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVILSGSARQLTF,,p65,CMV,I,21*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVINSGYSTLTF,,p65,CMV,I,12-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVINYGQNFVF,,p65,CMV,I,20*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIPAGNKLTF,,p65,CMV,I,1-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIPGNTGKLIF,,p65,CMV,I,21*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIPMDSSYKLIF,,p65,CMV,I,8-4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIPMDSSYKLIF,,p65,CMV,I,8-6*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVISDRGSTLGRLYF,,p65,CMV,I,21*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVISGGYQKVTF,,p65,CMV,I,12-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVISNNDMRF,,p65,CMV,I,20*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVIVNSGYALNF,,p65,CMV,I,21*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKDDKIIF,,p65,CMV,I,8-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKDGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKEGGSYIPTF,,p65,CMV,I,1-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKETSGSRLTF,,p65,CMV,I,21*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKETSGSRLTF,,p65,CMV,I,8-6*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKGGSYIPTF,,p65,CMV,I,21*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKGLDSGAGSYQLTF,,p65,CMV,I,41*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKGNNARLMF,,p65,CMV,I,21*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKGSGYALNF,,p65,CMV,I,12-2*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKGTDKLIF,,p65,CMV,I,8-1*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKKAAGNKLTF,,p65,CMV,I,8-4*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKNGGYQKVTF,,p65,CMV,I,1-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKNSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKQGFGNEKLTF,,p65,CMV,I,21*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKRGFQKLVF,,p65,CMV,I,12-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKRLSLTF,,p65,CMV,I,21*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKSKAAGNKLTF,,p65,CMV,I,12-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKSQTGANNLFF,,p65,CMV,I,21*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKSSNQGGKLIF,,p65,CMV,I,8-4*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKTDSNYQLIW,,p65,CMV,I,1-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVKWEDSSYKLIF,,p65,CMV,I,8-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLAGGGNKLTF,,p65,CMV,I,1-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLAGGSYIPTF,,p65,CMV,I,20*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLDNYGQNFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLETQGGKLIF,,p65,CMV,I,8-3*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLGGANNLFF,,p65,CMV,I,20*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLGGSQGNLIF,,p65,CMV,I,13-1*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLGGSQGNLIF,,p65,CMV,I,2*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLIYNQGGKLIF,,p65,CMV,I,12-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLIYNTDKLIF,,p65,CMV,I,2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLLMF,,p65,CMV,I,27*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLMDSSYKLIF,,p65,CMV,I,21*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLNQGGKLIF,,p65,CMV,I,5*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLNYGQNFVF,,p65,CMV,I,36/DV7*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLPGAGGTSYGKLTF,,p65,CMV,I,21*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLPISSGSARQLTF,,p65,CMV,I,21*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLPNDYKLSF,,p65,CMV,I,12-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLQTGANSKLTF,,p65,CMV,I,21*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLRSPSGTYKYIF,,p65,CMV,I,20*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLSGGGADGLTF,,p65,CMV,I,38-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLSLSGSARQLTF,,p65,CMV,I,21*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLTGTASKLTF,,p65,CMV,I,39*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLTSGTYKYIF,,p65,CMV,I,21*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVLYNFNKFYF,,p65,CMV,I,21*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVMGMDSSYKLIF,,p65,CMV,I,8-4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVMGMDSSYKLIF,,p65,CMV,I,8-6*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNAGGSYIPTF,,p65,CMV,I,8-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNAGGTSYGKLTF,,p65,CMV,I,12-2*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNAGGYQKVTF,,p65,CMV,I,8-1*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNALGSGYALNF,,p65,CMV,I,8-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNALYFNRGSTLGRLYF,,p65,CMV,I,12-2*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNAPSNYQLIW,,p65,CMV,I,8-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNARPARQLTF,,p65,CMV,I,8-1*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNEDSSYKLIF,,p65,CMV,I,21*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNEGASSGGYQKVTF,,p65,CMV,I,12-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNEVEGNKLVF,,p65,CMV,I,12-2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNFGNMLTF,,p65,CMV,I,3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNGDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNGGSSASKIIF,,p65,CMV,I,12-2*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNHRGSTLGRLYF,,p65,CMV,I,1-2*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNIGTGFQKLVF,,p65,CMV,I,12-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNLEYGNKLVF,,p65,CMV,I,12-2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNLGAAGNKLTF,,p65,CMV,I,12-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNLNSGGSNYKLTF,,p65,CMV,I,12-2*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNMATGRRALTF,,p65,CMV,I,12-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNMGRGSTLGRLYF,,p65,CMV,I,12-2*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNMVTGGGNKLTF,,p65,CMV,I,12-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNNAGNMLTF,,p65,CMV,I,1-1*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNNNARLMF,,p65,CMV,I,1-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNNYGGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNPDNTDKLIF,,p65,CMV,I,12-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNPMNRDDKIIF,,p65,CMV,I,8-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNPTGNQFYF,,p65,CMV,I,12-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNPYFGNEKLTF,,p65,CMV,I,12-2*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNQAGTALIF,,p65,CMV,I,12-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNRGGKSTF,,p65,CMV,I,8-1*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNRGRPSGSARQLTF,,p65,CMV,I,12-2*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNRGYGQNFVF,,p65,CMV,I,12-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNSDTGRRALTF,,p65,CMV,I,1-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNSGGYNKLIF,,p65,CMV,I,12-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNSGYALNF,,p65,CMV,I,12-2*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNSGYGQNFVF,,p65,CMV,I,12-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNSNDYKLSF,,p65,CMV,I,21*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNSYGNKLVF,,p65,CMV,I,41*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNTGFQKLVF,,p65,CMV,I,12-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNTGNQFYF,,p65,CMV,I,12-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNVPNFGNEKLTF,,p65,CMV,I,12-2*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVNYGGSQGNLIF,,p65,CMV,I,12-2*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPASGGSYIPTF,,p65,CMV,I,20*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPDDYKLSF,,p65,CMV,I,20*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPDLYNQGGKLIF,,p65,CMV,I,22*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPDNYGQNFVF,,p65,CMV,I,2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPGDSSYKLIF,,p65,CMV,I,3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPGFQKLVF,,p65,CMV,I,20*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPGGGADGLTF,,p65,CMV,I,20*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPGTSGSARQLTF,,p65,CMV,I,20*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPGTYKYIF,,p65,CMV,I,39*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPHGGATNKLIF,,p65,CMV,I,1-2*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPKNRDDKIIF,,p65,CMV,I,21*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPKSGGSYIPTF,,p65,CMV,I,21*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPNNARLMF,,p65,CMV,I,12-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPNQAGTALIF,,p65,CMV,I,12-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPNQAGTALIF,,p65,CMV,I,2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPNTGKLIF,,p65,CMV,I,23/DV6*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPPSGGGADGLTF,,p65,CMV,I,41*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPQTGANNLFF,,p65,CMV,I,21*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPRSNDYKLSF,,p65,CMV,I,20*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPSGGYNKLIF,,p65,CMV,I,1-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPSGGYNKLIF,,p65,CMV,I,13-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPTGNQFYF,,p65,CMV,I,12-2*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVPWGAAGNKLTF,,p65,CMV,I,8-1*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQADSGGYQKVTF,,p65,CMV,I,20*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQADSNSGYALNF,,p65,CMV,I,20*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAGGSQGNLIF,,p65,CMV,I,20*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAGNSGGYQKVTF,,p65,CMV,I,20*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAIAAGNKLTF,,p65,CMV,I,20*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAIAGNMLTF,,p65,CMV,I,20*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQALSNSGYALNF,,p65,CMV,I,20*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQALSSGSARQLTF,,p65,CMV,I,20*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQALTSYNNAGNMLTF,,p65,CMV,I,20*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAPSETSGSRLTF,,p65,CMV,I,20*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAQGSNDYKLSF,,p65,CMV,I,20*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQARAAGNKLTF,,p65,CMV,I,20*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQARDSNSGYALNF,,p65,CMV,I,20*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQARIPGTYKYIF,,p65,CMV,I,20*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQASGATNKLIF,,p65,CMV,I,20*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQASIRQNFVF,,p65,CMV,I,20*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQASRAAGNKLTF,,p65,CMV,I,20*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQATGNQFYF,,p65,CMV,I,20*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAVPDKLIF,,p65,CMV,I,20*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAWLTGGGNKLTF,,p65,CMV,I,20*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQAWTSGSARQLTF,,p65,CMV,I,20*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQDNAGNNRKLIW,,p65,CMV,I,20*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQDNQGGKLIF,,p65,CMV,I,20*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQDYQAGTALIF,,p65,CMV,I,20*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQENTGFQKLVF,,p65,CMV,I,20*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQERDNAGNMLTF,,p65,CMV,I,20*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQGFKTIF,,p65,CMV,I,8-3*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQGGGGKLIF,,p65,CMV,I,21*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQGGNMLTF,,p65,CMV,I,20*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQGNFNKFYF,,p65,CMV,I,20*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQGNTGFQKLVF,,p65,CMV,I,20*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQHRRALTF,,p65,CMV,I,12-2*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQPENNARLMF,,p65,CMV,I,1-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQPNSGGSNYKLTF,,p65,CMV,I,20*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQPTDDQTGANNLFF,,p65,CMV,I,20*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQQGGSYIPTF,,p65,CMV,I,20*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQSHNTDKLIF,,p65,CMV,I,20*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQSRGADGLTF,,p65,CMV,I,12-2*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQTGANNLFF,,p65,CMV,I,12-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQTLYGGATNKLIF,,p65,CMV,I,20*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVQVPPLFGGYQKVTF,,p65,CMV,I,20*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRAFYNQGGKLIF,,p65,CMV,I,3*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRAPSGGSYIPTF,,p65,CMV,I,1-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRAQETSGSRLTF,,p65,CMV,I,41*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRARDSSYKLIF,,p65,CMV,I,3*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDAGGSYIPTF,,p65,CMV,I,3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDANSGNTPLVF,,p65,CMV,I,3*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDARTGYSTLTF,,p65,CMV,I,3*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDDKIIF,,p65,CMV,I,3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDERNRLAF,,p65,CMV,I,3*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDETSGSRLTF,,p65,CMV,I,21*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDFTGGGNKLTF,,p65,CMV,I,3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDGDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDGDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDGNNRLAF,,p65,CMV,I,3*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDGSTGGFKTIF,,p65,CMV,I,1-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDIEGSYIPTF,,p65,CMV,I,1-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDIIARLMF,,p65,CMV,I,3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDIQGGKLIF,,p65,CMV,I,3*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDISARLMF,,p65,CMV,I,3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDISGTGGFKTIF,,p65,CMV,I,3*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDISTRLMF,,p65,CMV,I,3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDITGRRALTF,,p65,CMV,I,3*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDKGGSYIPTF,,p65,CMV,I,1-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDLDDYKLSF,,p65,CMV,I,3*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDLGAPRDDKIIF,,p65,CMV,I,1-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDLNQAGTALIF,,p65,CMV,I,1-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDLSNDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDMGYNNNDMRF,,p65,CMV,I,3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDMMAAGNKLTF,,p65,CMV,I,3*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDNEYGQNFVF,,p65,CMV,I,3*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDNNARLMF,,p65,CMV,I,1-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDNTDKLIF,,p65,CMV,I,3*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDNYGQNFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDPKGNNRLAF,,p65,CMV,I,1-2*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDPNNAGNMLTF,,p65,CMV,I,3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDPSGTYKYIF,,p65,CMV,I,3*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDQDDKIIF,,p65,CMV,I,3*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDQDYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDRDFNKFYF,,p65,CMV,I,1-2*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDRDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDRDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDRGSTLGRLYF,,p65,CMV,I,3*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDRNNAGNMLTF,,p65,CMV,I,1-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDRQNSGYALNF,,p65,CMV,I,1-2*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDSAGSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDSRDNYGQNFVF,,p65,CMV,I,3*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDTDYKLSF,,p65,CMV,I,3*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDTNARLMF,,p65,CMV,I,3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDTSASGTYKYIF,,p65,CMV,I,3*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDVGDSNYQLIW,,p65,CMV,I,3*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDWAMFSGGYNKLIF,,p65,CMV,I,3*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDWHSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDYGGSQGNLIF,,p65,CMV,I,1-2*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDYGGSQGNLIF,,p65,CMV,I,21*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRDYNNNDMRF,,p65,CMV,I,3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVREAGGGNKLTF,,p65,CMV,I,8-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVREALDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVREGFKTIF,,p65,CMV,I,1-2*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVREGRRGSYIPTF,,p65,CMV,I,1-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRELNTGFQKLVF,,p65,CMV,I,3*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRENDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRERGDGANNLFF,,p65,CMV,I,21*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRESYQLIW,,p65,CMV,I,3*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRFGNEKLTF,,p65,CMV,I,41*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRFRSNDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRFYGGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGAGNNRKLIW,,p65,CMV,I,8-6*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGDGGATNKLIF,,p65,CMV,I,21*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGFQKLVF,,p65,CMV,I,3*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGGATNKLIF,,p65,CMV,I,20*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGGGTSYGKLTF,,p65,CMV,I,20*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGHNQGGKLIF,,p65,CMV,I,21*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGMDSSYKLIF,,p65,CMV,I,1-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGNNNAGNMLTF,,p65,CMV,I,21*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGSGGGADGLTF,,p65,CMV,I,21*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGSGGSYIPTF,,p65,CMV,I,12-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGSRDDKIIF,,p65,CMV,I,1-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGSYIPTF,,p65,CMV,I,3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGTGGFKTIF,,p65,CMV,I,1-2*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGVSNSGYALNF,,p65,CMV,I,3*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGYNFNKFYF,,p65,CMV,I,3*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRGYNNDMRF,,p65,CMV,I,3*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRHPGNNRKLIW,,p65,CMV,I,21*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRHRSLGETSGSRLTF,,p65,CMV,I,21*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRISGGYQKVTF,,p65,CMV,I,21*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRLDDRGSTLGRLYF,,p65,CMV,I,21*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRLEGGGADGLTF,,p65,CMV,I,21*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRLENARLMF,,p65,CMV,I,21*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRLLSSGGSYIPTF,,p65,CMV,I,20*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRLNNAGNMLTF,,p65,CMV,I,1-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRMIKAAGNKLTF,,p65,CMV,I,21*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRNISARLMF,,p65,CMV,I,3*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRNNAGNNRKLIW,,p65,CMV,I,3*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRNPLRQAGTALIF,,p65,CMV,I,2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRNWENAGNMLTF,,p65,CMV,I,21*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPAGDSSYKLIF,,p65,CMV,I,21*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPANAGNMLTF,,p65,CMV,I,8-1*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPDAGGTSYGKLTF,,p65,CMV,I,21*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPGNAGNMLTF,,p65,CMV,I,21*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPGNTGKLIF,,p65,CMV,I,20*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPILTGGGNKLTF,,p65,CMV,I,21*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPILTGGGNKLTF,,p65,CMV,I,3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPIYSNSGYALNF,,p65,CMV,I,3*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPLADRGSYIPTF,,p65,CMV,I,3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPLSGGYNKLIF,,p65,CMV,I,3*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPLSNNNDMRF,,p65,CMV,I,21*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPNNAGNMLTF,,p65,CMV,I,21*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPPYMDSNYQLIW,,p65,CMV,I,20*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPRRDAGNMLTF,,p65,CMV,I,3*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPSGAGSYQLTF,,p65,CMV,I,21*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPSNAGKSTF,,p65,CMV,I,8-6*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPSQGTNAGKSTF,,p65,CMV,I,21*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPWDDKIIF,,p65,CMV,I,12-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRPYNAGGTSYGKLTF,,p65,CMV,I,20*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRQGLDFGNEKLTF,,p65,CMV,I,21*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRQYSSASKIIF,,p65,CMV,I,21*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRRDQTGANNLFF,,p65,CMV,I,21*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRRGGFQKLVF,,p65,CMV,I,21*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRRYDDKIIF,,p65,CMV,I,21*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSGKGGTASKLTF,,p65,CMV,I,41*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSHNAGNMLTF,,p65,CMV,I,1-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSNAGGTSYGKLTF,,p65,CMV,I,3*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSNDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSNDYKLSF,,p65,CMV,I,21*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSSASKIIF,,p65,CMV,I,20*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSSNDYKLSF,,p65,CMV,I,20*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRSYGNNRLAF,,p65,CMV,I,3*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRTFSGGYNKLIF,,p65,CMV,I,20*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRTGGGNKLTF,,p65,CMV,I,12-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRTISGGSYIPTF,,p65,CMV,I,8-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRTNQAGTALIF,,p65,CMV,I,20*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRTSGTYKYIF,,p65,CMV,I,1-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRTSGYSTLTF,,p65,CMV,I,21*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVDAGKSTF,,p65,CMV,I,3*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVLYSGAGSYQLTF,,p65,CMV,I,3*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVMYSGGGADGLTF,,p65,CMV,I,3*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVNDYKLSF,,p65,CMV,I,21*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVNRDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVRAGNNRKLIW,,p65,CMV,I,12-2*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVRDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVSGGYNKLIF,,p65,CMV,I,1-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVVPLSGGYNKLIF,,p65,CMV,I,1-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVVSNDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRVYSSASKIIF,,p65,CMV,I,20*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRWETSGSRLTF,,p65,CMV,I,21*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRWNFGNEKLTF,,p65,CMV,I,41*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVRYNSNYQLIW,,p65,CMV,I,41*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSADSSYKLIF,,p65,CMV,I,21*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSAGGGNKLTF,,p65,CMV,I,8-4*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSALISSGSARQLTF,,p65,CMV,I,8-4*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSAQGGSEKLVF,,p65,CMV,I,21*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSARQLTF,,p65,CMV,I,8-4*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDLDTGNQFYF,,p65,CMV,I,8-4*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDPGAGSYQLTF,,p65,CMV,I,8-6*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDPIKAAGNKLTF,,p65,CMV,I,8-6*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDPYNQGGKLIF,,p65,CMV,I,8-6*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDPYYGGSQGNLIF,,p65,CMV,I,8-6*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDRDSSYKLIF,,p65,CMV,I,8-6*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDRGSGGSNYKLTF,,p65,CMV,I,8-4*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDSGGYQKVTF,,p65,CMV,I,8-6*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDSSYKLIF,,p65,CMV,I,8-6*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSDYSGGGSQGNLIF,,p65,CMV,I,8-4*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSEAGSEKLVF,,p65,CMV,I,8-6*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSEDARLMF,,p65,CMV,I,8-4*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSEHSSASKIIF,,p65,CMV,I,8-6*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSEIWAAGNKLTF,,p65,CMV,I,8-6*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSENTDKLIF,,p65,CMV,I,8-4*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSFGNEKLTF,,p65,CMV,I,8-4*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSGAGSYQLTF,,p65,CMV,I,8-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSGGGADGLTF,,p65,CMV,I,8-4*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSGGNYGQNFVF,,p65,CMV,I,21*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSGGSYIPTF,,p65,CMV,I,8-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSGINTGNQFYF,,p65,CMV,I,21*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSLGGYNKLIF,,p65,CMV,I,3*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSLGTPLVF,,p65,CMV,I,1-2*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSLRSNDYKLSF,,p65,CMV,I,1-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSNAGGTSYGKLTF,,p65,CMV,I,22*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSNSGSARQLTF,,p65,CMV,I,3*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPFDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPFSGGYNKLIF,,p65,CMV,I,12-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPLYSSASKIIF,,p65,CMV,I,3*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPMDSSYKLIF,,p65,CMV,I,8-4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPPLHSGGGADGLTF,,p65,CMV,I,36/DV7*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPSNTGKLIF,,p65,CMV,I,8-6*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSPYNQGGKLIF,,p65,CMV,I,8-4*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSQAGTALIF,,p65,CMV,I,22*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSREETSGSRLTF,,p65,CMV,I,41*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSRFSGGYNKLIF,,p65,CMV,I,8-4*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSRNNAGNMLTF,,p65,CMV,I,8-6*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSSDYKLSF,,p65,CMV,I,1-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSSGGYQKVTF,,p65,CMV,I,1-2*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSSPSGGSYIPTF,,p65,CMV,I,3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSTNAGKSTF,,p65,CMV,I,21*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVSWEKLTF,,p65,CMV,I,12-2*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTDTGGFKTIF,,p65,CMV,I,21*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTFDRGSTLGRLYF,,p65,CMV,I,21*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTGKLIF,,p65,CMV,I,1-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTGYGQNFVF,,p65,CMV,I,1-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTILSNNAGNMLTF,,p65,CMV,I,8-6*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTLQSGGSYIPTF,,p65,CMV,I,8-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTMDSSYKLIF,,p65,CMV,I,12-2*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTNQAGTALIF,,p65,CMV,I,1-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTPPGFQKLVF,,p65,CMV,I,12-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTQNYGAGSYQLTF,,p65,CMV,I,21*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTRGGGSNYKLTF,,p65,CMV,I,22*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTRNNARLMF,,p65,CMV,I,21*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTRNYGQNFVF,,p65,CMV,I,8-6*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTRSARQLTF,,p65,CMV,I,8-4*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTSDYKLSF,,p65,CMV,I,12-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTSPPAYDKVIF,,p65,CMV,I,12-2*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTSTGTASKLTF,,p65,CMV,I,22*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVTVSQAGTALIF,,p65,CMV,I,21*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVASGGGADGLTF,,p65,CMV,I,8-3*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVDAGGTSYGKLTF,,p65,CMV,I,21*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVFTGGGNKLTF,,p65,CMV,I,8-3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVLRQAGTALIF,,p65,CMV,I,22*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVMDSNYQLIW,,p65,CMV,I,21*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVRRETSGSRLTF,,p65,CMV,I,22*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVRWEISGSRLTF,,p65,CMV,I,22*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVRWETSGSRLTF,,p65,CMV,I,22*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVRWETSGSRLTF,,p65,CMV,I,22*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVRWETSGSRLTF,,p65,CMV,I,36/DV7*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVRWETSGSRLTF,,p65,CMV,I,8-3*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVSSGGSYIPTF,,p65,CMV,I,8-3*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVTQTGANNLFF,,p65,CMV,I,8-3*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVVAYGQNFVF,,p65,CMV,I,22*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVWDPSQFYF,,p65,CMV,I,41*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVYNTDKLIF,,p65,CMV,I,1-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVVYTGTASKLTF,,p65,CMV,I,8-3*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVWDSNYQLIW,,p65,CMV,I,1-2*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVWVNAGNMLTF,,p65,CMV,I,21*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVWYSGGGADGLTF,,p65,CMV,I,21*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYESVGFQKLVF,,p65,CMV,I,1-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYGGSYIPTF,,p65,CMV,I,21*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYHNYGQNFVF,,p65,CMV,I,41*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYLFQTGANNLFF,,p65,CMV,I,36/DV7*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYPGNSGYSTLTF,,p65,CMV,I,12-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYTTNAGKSTF,,p65,CMV,I,22*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYVSGTYKYIF,,p65,CMV,I,21*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAVYYGQNFVF,,p65,CMV,I,3*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAWDSGGSGNTGKLIF,,p65,CMV,I,12-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYAPSGTYKYIF,,p65,CMV,I,38-2/DV8*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYAVPFNRDDKIIF,,p65,CMV,I,38-2/DV8*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYAYRNNRLAF,,p65,CMV,I,24*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYDTGANSKLTF,,p65,CMV,I,38-2/DV8*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYGDSNYQLIW,,p65,CMV,I,38-2/DV8*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYGDTGNQFYF,,p65,CMV,I,38-2/DV8*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYGRGKLIF,,p65,CMV,I,17*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYGSNDMRF,,p65,CMV,I,38-2/DV8*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYHNTDKLIF,,p65,CMV,I,24*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYHSQAGTALIF,,p65,CMV,I,38-2/DV8*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYIGRDDKIIF,,p65,CMV,I,38-2/DV8*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYKAGNTGKLIF,,p65,CMV,I,38-2/DV8*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYKDGNQFYF,,p65,CMV,I,38-2/DV8*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYNAGNMLTF,,p65,CMV,I,38-2/DV8*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYNTGTASKLTF,,p65,CMV,I,38-2/DV8*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYPDPGAQKLVF,,p65,CMV,I,38-2/DV8*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYPKAAGNKLTF,,p65,CMV,I,3*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYPNQAGTALIF,,p65,CMV,I,38-2/DV8*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYPNSGNTPLVF,,p65,CMV,I,38-2/DV8*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYPSNTGKLIF,,p65,CMV,I,36/DV7*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRANTGTASKLTF,,p65,CMV,I,38-2/DV8*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYREPNFGNEKLTF,,p65,CMV,I,38-2/DV8*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRNLLGANSKLTF,,p65,CMV,I,38-2/DV8*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRPLNSNYQLIW,,p65,CMV,I,38-2/DV8*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRAYGQNFVF,,p65,CMV,I,38-2/DV8*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRDDKIIF,,p65,CMV,I,38-2/DV8*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRDTGNQFYF,,p65,CMV,I,38-2/DV8*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRGGATNKLIF,,p65,CMV,I,38-2/DV8*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRGGNQFYF,,p65,CMV,I,38-2/DV8*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRGNNNDMRF,,p65,CMV,I,38-2/DV8*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRPLLFSSGSARQLTF,,p65,CMV,I,38-2/DV8*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRRDRGSTLGRLYF,,p65,CMV,I,38-2/DV8*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRSNNNAGNMLTF,,p65,CMV,I,38-2/DV8*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRRTVDSNYQLIW,,p65,CMV,I,38-2/DV8*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSAAGANSKLTF,,p65,CMV,I,38-2/DV8*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSAMIIF,,p65,CMV,I,38-2/DV8*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSANYGQNFVF,,p65,CMV,I,38-2/DV8*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSASGGWGGFKTIF,,p65,CMV,I,38-2/DV8*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSASKLIF,,p65,CMV,I,38-2/DV8*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSASYGQNFVF,,p65,CMV,I,38-2/DV8*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSFYTGTASKLTF,,p65,CMV,I,38-2/DV8*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSGGANSKLTF,,p65,CMV,I,38-2/DV8*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSGGSEKLVF,,p65,CMV,I,38-2/DV8*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSGGSGNTPLVF,,p65,CMV,I,38-2/DV8*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSGNSGYALNF,,p65,CMV,I,38-2/DV8*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSLYGQNFVF,,p65,CMV,I,38-2/DV8*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSPAGKLTF,,p65,CMV,I,38-2/DV8*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSPNYGGATNKLIF,,p65,CMV,I,38-2/DV8*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSPTLYNFNKFYF,,p65,CMV,I,38-2/DV8*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSPVTGANSKLTF,,p65,CMV,I,38-2/DV8*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSRNTGNQFYF,,p65,CMV,I,38-2/DV8*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSSNNDMRF,,p65,CMV,I,38-2/DV8*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSTPQGGSEKLVF,,p65,CMV,I,38-2/DV8*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRSVNYGQNFVF,,p65,CMV,I,38-2/DV8*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRTLAQGGSEKLVF,,p65,CMV,I,38-2/DV8*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRTPRGDDKIIF,,p65,CMV,I,38-2/DV8*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRTRLSGSARQLTF,,p65,CMV,I,38-2/DV8*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYRTSSGGGADGLTF,,p65,CMV,I,38-2/DV8*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYSLPGRGNEKLTF,,p65,CMV,I,38-2/DV8*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYSRGGADGLTF,,p65,CMV,I,38-2/DV8*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYSTGTASKLTF,,p65,CMV,I,38-2/DV8*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYTGDMRF,,p65,CMV,I,38-2/DV8*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYTGGGNKLTF,,p65,CMV,I,24*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYTRGGADGLTF,,p65,CMV,I,38-2/DV8*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYYGNEKLTF,,p65,CMV,I,38-2/DV8*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CAYYSNYQLIW,,p65,CMV,I,38-2/DV8*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGAASQGGSEKLVF,,p65,CMV,I,34*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGADAFTNTGNQFYF,,p65,CMV,I,34*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGADIIGNTGKLIF,,p65,CMV,I,34*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGADKSNDYKLSF,,p65,CMV,I,34*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGFNTGNQFYF,,p65,CMV,I,30*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGGTPLVF,,p65,CMV,I,34*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGMLGNTGKLIF,,p65,CMV,I,30*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGSMDSSYKLIF,,p65,CMV,I,30*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTADTDKLIF,,p65,CMV,I,30*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTENPPGSSNTGKLIF,,p65,CMV,I,30*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTESLNSGYALNF,,p65,CMV,I,30*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTESPSGAGSYQLTF,,p65,CMV,I,30*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTEVGTDKLIF,,p65,CMV,I,30*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTEVYNQGGKLIF,,p65,CMV,I,30*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTGGSGDSNYQLIW,,p65,CMV,I,30*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTPDQGSSNTGKLIF,,p65,CMV,I,30*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTPGNAGGTSYGKLTF,,p65,CMV,I,30*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTVINYGGSQGNLIF,,p65,CMV,I,30*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTVMNYGESQGNLIF,,p65,CMV,I,30*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTVMNYGGSQGNLIF,,p65,CMV,I,30*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CGTYNTDKLIF,,p65,CMV,I,30*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIALLSQGGSEKLVF,,p65,CMV,I,26-1*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIARATGNKLVF,,p65,CMV,I,26-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIAYQGAGNMLTF,,p65,CMV,I,26-1*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CICRSGTYKYIF,,p65,CMV,I,26-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIGEGGGADGLTF,,p65,CMV,I,26-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIGFSGGYNKLIF,,p65,CMV,I,26-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILDDNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILDNNNDMRFGAGTRLTVKPKTHNTVTTSGTYKYIF,,p65,CMV,I,26-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILDNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILDNNNGMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILDNNNNMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILDQTGANNLFF,,p65,CMV,I,26-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILGLSGNMLTF,,p65,CMV,I,26-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILGNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILGYNTDKLIF,,p65,CMV,I,26-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILIRSYNTDKLIF,,p65,CMV,I,26-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILKESSNTGKLIF,,p65,CMV,I,26-2*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILLDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILLRDTGFQKLVF,,p65,CMV,I,26-2*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILMNSGGSNYKLTF,,p65,CMV,I,26-2*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILNNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILNQGAQKLVF,,p65,CMV,I,26-2*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILPNAGNNRKLIW,,p65,CMV,I,26-2*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILPRSQGGSEKLVF,,p65,CMV,I,26-2*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDAGGTSYGKLTF,,p65,CMV,I,26-2*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDDNAGGTSYGKLTF,,p65,CMV,I,26-2*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDLIQGGSEKLVF,,p65,CMV,I,26-2*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDLNSNSGYALNF,,p65,CMV,I,26-2*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDRGNNARLMF,,p65,CMV,I,26-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDRNAGNMLTF,,p65,CMV,I,26-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDSFNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDSPTSGTYKYIF,,p65,CMV,I,26-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDSYTDRLIF,,p65,CMV,I,26-2*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDVDNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDVGEYGNKLVF,,p65,CMV,I,26-2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRDVLRKLIF,,p65,CMV,I,26-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILREAPTSGTYKYIF,,p65,CMV,I,26-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRFPPPGYGNKLVF,,p65,CMV,I,26-2*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRGDDKIIF,,p65,CMV,I,26-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRGGADGLTF,,p65,CMV,I,26-2*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRGGAYKYIF,,p65,CMV,I,26-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRLGGSQGNLIF,,p65,CMV,I,26-2*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRQAGTALIF,,p65,CMV,I,26-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRRETSGSRLTF,,p65,CMV,I,26-2*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRRNAGNMLTF,,p65,CMV,I,26-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRRYTSGTYKYIF,,p65,CMV,I,26-2*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRVGGQNFVF,,p65,CMV,I,26-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILRVPSGAGSYQLTF,,p65,CMV,I,26-2*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSDDYKLSF,,p65,CMV,I,26-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSDNYGQNFVF,,p65,CMV,I,26-2*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSETQKLVF,,p65,CMV,I,26-2*01,,54*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSNNNGMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSPGPFYNQGGKLIF,,p65,CMV,I,26-2*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILSRGDNARLMF,,p65,CMV,I,26-2*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILTGANNLFF,,p65,CMV,I,26-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILTLSGTASKLTF,,p65,CMV,I,26-2*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILTRDDKIIF,,p65,CMV,I,26-2*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILYNNNDMRF,,p65,CMV,I,26-2*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CILYNTNAGKSTF,,p65,CMV,I,26-2*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CISDQTGANNLFF,,p65,CMV,I,26-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVETSGTYKYIF,,p65,CMV,I,26-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVFAGNQFYF,,p65,CMV,I,26-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVLSSQTSGSRLTF,,p65,CMV,I,26-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVPKAAGNKLTF,,p65,CMV,I,26-1*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRADTGTASKLTF,,p65,CMV,I,26-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRAGSYQLTF,,p65,CMV,I,26-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRAYGALTNFGNEKLTF,,p65,CMV,I,26-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRDDKIIF,,p65,CMV,I,26-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRFGGNFNKFYF,,p65,CMV,I,26-1*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRFLSGANNLFF,,p65,CMV,I,26-1*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRFYDARLMF,,p65,CMV,I,26-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRGHSGAGSYQLTF,,p65,CMV,I,26-1*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVAENSGYALNF,,p65,CMV,I,26-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVAGYSTLTF,,p65,CMV,I,26-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVALTGFQKLVF,,p65,CMV,I,26-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVAPGGGADGLTF,,p65,CMV,I,26-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVDPGNTGKLIF,,p65,CMV,I,26-1*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVEAGANNLFF,,p65,CMV,I,26-1*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVLAGNTGKLIF,,p65,CMV,I,26-1*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVPSLNDYKLSF,,p65,CMV,I,26-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVSLYGQNFVF,,p65,CMV,I,26-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVVGNRDDKIIF,,p65,CMV,I,26-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVVWNDMRF,,p65,CMV,I,26-1*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVRVVWSGATNKLIF,,p65,CMV,I,26-1*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CIVSDTNAGKSTF,,p65,CMV,I,26-1*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLAILNTDKLIF,,p65,CMV,I,4*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLGGYYCDNNNDMRF,,p65,CMV,I,40*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLLGCLTGANSKLTF,,p65,CMV,I,40*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLLGDYCDNNNDMRF,,p65,CMV,I,40*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLLKSWGGTASKLTF,,p65,CMV,I,40*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLLQGGSEKLVF,,p65,CMV,I,40*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLLTQGGSEKLVF,,p65,CMV,I,40*01,,57*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLMNRDDKIIF,,p65,CMV,I,4*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLQTGANNLFF,,p65,CMV,I,40*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVAFTGTASKLTF,,p65,CMV,I,4*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVAYISGGYNKLIF,,p65,CMV,I,4*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVEEFSGGYNKLIF,,p65,CMV,I,4*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVFPGGAGSYQLTF,,p65,CMV,I,4*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGAAGNKLTF,,p65,CMV,I,4*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGAKYSSASKIIF,,p65,CMV,I,4*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGALSNAGNMLTF,,p65,CMV,I,4*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGAQPLNTGFQKLVF,,p65,CMV,I,4*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGARAYSSASKIIF,,p65,CMV,I,4*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGARNKLVF,,p65,CMV,I,4*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDERGANAGKSTF,,p65,CMV,I,4*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDESGGYQKVTF,,p65,CMV,I,4*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDGARLMF,,p65,CMV,I,4*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDINSNYQLIW,,p65,CMV,I,4*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDKGAGNMLTF,,p65,CMV,I,4*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDKGGGFKTIF,,p65,CMV,I,4*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDMGGGFKTIF,,p65,CMV,I,4*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDPTGGSYIPTF,,p65,CMV,I,4*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDRGAGNMLTF,,p65,CMV,I,4*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDSGGYQKVTF,,p65,CMV,I,4*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDSTGKLIF,,p65,CMV,I,4*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDTGTASKLTF,,p65,CMV,I,4*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDTNAGKSTF,,p65,CMV,I,4*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGDVGDMRF,,p65,CMV,I,4*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGEEKLVF,,p65,CMV,I,4*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGIFSGGYNKLIF,,p65,CMV,I,4*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGPWESSASKIIF,,p65,CMV,I,4*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGRGSYKLIF,,p65,CMV,I,4*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVGWLSDKIIF,,p65,CMV,I,4*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVVGYGQNFVF,,p65,CMV,I,4*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVVSGSARQLTF,,p65,CMV,I,4*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVVSYSSASKIIF,,p65,CMV,I,4*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVVYTGGFKTIF,,p65,CMV,I,4*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CLVYTNAGKSTF,,p65,CMV,I,4*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVADKIIF,,p65,CMV,I,10*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVANNAGNMLTF,,p65,CMV,I,12-1*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVATFSGGYNKLIF,,p65,CMV,I,12-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVAVTGNQFYF,,p65,CMV,I,12-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVAYNTDKLIF,,p65,CMV,I,10*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVCHTGTASKLTF,,p65,CMV,I,12-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVDPMFSGGYNKLIF,,p65,CMV,I,10*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVGMNYGGSQGNLIF,,p65,CMV,I,10*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVGRNTGFQKLVF,,p65,CMV,I,12-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVLGGTGANNLFF,,p65,CMV,I,10*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVLLMNSGYSTLTF,,p65,CMV,I,12-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVLPNNAGNMLTF,,p65,CMV,I,10*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVPMDSNYQLIW,,p65,CMV,I,10*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVPRAGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVPSSGYALNF,,p65,CMV,I,12-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVRPKAAGNKLTF,,p65,CMV,I,8-2*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVSESSASKIIF,,p65,CMV,I,12-1*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVAGNTGKLIF,,p65,CMV,I,12-1*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVAPSGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVDFTGTASKLTF,,p65,CMV,I,10*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVDPGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVEGGSYIPTF,,p65,CMV,I,8-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVFDSNYQLIW,,p65,CMV,I,10*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVFGGFKTIF,,p65,CMV,I,12-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVFPGAFNAGNNRKLIW,,p65,CMV,I,10*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVFSGGYNKLIF,,p65,CMV,I,12-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVFVGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVGDYNTDKLIF,,p65,CMV,I,10*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVGGLGSGNTGKLIF,,p65,CMV,I,10*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVGMDAGNMLTF,,p65,CMV,I,10*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVGNNNARLMF,,p65,CMV,I,12-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVHSGTALIF,,p65,CMV,I,10*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVIASNSGYALNF,,p65,CMV,I,12-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVIDRGSTLGRLYF,,p65,CMV,I,10*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVIILTGGGNKLTF,,p65,CMV,I,12-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVIPGGQAGTALIF,,p65,CMV,I,12-1*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVIRLNAGNMLTF,,p65,CMV,I,12-1*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVISLGGSYIPTF,,p65,CMV,I,8-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVITSGTYKYIF,,p65,CMV,I,12-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVKFNSGYSTLTF,,p65,CMV,I,12-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVKLGNTGKLIF,,p65,CMV,I,10*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVKRDDKIIF,,p65,CMV,I,12-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVKRSGGYQKVTF,,p65,CMV,I,12-1*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVLDPNAGGTSYGKLTF,,p65,CMV,I,12-1*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVLGNEKLTF,,p65,CMV,I,12-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVLRDSGAGSYQLTF,,p65,CMV,I,8-2*01,,28*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVLRGGYGQNFVF,,p65,CMV,I,12-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVMKTSYDKVIF,,p65,CMV,I,12-1*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVMMTGNQFYF,,p65,CMV,I,12-1*01,,49*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNAFNKFYF,,p65,CMV,I,12-1*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNAGNNRKLIW,,p65,CMV,I,12-1*01,,38*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNALGTMASNTGKLIF,,p65,CMV,I,12-1*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNATGTYKYIF,,p65,CMV,I,12-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNDDYKLSF,,p65,CMV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNDYKLSF,,p65,CMV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNFGLNDMRF,,p65,CMV,I,12-1*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNFSGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNGGAGANNLFF,,p65,CMV,I,12-1*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNGGDSSYKLIF,,p65,CMV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNGGLFSGGYNKLIF,,p65,CMV,I,12-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNGGSGGSNYKLTF,,p65,CMV,I,12-1*01,,53*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNGKDSSYKLIF,,p65,CMV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNIGNDYKLSF,,p65,CMV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNIGSTLTF,,p65,CMV,I,12-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNIRGKLIF,,p65,CMV,I,12-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNIVLTGGGNKLTF,,p65,CMV,I,12-1*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNKAAGNKLTF,,p65,CMV,I,12-1*01,,17*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNKDRGSTLGRLYF,,p65,CMV,I,12-1*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNKEGKLIF,,p65,CMV,I,12-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNKIYNQGGKLIF,,p65,CMV,I,12-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNKLEYGNKLVF,,p65,CMV,I,12-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNKNNFNKFYF,,p65,CMV,I,12-1*01,,21*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNLHGNKLVF,,p65,CMV,I,12-1*01,,47*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNMEAGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNMGGYSTLTF,,p65,CMV,I,12-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNMPPGTASKLTF,,p65,CMV,I,12-1*01,,44*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNNNNARLMF,,p65,CMV,I,12-1*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNNNQGGKLIF,,p65,CMV,I,12-1*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNPNFQKLVF,,p65,CMV,I,12-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNPSGGYQKVTF,,p65,CMV,I,12-1*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNREPGGYQKVTF,,p65,CMV,I,12-1*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNRIRGSTLGRLYF,,p65,CMV,I,12-1*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNRKYSSASKIIF,,p65,CMV,I,12-1*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNRQPGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNRSGGYNKLIF,,p65,CMV,I,12-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNRTGGFKTIF,,p65,CMV,I,12-1*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNSFSGGYNKLIF,,p65,CMV,I,12-1*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNSGTYKYIF,,p65,CMV,I,12-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNTGMDSNYQLIW,,p65,CMV,I,12-1*01,,33*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNWAPSGYALNF,,p65,CMV,I,12-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNWYLERF,,p65,CMV,I,12-1*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVNYPGGGADGLTF,,p65,CMV,I,12-1*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVPHASGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVPLNSGYALNF,,p65,CMV,I,12-1*01,,41*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVPRRGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVPWGGSQGNLIF,,p65,CMV,I,10*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVQPKPNQTGANNLFF,,p65,CMV,I,10*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVQVNRDDKIIF,,p65,CMV,I,12-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVRGIASGGYNKLIF,,p65,CMV,I,8-2*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVRGNTPLVF,,p65,CMV,I,12-1*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVRMNYGGSQGNLIF,,p65,CMV,I,8-2*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVRNQAGTALIF,,p65,CMV,I,12-1*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSADDYKLSF,,p65,CMV,I,10*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSAQAGTALIF,,p65,CMV,I,8-2*01,,15*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSARNSGGGADGLTF,,p65,CMV,I,10*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSARSGGGADGLTF,,p65,CMV,I,10*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSASAGGYNKLIF,,p65,CMV,I,10*01,,4*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSASGGSYIPTF,,p65,CMV,I,8-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSAWRYNNNDMRF,,p65,CMV,I,10*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDIYSSASKIIF,,p65,CMV,I,8-2*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDLGSSASKIIF,,p65,CMV,I,8-2*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDLRDNAGNMLTF,,p65,CMV,I,8-2*01,,39*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDNGGGSYIPTF,,p65,CMV,I,8-2*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDPPAGANNLFF,,p65,CMV,I,8-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDPTGANNLFF,,p65,CMV,I,8-2*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDRGSTLGRLYF,,p65,CMV,I,10*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDRTNAGKSTF,,p65,CMV,I,8-2*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDTGGFKTIF,,p65,CMV,I,8-2*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSDVNGGSQGNLIF,,p65,CMV,I,10*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSEWDSGYSTLTF,,p65,CMV,I,8-2*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSGGGADGLTF,,p65,CMV,I,10*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSGGGAGGTSYGKLTF,,p65,CMV,I,8-2*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSGLTGGGNKLTF,,p65,CMV,I,10*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSHSSGSARQLTF,,p65,CMV,I,12-1*01,,22*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSLSNFGNEKLTF,,p65,CMV,I,12-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSPDDKIIF,,p65,CMV,I,12-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSPDRGSTLGRLYF,,p65,CMV,I,10*01,,18*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSPGGGADGLTF,,p65,CMV,I,10*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSREGYSTLTF,,p65,CMV,I,12-1*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSRMDSSYKLIF,,p65,CMV,I,10*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSRSNDYKLSF,,p65,CMV,I,10*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSTNAGKSTF,,p65,CMV,I,12-1*01,,27*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSVFTGGFKTIF,,p65,CMV,I,8-2*01,,9*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSVGYSSASKIIF,,p65,CMV,I,8-2*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSVYSGGGADGLTF,,p65,CMV,I,10*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVSWGANDYKLSF,,p65,CMV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTAASGNTPLVF,,p65,CMV,I,12-1*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTCTGGGNKLTF,,p65,CMV,I,10*01,,10*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTDGRYGGATNKLIF,,p65,CMV,I,12-1*01,,32*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTFYGNNRLAF,,p65,CMV,I,10*01,,7*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTGGDYKLSF,,p65,CMV,I,10*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTLMNRDDKIIF,,p65,CMV,I,12-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTLPSGGSYIPTF,,p65,CMV,I,12-1*01,,6*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTNSGGGADGLTF,,p65,CMV,I,10*01,,45*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTRGAYNTDKLIF,,p65,CMV,I,12-1*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVTYNYGQNFVF,,p65,CMV,I,12-1*01,,26*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVVITIQKLVF,,p65,CMV,I,12-1*01,,8*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVVKTSYDKVIF,,p65,CMV,I,8-2*01,,50*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVVYTGRRALTF,,p65,CMV,I,12-1*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,CVYSRRDTGRRALTF,,p65,CMV,I,12-1*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,SSGNQFYF,,p65,CMV,I,21*01,,49*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CAAGAGLSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAALAVDTQYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CACFENYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CACLGTGTYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CACLTGATNEKLFF,p65,CMV,I,,30*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CACTPEIGNTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAFDKSNEKLFF,p65,CMV,I,,30*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAGGDRDTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAGSHEGSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAGSLAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAGSQAGMAEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAGSQTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAGYFNYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAHRENTEAFF,p65,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAHSDSIGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIASGTVRGNTIYF,p65,CMV,I,,10-3*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIGDSSSYNEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIGGGLADTQYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIGLAAADTQYF,p65,CMV,I,,10-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIKYRPRTGENYGYTF,p65,CMV,I,,10-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAILGFFSTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAILPVFRNNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAINAGDTGELFF,p65,CMV,I,,10-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAINTDRGGTEAFF,p65,CMV,I,,10-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIPDIKEGGYTF,p65,CMV,I,,6-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRDGRHSYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRDNSYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRDRDRNYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRDSFSYNEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRDVEETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIREPHKGGNYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRKTENTEAFF,p65,CMV,I,,10-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAIRTGGGEAFF,p65,CMV,I,,10-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISADSPAAQYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISAGAEAHEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISALAGVDEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDGSYWDEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDGTGVSPLHF,p65,CMV,I,,10-3*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDLAGVRPDTQYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDLKNYGYTF,p65,CMV,I,,10-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDLTNEKLFF,p65,CMV,I,,10-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDRDAYYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDRGGPTYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISDSETNTGELFF,p65,CMV,I,,10-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEEGGADEKLFF,p65,CMV,I,,10-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEGAGGQETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEGASGYTF,p65,CMV,I,,10-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEGGGVTEAFF,p65,CMV,I,,10-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEGTNTGELFF,p65,CMV,I,,10-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEGVGGLEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISELAGVHEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISELSGGEVYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEPTEWAGELFF,p65,CMV,I,,10-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISERNYRERDGYTF,p65,CMV,I,,10-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISESGELNQPQHF,p65,CMV,I,,10-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISESPDMLMGNEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISESRTGAYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISESVQGLAKNIQYF,p65,CMV,I,,10-3*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISESWTDYYGYTF,p65,CMV,I,,10-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISETLLDFSYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISEYGTGAFEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISGGAGGPGEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISGLAGVDTQYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISGLAGVNEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISGLTGSPDTQYF,p65,CMV,I,,10-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISGTGSYNEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISGWRQGSYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISKSKGYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISLEDSSYNEQFF,p65,CMV,I,,10-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISLKTSGETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISPLGTQIFSGNTIYF,p65,CMV,I,,10-3*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISPSSEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISQRTGGETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISQTQLWETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISSRSSYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISVGTGYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAISYRGTTQETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAITEGGAHNYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAITPLGLPYEQYF,p65,CMV,I,,10-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CALGQDSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CALGVDRTEAFF,p65,CMV,I,,6-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CALPSTDTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAMGGEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAMGPGQVYSGNTIYF,p65,CMV,I,,10-3*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANDRGAPNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANFRTGGLFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSFYFTGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSLAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSPVAGAPHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSQAGMAEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSQTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSQVIDQETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSSLSGPYEQYF,p65,CMV,I,,10-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CANSSVNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAPMWAPLHF,p65,CMV,I,,6-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAPRPGPRSTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAREGGNYGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAREQTGNTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CARLAGDTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CARPQETQYF,p65,CMV,I,,18*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CARSCEIVQRYGGCEQFF,p65,CMV,I,,5-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CARSLAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CARSQTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASAETGQGAAGYTF,p65,CMV,I,,12-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASAGLAGADEQFF,p65,CMV,I,,6-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASALAGGPGGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASANPVAVSTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASANSVNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASAPQGENQPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASASAGGPYNEQFF,p65,CMV,I,,12-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASASLTTVDGQYF,p65,CMV,I,,12-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASASPGASGGAGQNTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASATGGLYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASCAGGQGSDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASCFMNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASCIAPGVQETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASCPGPEGTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASCPLWEGGYTF,p65,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASCRPPDRVDNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASDRGASTDTQYF,p65,CMV,I,,4-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASDSGEYQETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASDTFAGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASEGLRYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASEMSGSVDEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASEQESSYNEQFF,p65,CMV,I,,12-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASETEGVLGGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASETEGVRGGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASETERVRGGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASEWGSNSNQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASFFRRDGDNQPQHF,p65,CMV,I,,7-4*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASFGEVQGAVEEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASFISGGADDTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASFSGTSYTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGASGSSEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGDGGAPNSYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGDGSYYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGDLNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGEARNQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGFGGNEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGFGNTEAFF,p65,CMV,I,,12-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGAVAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGDRVVWTEAFF,p65,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGGGAEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGGSEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGRNYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGSPQHEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGVYSGGAVEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGGYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGKQENEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLAPGATNEKLFF,p65,CMV,I,,12-5*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLDHGYEQYF,p65,CMV,I,,12-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLGDRVVDEQFF,p65,CMV,I,,12-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLGGETQYF,p65,CMV,I,,12-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLGLYYEQYF,p65,CMV,I,,12-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLPQGRGEQFF,p65,CMV,I,,12-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLQGARDTEAFF,p65,CMV,I,,12-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLTGFMDEQYF,p65,CMV,I,,12-5*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASGLVPTTGELFF,p65,CMV,I,,12-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGLYGNGPGADTQYF,p65,CMV,I,,12-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGPTGTDNSPLHF,p65,CMV,I,,9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGQGAGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGQGGTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGQGNTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGRGDGPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGRGLAGEFYNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGRGYTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGSDRGLVGEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGSGTLNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGTDRGTPYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGTGELFF,p65,CMV,I,,25-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGTGGNYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGTHFSPYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGTSWCGANVLTF,p65,CMV,I,,7-9*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGVGPQETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGVGSAYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGWGVQGESKSYGYTF,p65,CMV,I,,12-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGYNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGYQRGATYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGYSAGYNSPLHF,p65,CMV,I,,19*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASGYYSGGGSAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASHDRGNQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASHPGAGPSYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASHPPGLGDNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASHQGQFTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIALAETGELFF,p65,CMV,I,,6-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIGERETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIGIFNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIHGPSRDTGELFF,p65,CMV,I,,6-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIKGLMNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASILAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASILGAGSLNTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASILMGQSLGTQYF,p65,CMV,I,,5-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASINPMRAYQETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIPGTGQNTEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIPPGGTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIPSRQGAGDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIPSSGEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASISSGGWQETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASIVPENYGYTF,p65,CMV,I,,7-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKAAGFREQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKDALGETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKEGGGVYGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKERRENHNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKFAGGPYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKFTSSWSDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKGALEGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKGGSSGTDTQYF,p65,CMV,I,,13*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKGVGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKLGQGYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKLIRGVTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKMEAGLSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKPSGGQETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKQGAEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKQGSNDEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKRDNSYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKSQGFAEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKSTGGTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKTGQGSTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKTLGSTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKTVRGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKVSLSETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASKVTGDVNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLGQGNEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLIVPWGTSGTTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLPRGGPGANVLTF,p65,CMV,I,,19*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLQGRTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLRGAEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLRGRPTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLTRLAGGLYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASLVVGFYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMDKGERFDGYTF,p65,CMV,I,,7-8*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMGGNIQYF,p65,CMV,I,,25-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMGLGNTIYF,p65,CMV,I,,28*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMGQGPYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMGRLAGIYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMPIQDTTWTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASMSFSSGANVLTF,p65,CMV,I,,7-9*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNADRDYPGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNFTSDIQYF,p65,CMV,I,,5-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNFYFTGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNGLGPHTDTQYF,p65,CMV,I,,25-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNGLTNTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNGQVAFYNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNGRVQYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNHEGSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNHRDRGRGADEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNHRGLGYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNIAGDYGYTF,p65,CMV,I,,6-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLAGAREEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLAGARETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLGGGTGELFF,p65,CMV,I,,25-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLGGPNQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLGGPVDEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNLKGLAGGPGTQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNPLLGAGGTYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNPPTDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNPQGSNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNPQGSSYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNPRRDTGYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNPSLGFSYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQGPEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTATGAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTETGAYDYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTETGAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTGTEAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTGTGAYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTGTGAYSYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNQVTGTRAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNRGAEPQHF,p65,CMV,I,,25-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNSDRDDLLNTEAFF,p65,CMV,I,,6-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNSGNTIYF,p65,CMV,I,,6-6*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNSPGLLTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNVKIGELFF,p65,CMV,I,,5-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNWADYSNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASNYLSDLRYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASPGGRLAGNTIYF,p65,CMV,I,,6-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASPGPYEKLFF,p65,CMV,I,,30*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASPNPWLTRIEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASPPDLASTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASPPRHKYLPGETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASPSQLRPQETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASQDDYSNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASQDREGRGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASQIALQGEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASQLRESGNTIYF,p65,CMV,I,,6-5*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASQREGINTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRADGSAYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRADTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRAEGRTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRAGELDTDTQYF,p65,CMV,I,,5-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRAGHGSPGDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRAGIETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRAQGAYYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRASYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRATGSNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDAGGTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDEGLAEYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDGGQIDESQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDGGQIDKTQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDGGQINETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDGGRIDETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDGPSPYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDHRVPSDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDNPPYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDRGVNEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDRGYNQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDRTSGYNEQFF,p65,CMV,I,,13*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDRVEEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDSGEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDSLNEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDSRGTEAFF,p65,CMV,I,,4-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDTPYGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDVSGTPGSGEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRDWEGYEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASREDYNSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASREETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASREGANGYTF,p65,CMV,I,,25-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASREGYEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRELSQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASREPSGRADEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRETGVYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRFYFTGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGAQGSVIHIQYF,p65,CMV,I,,7-9*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGDSYNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGGGDNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGGGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGGGRTSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGGQGAYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGGSKPFNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGGVWNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGLAGVSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGLAVNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGLAVPTGEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGLTSGSSTDTQYF,p65,CMV,I,,4-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGRDEKLFF,p65,CMV,I,,2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGRTGTNEKLFF,p65,CMV,I,,13*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGSDNYYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGSVGLAKKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGTGGYYEQYF,p65,CMV,I,,5-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGTGPETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGTHTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGTSGGPNTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRGTSNHEQFF,p65,CMV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRHDRGEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRIQGYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRIYHEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKAGTRIYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKEASLYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKENQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKGERTLEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKGGSSYNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKGVTTEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKQGNTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRKTGNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLAGAADTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLAGGNYNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLAGVGEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLDSLNYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLFETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLGPEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLGQLYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLGTGADTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLLAGGSSIQYF,p65,CMV,I,,27*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLLAGPSYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLLGQETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLLGVNEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLMNTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLRDGLYTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLRESSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRLSGGAADTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRMDRGTYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRMGFSNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRMGGKNTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRNLGGGTNSPLHF,p65,CMV,I,,10-2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRNRDTVRTEAFF,p65,CMV,I,,5-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPEGGSNYGYTF,p65,CMV,I,,7-8*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPFSGSPYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGARQETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGELLLHF,p65,CMV,I,,28*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGQGDTQYF,p65,CMV,I,,6-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGRLNEKLFF,p65,CMV,I,,6-5*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGRTHLNTEAFF,p65,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGTSGSDEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGTVNTEAFF,p65,CMV,I,,5-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGVMNTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPGWASHYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPITGDLCPYEQYF,p65,CMV,I,,6-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPLGGSYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPPGVYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPPQGVNEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPPQGVREQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPPRGGEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPPTGGEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPRQGRGSYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPRTGRGVYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPRTGTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPSDLQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPTANYGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRPTTSSYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRQGDSYNSPLHF,p65,CMV,I,,5-4*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRQGPGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRQLQGITDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRQQGWGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRQRPEAPNTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRRDSHNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRREDTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRRFGTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRRGRNTGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRRTGGRETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSGGAGGEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSGQGNQPQHF,p65,CMV,I,,5-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSGSYNEQFF,p65,CMV,I,,13*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSGTGGYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSGTGGYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSGTGSPETQYF,p65,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSLGGVAEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSRGAWETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSSGGFWNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSSYVGLADLPETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSTGLAGYNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRSWTGEADTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTEGAGWTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGAQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGAYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGDNEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGGQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGHNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGVANEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTGYTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTLSGTLAGELFF,p65,CMV,I,,5-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTQGEVGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTRGGMNTEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTSGQGNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTSGTLLYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTSVDTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTTYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRTVNSYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRVEYVETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRVGPEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRVLPRLAETPLSTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRWDSSYNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRWRGEGYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRWTEFSEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRWTGEYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRWTGFSEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRWTGFSGQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRYQGGEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRYRGPVGEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASRYSDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAAGGGGHTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSADFGGGEKLFF,p65,CMV,I,,5-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSADGTAWNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSADSPPYTGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAEALGGYFSGYTF,p65,CMV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAFPCREGRNNEQFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGDGTDTQYF,p65,CMV,I,,25-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGGAYEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGGLAGDEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGQGGVSETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGQGVWQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGTDLISPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGTGEETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAGTGFLFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAIRDSFYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSALAGARYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSALGGAGTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSALLAGGPHYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSALSGSWGQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAMDRDEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAMGGAGVSDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAPSGVEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAQLAPSYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAQTGASYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSARDRVVDEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSARDSRYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSARGGGITDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSARGQGRPGELFF,p65,CMV,I,,5-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSARQRSYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSARSKNIQYF,p65,CMV,I,,7-7*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSASGGTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSASGRNSYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSASYEQYF,p65,CMV,I,,7-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSATDAYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSATGLPYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSATGTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSATSTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSATTSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAWLPLNYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSAYPSGPEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSCGTDPYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDAGGTGNEQFF,p65,CMV,I,,6-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDAGSYEQYF,p65,CMV,I,,10-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDAQASLSNYGYTF,p65,CMV,I,,18*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDASTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDFREETQYF,p65,CMV,I,,6-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGDEQFF,p65,CMV,I,,10-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGGGGTAELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGGGTTGELFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGQGGQDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGRAWELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGSGALETQYF,p65,CMV,I,,10-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGTASTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGTGGDSTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGTGGSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGTGLNEKLFF,p65,CMV,I,,2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGTGYGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGTSAFPYEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDGYTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDHSLAVFENEQFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDIKGEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDIQANTEAFF,p65,CMV,I,,10-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDKARGGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDKPGLAGPDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDLAEETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDLAGAGYNEQFF,p65,CMV,I,,6-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDLGAGDQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDLGREQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDLWPNSYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDLYGNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDNYGYTF,p65,CMV,I,,25-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPASGIDYEQYF,p65,CMV,I,,10-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPETYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPFHNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPGDYGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPGGTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPGNQPQHF,p65,CMV,I,,6-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPLRKGADEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPPAEFNEKLFF,p65,CMV,I,,2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPPSGGNTDTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPSGFVNEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDPWAGTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDQSLGPDTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDRASTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDRGAYDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDRGGLYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDRGKQYYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSAGQGDTGELFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSGQGWIEKLFF,p65,CMV,I,,2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSGTLNTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSRQGSYEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSSGYSGANVLTF,p65,CMV,I,,9*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDSVSFLNQPQHF,p65,CMV,I,,6-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDTGQGVDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDTGVYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDTYTDTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDYLYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSDYRENSPLHF,p65,CMV,I,,2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAARATGELFF,p65,CMV,I,,6-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEADRNTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAEWTSWGYNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAGGRGTDTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAGLGHEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAHNYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEARDGETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEARNQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEARSLQETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEASGSGANVLTF,p65,CMV,I,,6-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAYWAGVNTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEAYYEQYF,p65,CMV,I,,10-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDHTEFYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDHTGFYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDLRTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDREVSEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDRGHWNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDRGLADTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEDSFNQPQHF,p65,CMV,I,,7-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEEGEGTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEEKGNNANTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEESGAAETQYF,p65,CMV,I,,6-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEEVLQETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEEWLQGNSYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEFEGVNTEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGAGNQPQHF,p65,CMV,I,,7-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGFGGGTIYNEQFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGGGGNTIYF,p65,CMV,I,,27*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGGPYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGGRVADTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGGTGYIHEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGGTGYTDTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGLSGLRGNGFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGNRGETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGNTGELFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGPARVDTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGQGADTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGQGHQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGQGTMNGELFF,p65,CMV,I,,6-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGQVSPGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGRTRAKLFF,p65,CMV,I,,2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGSTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGSYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGTASYGYTF,p65,CMV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGTGGGSTDTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGTISTGELFF,p65,CMV,I,,10-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGTSVPLAELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEGVMVTEAFF,p65,CMV,I,,10-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEHPYPGGEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEIGWGEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEKAGQGAEEQFF,p65,CMV,I,,6-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSELAGSYNEQFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSELGGAGTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSELGTVPGNTIYF,p65,CMV,I,,2*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSELTGGGNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSENWDNTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPGQGYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPIVTLGFCEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPLAAADEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPPRRGGPNEKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPQEGPEAFF,p65,CMV,I,,6-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPTGGETQYF,p65,CMV,I,,6-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEPTGTSYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEQGAPYNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEQGPTTYYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEQNSNQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSERGGAGYGYTF,p65,CMV,I,,19*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSERGPNYGYTF,p65,CMV,I,,25-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSERTTSGEKLFF,p65,CMV,I,,6-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSERVSGLNEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESGSGGIYEQYF,p65,CMV,I,,10-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESGSGNEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESGTANEQFF,p65,CMV,I,,10-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESGTEHEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESGTGGYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESLEGVNEKLFF,p65,CMV,I,,25-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESLGNTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESLTSGGSTGELFF,p65,CMV,I,,10-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESNSVYEQYF,p65,CMV,I,,10-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESPGTAYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESTDEKLFF,p65,CMV,I,,10-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESVSSYNEQFF,p65,CMV,I,,10-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSESWDRNSPLHF,p65,CMV,I,,10-2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETDSNYEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETEGFYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETGFGNQPQHF,p65,CMV,I,,25-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETGGTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETGSSRNSPLHF,p65,CMV,I,,11-2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETGVVNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETGYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETRSGTWDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSETSTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEVKGAIEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEVNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEVPGISNQPQHF,p65,CMV,I,,6-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEVPGVDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEVWGREVSLPSTDTQYF,p65,CMV,I,,6-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEWGTGGNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEWLAGRDEQFF,p65,CMV,I,,10-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEWTGYQPQHF,p65,CMV,I,,6-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEWTYTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEWVAFSYEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEYFVGQGASYGYTF,p65,CMV,I,,25-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEYGGPNSPLHF,p65,CMV,I,,25-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEYGNGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSEYPGGPGETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAAGGRNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAARSTGSANEKLFF,p65,CMV,I,,7-8*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAGLNYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAGNQPQHF,p65,CMV,I,,28*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAGQGSTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAGVNEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAPGTANTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFAQGTYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFATGPFLEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDGGEMGRNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDGPAGAGETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDGSYNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDLAETQYF,p65,CMV,I,,5-4*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDPDRGLEGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDQGTGGFRETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDRAVYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDRGSAGNTIYF,p65,CMV,I,,5-8*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFDYTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEENSNQPQHF,p65,CMV,I,,6-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEGGGSLGEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEGIYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEGMSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEGNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEGQLAYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEGVGNTIYF,p65,CMV,I,,5-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFEMATFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFENSYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFESYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFFPNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFFPSFEGISMGTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFFVGAGVGETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFFVGAGVGGTQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGARGRNYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGENTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGENTEAFF,p65,CMV,I,,5-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGDEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGGTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGNAYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGNEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGNTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGRGNYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGSNQPQHF,p65,CMV,I,,7-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGTEFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGGYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGHSEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGHSQETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGLADYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGLEMNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGLNTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGNNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGPRAGTTGELFF,p65,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGQGAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGQGAYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGQGGGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGQGLSNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGQGNTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGQLAEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGRSNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGSGAPGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGTGGQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGVGETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGVMEVLGDEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFGVSNQPQHF,p65,CMV,I,,13*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFIDLSGAGGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFIGTNNNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFIRGRDSPLHF,p65,CMV,I,,28*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFKGQSNFYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFKTGDQGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLAGEGYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLAGLGDEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLEGTEAFF,p65,CMV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLGAGTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLGAGVADTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLGGITGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLGHGRVGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLGKSYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLLAEETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLRDGLYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFLWANQGATNTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFMGPAGKLNTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFNFYEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFNSEGYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGAEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGALNEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGALNIQYF,p65,CMV,I,,28*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGASTYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGGSDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGRLAGQVSSYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGSGGLDEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGTDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGTGEETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPGYSYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPLGGTYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPSAEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPSDGSSYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPSLNTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPSQNTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFPTSGETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFQERTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFQETQYF,p65,CMV,I,,5-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFQGFTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSFQGYTEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CASSFRATSENTGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDANTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDPYYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDRGLNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDRPYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDRSQPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRDSTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRGPPYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRGSGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRGSYNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRGVNTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRLAGGTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRLQRESDTEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRQGAFGDTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRQGARSNQPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRQSNYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRTADTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFRTGALAGYTF,p65,CMV,I,,5-4*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSANEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSETQYF,p65,CMV,I,,5-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSFRMNSPLHF,p65,CMV,I,,5-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGDYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGGAANEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGGAVSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGKLFSGANVLTF,p65,CMV,I,,27*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGQPKAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGTDTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSGTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSLPYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSLPYKQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFSRNSPLHF,p65,CMV,I,,5-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTDRVYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTGAYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTGRSPLHF,p65,CMV,I,,5-8*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTGSPLHF,p65,CMV,I,,7-3*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTGTQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTLGTGGVEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSFTSGGGYEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTSGGVTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTSSRTDTQYF,p65,CMV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTTGATNYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFTVGGANVLTF,p65,CMV,I,,7-3*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVGATNEKLFF,p65,CMV,I,,28*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVGDGDEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVGGGEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVGGIDGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVGPTNSPLHF,p65,CMV,I,,28*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVGSAYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVMGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFVNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFWRYEQYF,p65,CMV,I,,7-7*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFWTGGTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFWWGSTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFAGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTEAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGALYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGAPHNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGAPYDEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGAPYNDQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGAPYYEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTGTPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTRAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFTVAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYFYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYGAGGEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYGTDQETQYF,p65,CMV,I,,5-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYITGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYNEKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSFYRRELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGAGTIRGEEFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGAGTKVNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGAKDYSGEKLFF,p65,CMV,I,,25-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGANTGELFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDIGGTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDNYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDRGTEAFF,p65,CMV,I,,18*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDRGYHEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDRPRYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGDSGLSYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGEDRVVYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGEKVRENIQYF,p65,CMV,I,,2*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGELGDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGEQGFYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGDWIEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGGAIHNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGGGTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGGLPLSSGNTIYF,p65,CMV,I,,9*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGGQGYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGGSGETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGHVEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGPGDNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGQGPSEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGRVLTANTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGSRGGSTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGSTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGSVNNEQFF,p65,CMV,I,,11-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGTDPSWDGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGTGELFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGTGLIPYGYTF,p65,CMV,I,,11-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGGTGTSGRAVEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGHDRVYDTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGIGRSKETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGINNEQFF,p65,CMV,I,,11-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGKGPEEVSTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGLQGTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGMSSYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGPDGAWEKLFF,p65,CMV,I,,10-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGPGEYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGQEPGVLLGEETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGQGATEAFF,p65,CMV,I,,10-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGQGSPEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGQLRTPRGEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGQPYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGQTGESQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGRDRAYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGRDSHEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGRGLNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGRQTAVMSSYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGRRQGGNGYTF,p65,CMV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGRTEGDYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGSGGLDGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGSGNTIYF,p65,CMV,I,,28*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTAYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTELQETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTGDTGELFF,p65,CMV,I,,6-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTGGADEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTGGFYEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTGGSTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTGWEETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTSGGQGYTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTSGGYNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTTGTGPYGYTF,p65,CMV,I,,5-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTVNYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGTVPTFNSPLHF,p65,CMV,I,,2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGVEFYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGVESSTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGVGAYTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGVGGWDEQYF,p65,CMV,I,,10-1*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CASSGVGNEPYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGVLGWVADGTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGWEAAYGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGWRGDLFEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGWTKNIQYF,p65,CMV,I,,19*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSGYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHADRVFTGELFF,p65,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHDLNSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHDPLEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHDTPRCLNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEDSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGAGANVLTF,p65,CMV,I,,3-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGLGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGSGCYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGSGGFTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGSGGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGSGSYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEGSSGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHEQGRNYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHESSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGGAYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGGGQNTEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGGKDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGGQAGREETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGGSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGHLTEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGTGGSLVGDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGTGGYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHGTSGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHHGSGNTIYF,p65,CMV,I,,3-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHKGSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHLGPGGPSYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHLGTGFWGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHLLDRGQETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHLQGSHGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHPGGQPQHF,p65,CMV,I,,4-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHPIDVSSYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHPLNTEAFF,p65,CMV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHPTGVFYGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHQAGEVNEQFF,p65,CMV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHQGLAASYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHQLAGSTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHQTGQGETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRDSDLYGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRDTGRNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRENTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRFNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRGTSGSTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRTDYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHRTSSGYQETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHSAKCTAYEQYF,p65,CMV,I,,7-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHSGGEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHSSGFNYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHTLGGKQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHTQGNTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSHVGRTDTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIAAGASNYGYTF,p65,CMV,I,,19*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIAAYYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIAGSGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIAGSKTQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIALYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIATGSEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIAVTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIAYEGLRTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIDAGLFSYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIDGGDGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIDGGLYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIDVGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIDWTSGGLFNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIEGAYSYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIEGQGAYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIEGSSSYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIFGGQIYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIFGGQNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIFSEGVGTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIFSGVSYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGGTGGLPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGKSWELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGRTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGRTYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGSAMGDIQYF,p65,CMV,I,,9*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGSPSGRANEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGTASYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGTGFHTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGTGNEQFF,p65,CMV,I,,11-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIGTNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIHQGLAEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIIAGDVDEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILAGGPDEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILAGYTSTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILAPPADYGYTF,p65,CMV,I,,19*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILDVSWTGSNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILFGQGGNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILGGNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILGSGEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILNVSWTGSNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSILPPPAGLNNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIPATPTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIPPGYYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIQGSSYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIQLGDEKLFF,p65,CMV,I,,19*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIQREGGTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRAAETRYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRAAGTQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRAGNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRGARNEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRLAGPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRTAETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIRTGQTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSISGGYYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSISGTEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSISTGNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSITGGAPLAGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSITLGTGGVEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSIVGGAYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIVHTYGSPLHF,p65,CMV,I,,19*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIVLVPGLAGGISYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIVPISYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIVPTYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIWGQPQHF,p65,CMV,I,,6-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSIYGLAGANNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKAERPGYGRLTESYNSPLHF,p65,CMV,I,,7-9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKDRGADTQYF,p65,CMV,I,,7-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKEAGASGYAPETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKEPRVGAPEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKEQGAYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKEVAGYEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKGGVVNTEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKGQANTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKGQGAYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKGTANTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKGTGGLQETQYF,p65,CMV,I,,7-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKIWGQGVDTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKLGGAGTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKNRDSVAKNIQYF,p65,CMV,I,,7-9*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKPKGHHPIPPFNTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKQQRSDYGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKSPTGTHSTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKTGTNTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKTSGGYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSKYDSPLECEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAAGGRDQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAAGLGDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAAGNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAANTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAARNTEAFF,p65,CMV,I,,5-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAATSGPYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAATYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAEARQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAEGLYETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGAYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGDHQPQHF,p65,CMV,I,,5-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGAAEKLFF,p65,CMV,I,,5-4*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGAGTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGDTGELFF,p65,CMV,I,,5-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGGNTGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGGTGELFF,p65,CMV,I,,7-7*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGHNSPLHF,p65,CMV,I,,7-6*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGINEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGNNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGRDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGRDEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGSDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGIGNPYGYTF,p65,CMV,I,,7-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGLAGRTYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGPNNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGQGATDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGQTHSGNTIYF,p65,CMV,I,,7-6*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGRETQYF,p65,CMV,I,,13*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGSNYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGTDIYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGTDYTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGTPTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGVGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAGVSYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAIGQGNYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAIGSDSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLALAGITDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLALLGGSGNFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLALSHEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLALSRIYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLANLVEETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPEATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGAANEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGAINEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNEKLFF,p65,CMV,I,,11-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNEKLFF,p65,CMV,I,,7-8*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNGKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNKKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGATNQKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGGSGQETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGTTNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPGVTNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPQETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPRATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPRRDRNYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPSTETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAPTGGPYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAQGLTYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAQGTDSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAQGTDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAQGWTEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLAQHEQYF,p65,CMV,I,,11-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLARGNNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLARGQYSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLARGTGSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLARVTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLARYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASGELYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASGGNTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASGGQETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASGITDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASGTDSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASKGDYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASRVGTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLASSTEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLATEYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLATGGTDSPLHF,p65,CMV,I,,5-4*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLATGISYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLATGMTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLATGRHNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLATGTGWDQPQHF,p65,CMV,I,,7-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDAGSGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDASGSSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDAVGFYGYTF,p65,CMV,I,,7-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDEGALFTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDESLAGGNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDGALVTDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDGAYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDGDWRAQPQHF,p65,CMV,I,,11-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDGGTAYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDGNYSNQPQHF,p65,CMV,I,,11-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDGVLGLNSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDHTNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDKDTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDLGARGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDLGREPRETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDLRTGRTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDLYNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDPGLPLYNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDPGSSGANVLTF,p65,CMV,I,,28*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDPIITGLAGSYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDPSLFATDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDPVGRNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRAEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRASLDEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRAYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRDLYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRGEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRGEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRGETQYF,p65,CMV,I,,7-7*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRGPLNEQFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRGPWGNTEAFF,p65,CMV,I,,18*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRGSSYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRHRRQGSWETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRLEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRTDYGYTF,p65,CMV,I,,5-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDRVANTEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDSLNTIYF,p65,CMV,I,,5-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDSPRTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDSSSFDEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDSTGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDSTGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDSTSGGGYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDTGGRLNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDTGMTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDTGTALSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDTGTGLEEQYF,p65,CMV,I,,5-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDVPDTQYF,p65,CMV,I,,7-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDYEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLDYWLYNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEAGAYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEAGGPTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEAGLDGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEARSNKETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEASGSGETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEASGSSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEATRYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEDSTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEEEGTNEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEEGPDEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEEGYEQYF,p65,CMV,I,,7-7*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEFDQPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEFGQGASSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEFIYGYTF,p65,CMV,I,,5-4*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGAGGPFDIQYF,p65,CMV,I,,5-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGAPTDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGDPFYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGFTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGGQGIPEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGGRFQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGGTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGGTYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGLNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGPRSGSIWELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGQGPLYYGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGRGYYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGSHLGAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGWGSSYEQYF,p65,CMV,I,,5-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGYGSTYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEGYTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEIAGGNYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLELAGAQETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLELAGLDNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLELGNPQYF,p65,CMV,I,,5-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLELGQQNTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEPGEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEPGGSSYNEQFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEPKAPYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEPNYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEQGDAEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEQGNNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEQGYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERDEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERFTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERGLDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERHEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERLAWDIQYF,p65,CMV,I,,11-2*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERRIETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERSEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLERYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLESAGHSNTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLESRGSGVTDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLESRTYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLETQYF,p65,CMV,I,,5-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVAGGGYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVAGGLTDTQYF,p65,CMV,I,,7-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVGLRNQPQHF,p65,CMV,I,,5-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVGRPDTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVGSTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVSGDDEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEVTMNTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEWDRNQPQHF,p65,CMV,I,,11-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEWDRNQPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEWDRVYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLEYREADTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFAGTYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFDLRGGTEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFDRDDSPLHF,p65,CMV,I,,7-9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFGTGGLEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFLAGSYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFLGGANVLTF,p65,CMV,I,,27*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFPGADGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFPGPYNEQFF,p65,CMV,I,,7-7*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFPHTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFQATSGGVDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFQGPSGNSGNTIYF,p65,CMV,I,,28*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFQGSSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFRGPEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFSTVPIIVRTEGNTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLFVTEAFF,p65,CMV,I,,5-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGAEEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGASGDETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGASGIRNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGASGSAGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDDNSPLHF,p65,CMV,I,,28*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDEYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDQPQHF,p65,CMV,I,,7-9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDRRALFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDTEAFF,p65,CMV,I,,5-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGDTWYGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGEDSQRVQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGEFTGTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGENTGELFF,p65,CMV,I,,5-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGETTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGFPGTFFYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGAGDYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGAIDEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGALDIQYF,p65,CMV,I,,5-8*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGEGSGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGGAGNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGGNTEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGGQAGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGGQGEGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGGTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGLGGRYGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGNRYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGPYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGQGYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGQKETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGQKNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGQNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGQSGNYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGRAVDEQFF,p65,CMV,I,,6-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGRQGVISYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGSEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGSETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGSSWDADTQYF,p65,CMV,I,,5-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGSTDTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGSTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGTGAAGQPQHF,p65,CMV,I,,11-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGTTEAFF,p65,CMV,I,,5-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGWNTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGYNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGIGDRGLGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGISYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGKAGLSNTEAFF,p65,CMV,I,,11-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLAGIQETQYF,p65,CMV,I,,13*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLAGVNGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLASAYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLEGWDEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLGVNTEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLTAYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGLYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGNSSGQPQHF,p65,CMV,I,,5-4*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPAYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPDLNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPIDEQFF,p65,CMV,I,,7-7*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPLEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPNTGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPPYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPSTYNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGPYNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQALTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGAHNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGDQPQHF,p65,CMV,I,,5-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGGIDGSRHEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGITEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGIYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGNTEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGPSYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGRNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGSNEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGSNQPQHF,p65,CMV,I,,3-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQGVFYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQLGEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQLHTWGNEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQSSGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGQTPYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGREGQDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGRGLGAAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGRGREAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGRNTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGRNYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGRVDEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGRVRSPLHF,p65,CMV,I,,5-8*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSFYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGGEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGGPNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGGSYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGGYTDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGSEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSGSHPAEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSKQNTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSQIYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSSGATNTGELFF,p65,CMV,I,,7-8*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGSTNRNTIYF,p65,CMV,I,,11-2*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTEAFF,p65,CMV,I,,5-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTEYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGDTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGEGTYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGGLFGEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGGVTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGPYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGSAEPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTGSPYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTIQGANYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTLEETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTLSGQPQHF,p65,CMV,I,,28*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTMNTEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTNANTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTNGYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTSGGNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTSGIYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTSPGAEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTVYYEQYF,p65,CMV,I,,11-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGTYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVHYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVSYNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVTNGETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVWDSALSQALHF,p65,CMV,I,,11-2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVWGGEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGVYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGWAGKTDTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGWGRPNYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLGWGSDAGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLHRTMTGIDYGYTF,p65,CMV,I,,5-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIAGGHTGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIASHYSEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIGGGMGWEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIGGTAGANVLTF,p65,CMV,I,,4-3*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIGQGDPTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIGRGTYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIGTGYTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIPGAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIPGPEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIPRTGNINQPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIPVSGELFF,p65,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIRENQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIRSGEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLIVAGGYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKGANYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKGTGELFF,p65,CMV,I,,13*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKILTVGRYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKPGTGPYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKRLWQRYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKSSTFTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLKTGFDEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLADEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLAGANEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLAGGTDTQYF,p65,CMV,I,,7-7*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLAGVQTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLASGSSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLDGQGARYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLDSHSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLFGNYNSPLHF,p65,CMV,I,,28*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLFWTGNGSYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGAEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGAYTGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGDQPQHF,p65,CMV,I,,3-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGDTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGDTGRTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGITDTQYF,p65,CMV,I,,7-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGLAGDYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLGYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLKGGGTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLKRFWETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLLGQGTNEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLLSGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLPDPTFFDEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLPYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLQGGEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLQGGLNTGELFF,p65,CMV,I,,13*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLQQGGIDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLRLAGGETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLSGGQEKLFF,p65,CMV,I,,5-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLSNTEAFF,p65,CMV,I,,5-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLTSGGTYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLTSGYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLVAGVYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLVGSGANVLTF,p65,CMV,I,,27*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLVGWNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLVSSSYNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLYGGGFQTQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLLYQGGNEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMDSKTYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMDTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMGDPQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMGGTYSNQPQHF,p65,CMV,I,,28*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMGPDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMGQGLSSYNSPLHF,p65,CMV,I,,7-3*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMGTSGFTGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLMLFGGYPMNTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNEPLHF,p65,CMV,I,,11-2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNIEQAVDEKLFF,p65,CMV,I,,5-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNIYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNPGEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNPQQPQHF,p65,CMV,I,,4-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNPRDIQYF,p65,CMV,I,,28*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNPSSYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNPWGTDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNRDEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNRDEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNRDIQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNRGQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNRPFTDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNRRQNGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNSLYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNVPRSGYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNWEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLNYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPDGEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPERKYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGGGTNTGELFF,p65,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGGKVSGANVLTF,p65,CMV,I,,12-3*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGGYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGISYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGLAYNEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGLFEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGQGDEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGQGENTEAFF,p65,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGTFLGGCGNQPQHF,p65,CMV,I,,5-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPGTGHGNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPLSDSPTHTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPPEATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPPFASTSTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPRFPYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPRVGELFF,p65,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPSGAYGYTF,p65,CMV,I,,5-4*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPTEQETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPTSGSSTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLPVGDYTGELFF,p65,CMV,I,,13*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQASGSSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQGFAEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQGLESSSTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQGLGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQGLVDTGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQGSNSPLHF,p65,CMV,I,,2*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQRELGNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQTGAGAYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQTGAGAYGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQTGAGAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQTSGRHEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQVGMNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLQVLGGETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRDRAPNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRDRGYEQYF,p65,CMV,I,,5-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRDWNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGGMIHIQYF,p65,CMV,I,,27*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGGTGDGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGLLGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGPGYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGPNVLTF,p65,CMV,I,,12-3*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGQASGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGRVRETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGSHETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGSSYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRGSTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRPLTPGQGFYEQYF,p65,CMV,I,,7-7*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRPTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQGARGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQGEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQGIRAFF,p65,CMV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQGLINEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQGRLETQYF,p65,CMV,I,,13*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQMNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRQYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRSSFVLGGREDGEQFF,p65,CMV,I,,5-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRTARSYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRTGAGAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRTRELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRVGFDYGYTF,p65,CMV,I,,11-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRVKPYGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRVNLAGGHETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRVTEAFF,p65,CMV,I,,5-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLRVVGTVYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSASGYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSEGWIYEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSEMSSYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGDTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGEQYF,p65,CMV,I,,25-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGGALNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGGQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGMLNQPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGNSPLHF,p65,CMV,I,,7-6*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGRDYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGSWTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGTGFYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGTGGTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGTMNTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGTSGNNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSGVSSYNEQFF,p65,CMV,I,,11-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSHEGRNTEAFF,p65,CMV,I,,11-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSIAGTNTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSIRAGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLAHEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLGGAAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLGQAFNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLGWETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLPAGGRETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLQGDGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSLVGPHQPQHF,p65,CMV,I,,7-9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSMGEKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSNDFRGEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSPGQGDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSPLAGGISSYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSPTPYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRDSYEQYF,p65,CMV,I,,7-7*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRGDYGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRGPYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRGQTSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRNEQYF,p65,CMV,I,,5-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSRQPQHF,p65,CMV,I,,13*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSSGGNYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSSGTGTYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSSGTRLAPLHF,p65,CMV,I,,7-9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSSHTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSSQSYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSSRDTGELFF,p65,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSTGQGGEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSTQGATEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSVGGIEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSVGLVETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLSWGQETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTAGVDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTATSGFYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTEAHGYTF,p65,CMV,I,,5-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTELPYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGANVLTF,p65,CMV,I,,13*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGDSGYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGENYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGGLRYTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGGVSGNGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGLEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGMNTEAFF,p65,CMV,I,,7-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGMWETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGPTTTETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGQGRNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTGVNTEAFF,p65,CMV,I,,7-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTKGGDEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTLAGGPGTYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTPGATNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTRAGGGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGDRGRWNIQYF,p65,CMV,I,,7-9*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGGANEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGGHSSYNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGGNTDTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGRVDEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGSSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSGSSYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTSNTEAFF,p65,CMV,I,,5-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTTESGEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTTGGKTGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTTGLEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTTSPGEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTYGQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTYGYEQYF,p65,CMV,I,,7-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTYGYTF,p65,CMV,I,,11-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLTYTDRTFQETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVAGASTDTQYF,p65,CMV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVAGPGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVAGQIITDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVAGTGELFF,p65,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVANTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVASGGPPYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVASGSLRGSQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVAWPGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVDLLAGDSNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVDLRAGETEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVDSIGEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVEGLGTGGPRLAEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGAGGGLDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGAWPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGEPIQETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGEYTGANVLTF,p65,CMV,I,,5-4*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGGGMGWEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGGRYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGQGAKSSYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGRLHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGSSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVGVNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVHKNNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVHYNSPLHF,p65,CMV,I,,7-9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVIGDRGHSEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVLGIRETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVLMETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVLTGINYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVPGINSYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVPRAYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVPSGPGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVQGIEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVQRPGNTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVRETADTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVRGDEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVRGISTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVSGGFTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVSGSLDIQYF,p65,CMV,I,,5-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVSLGLAGGPGNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVSSTEAFF,p65,CMV,I,,5-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVTGGPGEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVTGGRYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVTGPGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVVGSGKYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVVREQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVWGSGGTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVWSSGGQETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLVYGGASDSYNEQFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWANTGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWARGYQETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWDQPQHF,p65,CMV,I,,7-9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWDRGRYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWDRSSGANVLTF,p65,CMV,I,,7-8*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWDTGEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWDTREQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWEGTDEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGFDRTDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGGEKLFF,p65,CMV,I,,5-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGLAGQDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGQGAAGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGQGWHEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWGRSNYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWRGSYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWRHLNQPQHF,p65,CMV,I,,4-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWSSTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWTGTFNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWVENYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLWWGIGNTIYF,p65,CMV,I,,7-2*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYDGGTSTDTQYF,p65,CMV,I,,5-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYFTGAPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYGANEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYGLVEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYGRRETQYF,p65,CMV,I,,11-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYQGSYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYRGQGGQPQHF,p65,CMV,I,,28*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYSEVSGDEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYSSSYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYTAYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSLYTGFTNEKLFF,p65,CMV,I,,7-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMDSSYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMEASGSSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMEGVPLHF,p65,CMV,I,,5-4*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMGLDRGANNYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMGPGEWPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMGQPKETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMGRNYGYTF,p65,CMV,I,,19*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMGRTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMGTGINEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMIGGDTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMIGGGTQAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMLGEGAGTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMLGEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMRAAETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMTGGPNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMTGGYIAEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMVLGDTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMWVNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMYDSNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSMYGIGNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNDRELYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNEFATNEKLFF,p65,CMV,I,,7-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNEGGGRGGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNGRVSGANVLTF,p65,CMV,I,,28*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNHTRFTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNLPGTGEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNNGRFTEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNPGQGGPSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNRDRPYEQYF,p65,CMV,I,,11-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNRETDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNRTSGASTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNTGTGYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSNVEGTGETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAFSPKNQPQHF,p65,CMV,I,,18*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAGDYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAGGTYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAGPQETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAGVSYEQYF,p65,CMV,I,,7-7*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPALLAGVHYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAPGTANTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAQGQGQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPASRTGARGYTF,p65,CMV,I,,7-8*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPATGNTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPAYQETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDFGSYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDGSGANVLTF,p65,CMV,I,,5-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDGSQETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDGSSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDGTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDIGGYQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRANEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDREGTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRGDPYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRGHGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRGPPLHF,p65,CMV,I,,5-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRGRTNEQFF,p65,CMV,I,,7-7*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRGYYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRTGPWEEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDRYQETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDTTETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDVAGNSYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPDVGGSDGYTF,p65,CMV,I,,7-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEAGWDAHNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEAQGAGHNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEESSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEETGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEGLLGAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEGNLYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEGNTGELFF,p65,CMV,I,,7-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEGRTDSPHTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEGSAGSGANVLTF,p65,CMV,I,,4-2*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEPGLLNQPQHF,p65,CMV,I,,5-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPEQGIYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPERNPGWNTEAFF,p65,CMV,I,,18*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPETGIEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFGAGPYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFGEGGANVLTF,p65,CMV,I,,3-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFGGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFGGHGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFGTSGSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFNEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFPSGFTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPFRTGIGNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGAAGTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGAGEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGDEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGDLYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGDRGIGGAQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGDRTDSPHTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGEARGEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGAQETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGDPDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGDTSYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGGGYQPQHF,p65,CMV,I,,5-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGGNQPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGLTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGNTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGRGNTEAFF,p65,CMV,I,,18*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGRSSYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGRTDGPHTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGRTDNPHTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGSEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGSLGGQDGYTF,p65,CMV,I,,5-8*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGTGDEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGGYEQYF,p65,CMV,I,,10-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGHIDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGIGLADYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLAGEDEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLAGLTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLGWPQHF,p65,CMV,I,,18*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLIRITGELFF,p65,CMV,I,,5-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLIYNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLLNEKLFF,p65,CMV,I,,16*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLNTGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLVDRVVGETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGLVRYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGNRGETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGPGTLNLTGWYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGPKETQYF,p65,CMV,I,,18*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGPWNEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGAEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGASETQYF,p65,CMV,I,,6-4*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGAYTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGPYEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGVDEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGVNTEAFF,p65,CMV,I,,2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGWFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQGYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGQSLIYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGRENTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGRGNYGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGRGTINEKLFF,p65,CMV,I,,5-4*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGRPSYGYTF,p65,CMV,I,,18*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGSHFYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTAFEETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTASTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTATGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTDMNTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTGDADEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTGDNQPQHF,p65,CMV,I,,4-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTGFYSEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTGGDNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTGLEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTNDEKLFF,p65,CMV,I,,5-4*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTSGAFAVNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTSGVNEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTVNTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGTYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPGWTNGAANYGYTF,p65,CMV,I,,11-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPHAGGEETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPHAPGYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPHQAGGQTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPHQETQYF,p65,CMV,I,,18*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPHQHEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPIAGRRDTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPIGGMGTGELFF,p65,CMV,I,,10-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPIGTAAELIHNEKLFF,p65,CMV,I,,4-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPILGGTDTQYF,p65,CMV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPILGQESSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPITGTNEKLFF,p65,CMV,I,,6-5*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLAGADTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLAGENYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLAGISSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLATGAYGYTF,p65,CMV,I,,28*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLGGAGEDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLGGNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLGQNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLGTLYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLKNIQYF,p65,CMV,I,,14*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLLSTYNEQFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLLYEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLPSGGPDEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLTLDRGLTYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPLTSTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPMVAGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNFGEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNGGLHEKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNLAGVKNIQYF,p65,CMV,I,,27*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNRAGNYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNRQGHGHGYTF,p65,CMV,I,,16*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNTGELFF,p65,CMV,I,,18*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPNTGELFF,p65,CMV,I,,6-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPASGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPDGDQPQHF,p65,CMV,I,,7-9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPDPQETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPDRANTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPDSSYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGAANYGYTF,p65,CMV,I,,7-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGEGSTDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGLEWGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGLSQSYGYTF,p65,CMV,I,,18*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGPLKADTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGQNYGYTF,p65,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGSSDNSPLHF,p65,CMV,I,,7-9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGTGGPGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGTSFNEFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPGVRSLLQETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPLGGELFF,p65,CMV,I,,11-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPLQGSTTYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPLTGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPNSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPPGTTYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPQDNREETQYF,p65,CMV,I,,18*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPRAENTIYF,p65,CMV,I,,28*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPRDRDPSSWFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPSAGPGEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPSGSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPSSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPTVTYTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPVGEQTQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPVSTDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPPYRGSGTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQATSYNSPLHF,p65,CMV,I,,3-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQGDGEKLFF,p65,CMV,I,,19*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQGLASNIQYF,p65,CMV,I,,4-2*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQGTSGFTGELFF,p65,CMV,I,,5-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQGVGYNQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQGVSSGNTIYF,p65,CMV,I,,28*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQGYNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQQATNEKLFF,p65,CMV,I,,4-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQQSSYEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQRERYNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQTGLYGYTF,p65,CMV,I,,6-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQTGTLSYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQTGVGNYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPQVLSSYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRAGEGTEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRATTNEKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRDDGGELFF,p65,CMV,I,,13*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRDGQETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRDRESPEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPREGANAYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPREPMRLAGAPSTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGAYQPQHF,p65,CMV,I,,7-9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGGAIYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGGRTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGLYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGMRADGTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGNYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGPYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGRTGFITEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRGWNTGELFF,p65,CMV,I,,14*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRLAGEINNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRLDGNTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRPGLADNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRPGQGNFFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRPLSGNTIYF,p65,CMV,I,,9*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRQDEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRQGSYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRRVGTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRSGEGVWSSYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRTFNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRTGRDTEAFF,p65,CMV,I,,6-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRTIYTYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRTSGMSYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRTSGRANEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRTSGSSTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRVQETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPRYNTYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSAGVVEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSEETNYGYTF,p65,CMV,I,,18*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGFTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGGYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGPSNQPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGQYYGYTF,p65,CMV,I,,6-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGRIHEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGRYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGTVYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGVSYEQYF,p65,CMV,I,,7-7*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSGVSYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSLGGNQPQHF,p65,CMV,I,,7-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSMSTEAFF,p65,CMV,I,,4-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSPPATDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSPSGDDEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSRFLRGALETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSSAIYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSTGGNTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSTKYTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSTYTDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSVSVQHRSYGYTF,p65,CMV,I,,18*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPSYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTASTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGANVLTF,p65,CMV,I,,18*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGARGPNEKLFF,p65,CMV,I,,11-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGDNTGELFF,p65,CMV,I,,18*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGDQPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGEVPFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGGNQPQHF,p65,CMV,I,,2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGGSSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGGSYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGGTGNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGGWADTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGGYADTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGLVDEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGNTEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGQGAYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGQGETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGTGFVGNTEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGTGIETQYF,p65,CMV,I,,7-7*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTGWTAFF,p65,CMV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTLRPPIAKNIQYF,p65,CMV,I,,2*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTNGRSAGGTRGYTF,p65,CMV,I,,7-8*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTRGAEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTSGGADTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTSGRDRSGQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTSTLNTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTTGAPAYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTTGASYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTTGTESYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTTGTGHYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CASSPTTRLPETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPTYGTGGGQPQHF,p65,CMV,I,,3-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVAGAPHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVAGAPHKQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVAGTPHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVARAPHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVATSYNEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVEDEQFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVGGDNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVGTEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVLDTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVLSYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVMNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVRGSTDTQYF,p65,CMV,I,,6-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVRKARYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVSGTGNYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVSGYNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVTGAPHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPVTGTGHYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CASSPVVRAEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWASGQQETQYF,p65,CMV,I,,18*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWASGVIQETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWDRQTSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWEAGGAYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWEGGGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWGGQHYEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWIDYSNQPQHF,p65,CMV,I,,18*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWLTSGRENEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWLTSGYTDTQYF,p65,CMV,I,,5-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWPEPNTEAFF,p65,CMV,I,,18*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWSGGVVTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTGAGDEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTGDEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTGTLGETQYF,p65,CMV,I,,14*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTSANEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTSGMDTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPWTTLHPYESSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPYGGNTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPYREPLYEQYF,p65,CMV,I,,18*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPYSNQPQHF,p65,CMV,I,,7-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSPYTGNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAAGPYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAEGGRRLDTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAEKTGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAEMAEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGGAYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGIAEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGMAKQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGMTEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGSSYNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGTGGYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAGVAEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQALGPPVPAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQALGSGANVLTF,p65,CMV,I,,4-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQALPYEQYF,p65,CMV,I,,12-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSQAMNTEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAPGTGDGYTF,p65,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAPTSGNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAQLTTSSYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQARGEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQARGNYEQYF,p65,CMV,I,,4-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQARMAEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQARRGFEDTIYF,p65,CMV,I,,4-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQASGGYTGELFF,p65,CMV,I,,14*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQASGRSHEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQASHQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQAYSGGLGTDTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQCPPSYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDAGSSYNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDAQGVLKRFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDATSGLSYNEQFF,p65,CMV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDEGELKLFF,p65,CMV,I,,4-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDEGNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGASLLYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGGGGLETQYF,p65,CMV,I,,4-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGGLGTDTQYF,p65,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGGTYTQYF,p65,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGGVRQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGLAGAHTDTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGNRYNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGPPKPEEQETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGTGINIQYF,p65,CMV,I,,4-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGTGSGPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGTGTLRQQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGTNPYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGTSGADTQYF,p65,CMV,I,,4-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGTTGNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDGVGGSGTGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDHGQGAEKLFF,p65,CMV,I,,4-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDIGAGEQFF,p65,CMV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDIRQNTGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDKAGNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDKRPGGELFF,p65,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLAGHTGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLGGSKTQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLGGTEAFF,p65,CMV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLGGTYRGNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLGGVMNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLGTLQPQHF,p65,CMV,I,,4-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLIWSYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLKETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLLTGEQYF,p65,CMV,I,,4-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLRQGDQPQHF,p65,CMV,I,,3-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLSGGQETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLTGVQPQHF,p65,CMV,I,,4-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDLVAEAFF,p65,CMV,I,,4-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDMGGLSYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDPGPNSNQPQHF,p65,CMV,I,,4-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDPNYGTGHLMNTEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDPRASHRGAQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDPSGRGNTIYF,p65,CMV,I,,3-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDQSISYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDQVTQYF,p65,CMV,I,,4-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDRAGGYGYTF,p65,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDREVFNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDRGFGNQPQHF,p65,CMV,I,,4-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDRGSGGHEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDRGSGSPYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDRVSANNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDRVVNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDSIGFTGELFF,p65,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDSKGPTSYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDSRGSGNTIYF,p65,CMV,I,,4-3*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDSSGGYNEQFF,p65,CMV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDSYGGLGNTIYF,p65,CMV,I,,4-2*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDTSGGFYGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDVGVFYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDVNPRASLGYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDVSNQPQHF,p65,CMV,I,,4-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDWGSSYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDYFSAKNIQYF,p65,CMV,I,,4-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDYQGNYGYTF,p65,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQDYSSYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEAGGEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEAGLGNHPQHF,p65,CMV,I,,4-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEALTGAKNIQYF,p65,CMV,I,,4-3*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEDRSYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEEGPWNQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEERGGTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEETGDLSETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEETGLSEKLFF,p65,CMV,I,,3-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGGGYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGGILAEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGGQVHIQYF,p65,CMV,I,,3-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGIGRVEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGPNQETQYF,p65,CMV,I,,4-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGWETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGWTSDETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGWYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEGYQPQHF,p65,CMV,I,,3-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEKGITGELFF,p65,CMV,I,,14*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEKGPGNQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEPGDEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEPGLAAYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEPGYGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEPPTASGANVLTF,p65,CMV,I,,4-2*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEQAEPYEQYF,p65,CMV,I,,4-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEQGGDEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQERWAEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQESRDYGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQETGLSNYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQEVSAGLREGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQFDGVNEKLFF,p65,CMV,I,,3-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQFELAGEETQYF,p65,CMV,I,,16*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQFLGAYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQFVLGDQDLNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQFVYTSTDTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGAGNSPLHF,p65,CMV,I,,4-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGAGQPQHF,p65,CMV,I,,6-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGDGGELFF,p65,CMV,I,,4-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGDRDTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGDSSYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGFLLGAMETEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGFNPGGGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGGASGGDTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGGGAADTQYF,p65,CMV,I,,7-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGGGGAEEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGGVLRGETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGGVRQGAADTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGIGTGLLTDTQYF,p65,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGLAEASSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGLAETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGLAGDTDTQYF,p65,CMV,I,,16*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGLGTSGPYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGLTSEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGLYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGNQPQHF,p65,CMV,I,,3-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGNRVENTEAFF,p65,CMV,I,,4-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGPGGWTEAFF,p65,CMV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGPGMVPQYF,p65,CMV,I,,4-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGPGQGDYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGPIKNIPYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGPRTEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGQGLNGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGRGEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGRGGKNIQYF,p65,CMV,I,,4-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGRGSGNTIYF,p65,CMV,I,,4-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGRLNYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGRNTIYF,p65,CMV,I,,4-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGRRSTDTQYF,p65,CMV,I,,4-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGSDEPNTGELFF,p65,CMV,I,,14*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGSGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGSGQGTEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGSGSTDTQYF,p65,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGSGVGEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTESYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTFPAGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTGEAGELFF,p65,CMV,I,,4-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTGGFYEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTGLDGNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTGMENTIYF,p65,CMV,I,,4-3*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTHDNQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGTMADTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGVDTSASYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGVRTASYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGYAGIWYF,p65,CMV,I,,25-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQGYGSTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQIAGGPYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQIGGLAGAHSYNEQFF,p65,CMV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQISGLAEETQYF,p65,CMV,I,,14*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQKVGFSYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLDTQYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLEETNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLGQYTDTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLGTAYGYTF,p65,CMV,I,,7-8*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLGTDTQYF,p65,CMV,I,,4-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLINRDRGLNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLLADPPDEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLLAGGSGNIQYF,p65,CMV,I,,4-3*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLLAGVTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLSGRVNEQFF,p65,CMV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQLTGEEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQMTSGGVQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQNAGDNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQNPGTTNEKLFF,p65,CMV,I,,4-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQNRGEFEKLFF,p65,CMV,I,,4-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQNTGEDEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPAGESLRETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPDRARGETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPGQPQETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPGSYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPPQREQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPSGKTQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQPWVAGGQNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQQGYTEAFF,p65,CMV,I,,28*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQQMVSSASGTALSGNTIYF,p65,CMV,I,,3-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQQTGTIGGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSQRARAKNIQYF,p65,CMV,I,,4-2*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQRESYNEQFF,p65,CMV,I,,3-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQRQGPEYPGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQRQGPYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQRTSGNTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSDTNQPQHF,p65,CMV,I,,16*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSGGGPYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSGIKDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSLRGFYEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSNRANEQFF,p65,CMV,I,,16*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSQALAGDEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQSYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTAGAQGYYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTENTGELFF,p65,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTGGGEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTGGLNQPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTGNQPQHF,p65,CMV,I,,18*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTGQSRTSGSTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTGTDTEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQALEKLFF,p65,CMV,I,,14*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQFWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWEAQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWEIQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,11-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,16*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,4-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,5-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,7-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWETRYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWGTQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQLWKTQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQPWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTSGGYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQTSGSSYEQYF,p65,CMV,I,,3-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVAREDEKLFF,p65,CMV,I,,4-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVDSFTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVEGPGNQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVERGGVETQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVFQGASGELFF,p65,CMV,I,,4-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVFRSAGPQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGDNGDGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGHHGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGHYGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGIHGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGLRIYNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGQGNYGYTF,p65,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGSAPLDEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGTYGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGVHEQYF,p65,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGYDGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGYRTYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVGYYGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVIDQETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVIGNSPLHF,p65,CMV,I,,14*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVILGFGNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVLQGNTGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVQDTNTGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVQGWTEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVQSSYNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVRGASTEAFF,p65,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVSAELYGYTF,p65,CMV,I,,3-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVTGSKETQYF,p65,CMV,I,,4-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVTSTGTSETYTQYF,p65,CMV,I,,3-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVVVGGRDPYEQYF,p65,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVVVSSSTNEKLFF,p65,CMV,I,,4-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVWDSTNYGYTF,p65,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVYGAPDQPQHF,p65,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQVYVEVREHGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQWGSGANVLTF,p65,CMV,I,,14*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQWSGVGGGTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQWSSTGELFF,p65,CMV,I,,4-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQWVGTDLQETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQYDTFISPLHF,p65,CMV,I,,16*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQYGGGSQETQYF,p65,CMV,I,,3-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQYPPENTEAFF,p65,CMV,I,,7-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSQYTGANTEAFF,p65,CMV,I,,16*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRAGQGHGHLDGSGNTIYF,p65,CMV,I,,6-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRAGQLNTEAFF,p65,CMV,I,,16*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRAVRDDEKLFF,p65,CMV,I,,5-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDLDYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDPSSGANVLTF,p65,CMV,I,,19*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDRGYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDRSSYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDRVENEQFF,p65,CMV,I,,10-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDRVTDTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDSSANEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRDSSSTDTQYF,p65,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSREGGNSPLHF,p65,CMV,I,,4-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSREGSGGYTF,p65,CMV,I,,4-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRERVGETQYF,p65,CMV,I,,4-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSREYTDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGAGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGASRETQYF,p65,CMV,I,,5-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGGAYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGGDNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGGTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGLAGGYNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGQAPGYTF,p65,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGQETGELFF,p65,CMV,I,,7-8*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGQGNTEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGQGRETHEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGQLEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGQSFSYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGRLATGEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGTGPFSYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRGTSGRGNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLAGGNNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLAGIGYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLATGQITDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLGTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLLGQRQETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLPTGSQTDTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLYGNTGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRLYGNTRELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRMVVAGVGTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRPGHPYEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRQGDEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRQTGTSYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRRGGMETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRRGTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRRTAGLNTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRSGRDSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRSGTIDEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRSSGANVLTF,p65,CMV,I,,7-9*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTAQGDTEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTGKAYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTGRTDTQYF,p65,CMV,I,,2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTGTSEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTLTGLDNEQFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTPTAQQEETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTQLWETQYF,p65,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTSGGATDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRTTGLEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRVIAGSDEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRVIDAHTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRVIGAHTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRWDTTYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRWGQGTRGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSRYSNQPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSACYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAFDNYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAGGGRDRDYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAGVLNQPQHF,p65,CMV,I,,6-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAGVVHEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSANYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSANYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSARATEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSARQRNYGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSASYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAYCGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAYYDYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAYYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSAYYSYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDGGLWDTEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDGTSGLDEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDGYEQYF,p65,CMV,I,,14*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDRDVGKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDRGGSPLHF,p65,CMV,I,,28*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDRGLTYNQPQHF,p65,CMV,I,,6-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDSSYEQYF,p65,CMV,I,,7-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDSYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDVLPEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSDWSKDNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSEDYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSEGDTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSEQTFYGYTF,p65,CMV,I,,11-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSESYNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSETELLYYGYTF,p65,CMV,I,,6-6*02,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSSFGFTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSFLTYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSFPGTGLSGNTIYF,p65,CMV,I,,11-2*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGDTNTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGESGNTIYF,p65,CMV,I,,6-6*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGETDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGDSNQPQHF,p65,CMV,I,,11-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGGPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGNEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGREAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGGWGEQYF,p65,CMV,I,,13*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGLAGEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGLAGGPITGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGLAGGRDTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGLAGRTSYYNEQFF,p65,CMV,I,,5-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGLAGVVGYEQFF,p65,CMV,I,,13*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGLISFYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGPAFEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGPEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGPYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGQGESWTYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGQGGDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGQGLDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGSIETSGGPEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGSKQNTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGSPSFEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGSYYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTDEEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTGAEYQETQYF,p65,CMV,I,,11-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTGGGDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTGGVGELFF,p65,CMV,I,,6-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTGHTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTSGGETQYF,p65,CMV,I,,10-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTSGGSTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTSGNGATDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTSYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTTSSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGTVNNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGVGADTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSGWGVGAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSHMNTEAFF,p65,CMV,I,,11-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSIDRDINEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSIGQYNSPLHF,p65,CMV,I,,5-4*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSILAGDADEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSINEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSIPRPEAFF,p65,CMV,I,,5-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSIRGAQMNTEAFF,p65,CMV,I,,7-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSIRTGTFDYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSISGSYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSKEGNTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSKGMDDIQYF,p65,CMV,I,,27*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLGGKNYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLGWGVTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLNGAVNTGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLPREGGDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLQETQYF,p65,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLRGEGLSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLRTVNNEKLFF,p65,CMV,I,,28*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLSGLGYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSLSGPYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSMDGNYGYTF,p65,CMV,I,,11-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSMGGDEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSMLDRHAAQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSNDALAGGYEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPAESRVGEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPDRQREETQYF,p65,CMV,I,,7-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPDVRTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPGQDYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPGQGAGETQYF,p65,CMV,I,,5-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPGQTYEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPGTGTYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPLAPGIDEQFF,p65,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPPGGASDTQYF,p65,CMV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPREREITDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPSGALSGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPSGGVEDEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPTLSRETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPVAEYNSPLHF,p65,CMV,I,,7-9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPWTDSYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSPYDDQLGDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQAGAGDTYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQGGEELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQGGLNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQGSNSYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQGSTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQGYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQPAETQYF,p65,CMV,I,,7-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQQESIFTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQRADTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSQRTNFYGYTF,p65,CMV,I,,25-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRDGNNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRDGTYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRDKPQETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRDLEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRDRAVANYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRDRPMGPQHF,p65,CMV,I,,12-3*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSREGSGRERNTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRGFTYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRGGNNEQFF,p65,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRGSSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRHNEKLFF,p65,CMV,I,,7-8*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRLAGKGNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRLTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRQNSGNTIYF,p65,CMV,I,,7-3*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRTGTGETQYF,p65,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRTGWASAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRTGWDSPLHF,p65,CMV,I,,9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRTGYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSRTSGRFYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSDSPLADTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSDTSYGYTF,p65,CMV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSGGAYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSGGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSGGGEDIQYF,p65,CMV,I,,6-5*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSGQPPQETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSGTDLYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSLASTDTQYF,p65,CMV,I,,7-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSLDYDTGELFF,p65,CMV,I,,6-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSLEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSLGQGASRYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSPDEQQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSPGGVLTF,p65,CMV,I,,5-6*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSRASKSYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSRSSYEQYF,p65,CMV,I,,11-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSRTSEPYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSWGATEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSWYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTAGLAKNIQYF,p65,CMV,I,,7-9*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTFEGLADTQYF,p65,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTGGGLYEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTGNYGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTGTGGRAYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTLAGEKKPYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTNSGGTDTQYF,p65,CMV,I,,13*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTRGVGQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTRTWDTEAFF,p65,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTSSGANVLTF,p65,CMV,I,,6-2*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTTGDGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTTGVVTEAFF,p65,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTWDGSYNEQFF,p65,CMV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSTYPQSTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVAGGFFSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVDEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVDRGRFDEQYF,p65,CMV,I,,5-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVGEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNEQFF,p65,CMV,I,,6-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNGQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVNKQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVPAPHQETQYF,p65,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVPTGENTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVRAGATYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVSGFHEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSVTGTPLEAFF,p65,CMV,I,,13*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSWDRASGANVLTF,p65,CMV,I,,11-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSWEADTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSWGTANTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSWSVNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSWTSGGSTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSWTSGRTSSANEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSYNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSYRENTGELFF,p65,CMV,I,,11-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSSYRGLVSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTAAYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTDPAYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTDPRGYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTDRTYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTDSGTDTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTEETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGGSKNIQYF,p65,CMV,I,,2*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGHTDTQYF,p65,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGPEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGPRGVNQPQHF,p65,CMV,I,,7-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGQDYQPQHF,p65,CMV,I,,6-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGQHYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGQHYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGSGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGTGGIGGNTIYF,p65,CMV,I,,5-4*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGTGQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGTGVGNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGTGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTGVMTGALGNQPQHF,p65,CMV,I,,6-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTKETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTLAEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTNFKNTEAFF,p65,CMV,I,,5-8*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTNLGHKEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTNPDRSNIQYF,p65,CMV,I,,3-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTNRASNQPQHF,p65,CMV,I,,6-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTNSYSRHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTNTGTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTPATGQLETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTPGRSFEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTPPGTPYGEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTPPNTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTPSGGSGDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRDSLLETQYF,p65,CMV,I,,28*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRDSNTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRELGLAGVIPQETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRGESTDTQYF,p65,CMV,I,,6-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRNYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRPGLKSSYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRRTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRSSTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRTGNPYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRTSGINEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTRTSGSYNEQFF,p65,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTSNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTSSSEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTTGANTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTTGTNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTTRSTLNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTTVNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTVGEKLFF,p65,CMV,I,,12-3*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTYSGTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSTYTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVAAGGPDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVAAGLRDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVADNPYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVAEGGEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVAGGGLNEQFF,p65,CMV,I,,6-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVAGRGQETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVAMGLDYTF,p65,CMV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVASGGFSDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVASGQGYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDEQGPYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDGDTYTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDGGEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDGMNQPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDGNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDGSSYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDISTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDRGVTYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDRLGYGYTF,p65,CMV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDRSSGNTIYF,p65,CMV,I,,9*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDSNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDVAGGYNEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CASSVDWDRVSGNTIYF,p65,CMV,I,,9*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVDWNAYEQYF,p65,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEAGAGVQQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEDRANTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEGAPPDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEGARFGYTF,p65,CMV,I,,5-4*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEGGSGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEGGYASGANVLTF,p65,CMV,I,,9*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEQGAPTVETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVETSGRLNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVEVGRDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVFGNPGAGANVLTF,p65,CMV,I,,9*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVFGTSGEETQYF,p65,CMV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVFLLGTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGALSQETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGAPGGDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGASGGFNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGDTSYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGGDPYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGGGNYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGGPGELFF,p65,CMV,I,,5-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGGQGDWYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGGVSTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGGVSYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGLAGGGEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGLAGSGYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGLHGQPTNEKLFF,p65,CMV,I,,9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGPLLRRLFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGQDGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGQDYSNQPQHF,p65,CMV,I,,6-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGQGAFQETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGQGSQPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGRTGQGWGNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGSPDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGTGPNLQETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGTSGTYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVGTTPYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVIPGELFF,p65,CMV,I,,25-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVLAGSSYEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVLDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVLLLAGTYEQYF,p65,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVLNNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVLTSGAGDEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVMLGETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVNMEGTYGYTF,p65,CMV,I,,7-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVQGATDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVRDWGSPLHF,p65,CMV,I,,9*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVRGGGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVRTTGSTDTQYF,p65,CMV,I,,19*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVRVTGELFF,p65,CMV,I,,10-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSAGIGYEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSGDFTYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSGTGELFF,p65,CMV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSLAVSYNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSRAGTGELFF,p65,CMV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSSDTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVSWGSGETQYF,p65,CMV,I,,9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTAGDSEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTAGGPFLLYNSPLHF,p65,CMV,I,,3-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTAGRPFLLYNSPLHF,p65,CMV,I,,3-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTARGPFLLYNSPLHF,p65,CMV,I,,3-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTGADTEAFF,p65,CMV,I,,11-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTGGFTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVTGHPNTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVVAEDTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVVGGTDEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVVGNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVVPQQPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVYGANNEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVYHNNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSVYPPGQGRNEQFF,p65,CMV,I,,6-4*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWDPAGTYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWDREVGLNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWDRGSAGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWETGGTGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWETNTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGGDNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGGGAHNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGGNTQYF,p65,CMV,I,,5-4*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGGQVAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGQMNTGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGTGGSTDTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGTGSGPQHF,p65,CMV,I,,7-9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGTGTGELFF,p65,CMV,I,,5-6*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGTSGSNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGTVYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWGVGQGFTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWIPGGSEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWNPSLYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWRDRGHGNTIYF,p65,CMV,I,,6-5*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWRFGTSSSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWSGGSYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWSGTSYGYTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWSSYEQYF,p65,CMV,I,,5-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTDENMNTEAFF,p65,CMV,I,,11-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTGDNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTGGLDTQYF,p65,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTGTDHYEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTGTSVGPEETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTKSAGEQYF,p65,CMV,I,,4-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTSGGSDTQYF,p65,CMV,I,,18*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWTTGTGGFYNEQFF,p65,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSWYRGLDYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYAAGDNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYAPGQGNTGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYAVSDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYDGRGPYQETQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYDGTTSPLDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYDRGTGELFF,p65,CMV,I,,5-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYDRPSFNQPQHF,p65,CMV,I,,6-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYDSGSSYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYEEEEYNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYELQTGVFDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYELRTGVFDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYFGANTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYFGGLTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYFLAGHTGELFF,p65,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYFLAQTGINTGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYFRGYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGARGAEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGEGLSEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGGGDEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGGGTYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGGNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGGRNTEAFF,p65,CMV,I,,6-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGGSYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGGYEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGKGGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGLADHSGANVLTF,p65,CMV,I,,6-2*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGLADYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGLAVTDTQYF,p65,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGLNYGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGLSYEQYF,p65,CMV,I,,11-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGMEETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGMFAEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGNPNTGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGPEAHNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGPWDEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGQGGEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGQGLYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGQGVGYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGRETGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGTGFEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGTGGRYEQYF,p65,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGTGKDFEQFF,p65,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGTSGMETQYF,p65,CMV,I,,6-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGTSRYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGYGEKLFF,p65,CMV,I,,27*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYGYGYTF,p65,CMV,I,,5-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYIAGAYNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYILAGGPPSDTGELFF,p65,CMV,I,,11-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYIPSYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLAGGTTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLAGVYNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLGEWNTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLGGAETQYF,p65,CMV,I,,6-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLGLAALETQYF,p65,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLGQSFHYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLGRGEETQYF,p65,CMV,I,,11-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLGTGTGNTIYF,p65,CMV,I,,6-5*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLRGSPLHF,p65,CMV,I,,11-3*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLSDLRYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLTGSTEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYLYGTGGIEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYMGGVGTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYMGLPNSPLHF,p65,CMV,I,,6-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYMGPNTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYMTGDQPQHF,p65,CMV,I,,27*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYNEQFF,p65,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYNRAYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYNRGPSQPQHF,p65,CMV,I,,7-8*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYPGLANEQFF,p65,CMV,I,,6-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYPQAGQGEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQANTGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQAVLSGLSTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQRGAGETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQTGAIYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQTGASYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQTGAVYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQTGDTGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQTGELFF,p65,CMV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYQTGTGNYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CASSYQTGTGVYGYTF,p65,CMV,I,,13*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CASSYQTGTIYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRAGGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRDRATNEKLFF,p65,CMV,I,,7-9*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRDTGELFF,p65,CMV,I,,6-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRGLDNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRGQVSYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRKSTDGQGLFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRPIFWEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRQVSETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYRRTNYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSAGGSYNEQFF,p65,CMV,I,,6-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSAVNTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSDTDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSEGTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSEGTKAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSEVYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGATSGRNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGGEASPLHF,p65,CMV,I,,6-6*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGGETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGNSGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGPYEQYF,p65,CMV,I,,10-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGQGTDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGRFREQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGRSYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGTDTQYF,p65,CMV,I,,5-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSGTNEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSIAGHEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSIGALEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSIRDELNTEAFF,p65,CMV,I,,6-6*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSIVPQGAETQYF,p65,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSKGPSSGANVLTF,p65,CMV,I,,6-6*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSLGWQQKLFF,p65,CMV,I,,6-6*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSLRYTEAFF,p65,CMV,I,,6-2*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSMGASYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSMGVDYGYTF,p65,CMV,I,,6-6*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSMRGTSTDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSNEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSPEAYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSPGGSLSYNEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSPSGKEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRAGANEQFF,p65,CMV,I,,6-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRDKAEGFSYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRGLDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRGSNYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRQWNTEAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRSQIYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSRTANEKLFF,p65,CMV,I,,6-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSSGEPQHF,p65,CMV,I,,6-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSSGGLQETQYF,p65,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSSNPGELNSPLHF,p65,CMV,I,,6-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSSTASGANVLTF,p65,CMV,I,,6-5*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSTDTQYF,p65,CMV,I,,6-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSTGAGETQYF,p65,CMV,I,,6-5*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSTGAPSYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSTGVGSPLHF,p65,CMV,I,,6-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSTSGGGYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSVAPEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSVPSGRGEQFF,p65,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSWDVVNYGYTF,p65,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYSYPGTGFYEQYF,p65,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYTGDEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYTLTGLNTEAFF,p65,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYTSGAEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYTWDEQYF,p65,CMV,I,,6-6*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYTYEQFF,p65,CMV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYVARVRTNEKLFF,p65,CMV,I,,6-2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYWDLNYGYTF,p65,CMV,I,,6-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYWDRGSGANVLTF,p65,CMV,I,,6-6*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYWGALGDTQYF,p65,CMV,I,,6-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYYAAGLGTGELFF,p65,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASSYYSGGGSAFF,p65,CMV,I,,6-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTAGASGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTAGLVPNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTAGQGDYEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTASGGDTGELFF,p65,CMV,I,,6-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTAVPYQETQYF,p65,CMV,I,,6-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTDGLAGELFF,p65,CMV,I,,5-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTDRGTVNEKLFF,p65,CMV,I,,2*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTDRRYGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTDTTYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTEEGSPLHF,p65,CMV,I,,12-5*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTEGHEQYF,p65,CMV,I,,10-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTERVAKNIQYF,p65,CMV,I,,25-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTFGAYNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTFLTSGYNEQFF,p65,CMV,I,,5-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTFRDSRREQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTGGGLFGYTF,p65,CMV,I,,2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTGLAGTHSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTGQGFYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTGTGNYEQYF,p65,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTISAEQYF,p65,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTISGNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTKDRIKTQYF,p65,CMV,I,,5-8*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTKGFSGGASLYEQYF,p65,CMV,I,,10-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTKGGGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTKTSGAPYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLAEGTDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLAGGTDTQYF,p65,CMV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLGGESNQPQHF,p65,CMV,I,,9*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLGGSYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLIGDSGMVNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLPGPEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLTVAGWTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTLVAGEGNEQFF,p65,CMV,I,,11-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTMEDGGQGDTQYF,p65,CMV,I,,28*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTMGLAGGGGTDTQYF,p65,CMV,I,,6-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTNLGTSQFYEQYF,p65,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTNRDRGNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTNSESSYNEQFF,p65,CMV,I,,2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPEKSLGPGTQYF,p65,CMV,I,,6-6*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPGELAGGGETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPGGLTEAFF,p65,CMV,I,,25-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPGLAGAGNEQFF,p65,CMV,I,,25-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPGTGALTDTQYF,p65,CMV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPGVGGRSRYNEQFF,p65,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPLGAGPVNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPLGGTSYEQYF,p65,CMV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPSSGIGYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPSTGQKFLGGTF,p65,CMV,I,,7-9*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPTRGLYEQYF,p65,CMV,I,,2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPWGVGNTIYF,p65,CMV,I,,6-6*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTPWVAGGGELFF,p65,CMV,I,,7-8*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTQGQGNQPQHF,p65,CMV,I,,5-6*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTQGSEAFF,p65,CMV,I,,5-5*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTQLEGTQYF,p65,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRDSYQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRGGETQYF,p65,CMV,I,,12-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRGTSGQETQYF,p65,CMV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRNRGLNTEAFF,p65,CMV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRSADTQYF,p65,CMV,I,,5-6*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRSWDSNSPLHF,p65,CMV,I,,5-8*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRTGLAGGYHNEQFF,p65,CMV,I,,6-6*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRTISVSDTQYF,p65,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRTSGRRSGELFF,p65,CMV,I,,28*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTRWVAGGKGDEQFF,p65,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTSEGGGGTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTSGNEQFF,p65,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTSGPALYNEQFF,p65,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTSGTGLSNQPQHF,p65,CMV,I,,7-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTSMSKGRPYEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTSTGSGAKNIQYF,p65,CMV,I,,12-3*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTTDRGYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTTGANVLTF,p65,CMV,I,,27*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTTGLAVMEQYF,p65,CMV,I,,12-3*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTTGSGEQYF,p65,CMV,I,,19*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTVETGELFF,p65,CMV,I,,5-4*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTWPGEFDEQYF,p65,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTWTGVGYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASTYQAGFYNEQFF,p65,CMV,I,,27*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASVGGRSYNEQFF,p65,CMV,I,,12-3*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASVGVDTSYGYTF,p65,CMV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASVLGDHRNQPQHF,p65,CMV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASVLSASGYNEQFF,p65,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASVPRPGDSTDTQYF,p65,CMV,I,,12-3*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASWGLSYNEQFF,p65,CMV,I,,5-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASWLNTEAFF,p65,CMV,I,,5-4*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASYQGAMNTEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASYTAGLNAEAFF,p65,CMV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CASYYQGGANTGELFF,p65,CMV,I,,4-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATAGGTSEYRTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATARGGQETQYF,p65,CMV,I,,10-3*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATASLAEENIQYF,p65,CMV,I,,28*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATEDSYNSPLHF,p65,CMV,I,,30*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATGDRNTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATGHQPQHF,p65,CMV,I,,6-2*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATGKTSGLTGAGELFF,p65,CMV,I,,6-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATHPWGAGGYTF,p65,CMV,I,,12-3*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATILYEILLGKATLYAVLVSALVLMATNEKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATIPSVGQETGELFF,p65,CMV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATKGTESNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATKTGTAEKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATLKQGAMDWETQYF,p65,CMV,I,,25-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATLNTDGVRETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATLSTRVTGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATMEGHEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATQEGQLGNTIYF,p65,CMV,I,,15*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRDLTAGELFF,p65,CMV,I,,10-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRFGNTIYF,p65,CMV,I,,27*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRKRRGHLNTEAFF,p65,CMV,I,,5-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRLGGNNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRPGANTGELFF,p65,CMV,I,,19*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRQETNEKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRQGADSEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRQYSGNTIYF,p65,CMV,I,,27*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRRGDEQYF,p65,CMV,I,,5-4*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRRGEGQEKKQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATRTGAYEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSAAGRSEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSADRDRSYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSAGNTGELFF,p65,CMV,I,,24-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSAGPSVEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSARDRGISPLHF,p65,CMV,I,,15*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDDDYNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDFGDGGYEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDFLNTGELFF,p65,CMV,I,,24-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDFTAAEGYTF,p65,CMV,I,,24-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDFVGGTEAFF,p65,CMV,I,,24-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDGLAGDYEETQYF,p65,CMV,I,,24-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDGQGGYNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDGRSGFLNTGELFF,p65,CMV,I,,24-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLGGLSYNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLHRGDEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLLEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLNTGRTTNEKLFF,p65,CMV,I,,24-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLPGGRETQYF,p65,CMV,I,,24-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLPVDSYTDTQYF,p65,CMV,I,,24-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLWFRNNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDLWRQGGPDTQYF,p65,CMV,I,,24-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDPGLAGPGEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDPGTSGSYEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDPQREVNTDTQYF,p65,CMV,I,,24-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDPRDRAFYGYTF,p65,CMV,I,,24-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDRGTGGSYEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDRLVPDTQYF,p65,CMV,I,,24-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDRPGGEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDSRGYEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDSVNRGTPYEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSDYSGSVNEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEALYEQYF,p65,CMV,I,,24-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEGARTSGRYNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEGNLDQPQHF,p65,CMV,I,,24-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEGRGLGYTF,p65,CMV,I,,24-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEGSWSREKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEHDSTGELFF,p65,CMV,I,,24-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEQGQGPSDTQYF,p65,CMV,I,,24-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSETETTIYNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSEVGTPNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSFRGVQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSGDISSYNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSGFPDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSGNVGTEAFF,p65,CMV,I,,24-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSGRPGSSYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSGTGDNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSGTVPGRTEAFF,p65,CMV,I,,24-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSIDIEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSIDTSPLHF,p65,CMV,I,,15*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSIGQSNTEAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSKDPSTGSDEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSKDRVSEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSLSGGGSDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSLTSGGRNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSLTTDTGELFF,p65,CMV,I,,24-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSNWGMGSKDTEAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSPGLAGGWSDTQYF,p65,CMV,I,,24-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSPLFSYSDEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSPRTGGDEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSPTGVNTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSQGAWYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRAGQGGGYTF,p65,CMV,I,,15*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRAQGQTQYF,p65,CMV,I,,15*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDFTNYGYTF,p65,CMV,I,,15*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDGTSGANVLTF,p65,CMV,I,,15*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDIEFSLYGYTF,p65,CMV,I,,15*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDKGGATTGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDKGTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDLGGADTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDLGGGAEDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDPGGAYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDPGSYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDQGDSNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRANYGYTF,p65,CMV,I,,15*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRARAVNSLIGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRAYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRGGGTQETQYF,p65,CMV,I,,15*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRGHTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRGTGTEAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRSGAGGGYNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDRYNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDWASGRSGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRDYRDRGAWRWEKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSREESGPYNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSREGETYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSREGGAPVSNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRENGGGTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRERGVTTGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRESGTGGPIQYF,p65,CMV,I,,15*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSREVETGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSREWASGTYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGAGTSTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGDTGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGFAQQETQYF,p65,CMV,I,,15*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGKGDNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGQGYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGRDNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGRDYSNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRGTSGGSDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRIPGGVTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRPGGNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRPGWTGGTEAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRPLLVGGRYTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRPVEGPYSYTF,p65,CMV,I,,15*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRRQGADEKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRSGQGYTLGQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRSLGGAYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRSTGGLNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRTGAHEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRTSGRPSTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRVPSGSYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRVPTGADNEQFF,p65,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRVQQENEKLFF,p65,CMV,I,,15*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRVSGFGTEAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSRVSWTDEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSSLNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSSQRGLASYEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSSTGSEDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSSVRSGADTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSSWDRSSGANVLTF,p65,CMV,I,,15*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSTDGISNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSTGGTEAFF,p65,CMV,I,,15*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSTSQDLNQPQHF,p65,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSTTGTSGGLLGELFF,p65,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSTWDRGSGANVLTF,p65,CMV,I,,15*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSTYDNPTDTQYF,p65,CMV,I,,15*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSVGLNTEAFF,p65,CMV,I,,24-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSVPRGEQYF,p65,CMV,I,,15*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATSVRAGGQKVNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATTEGGGGGADEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATTGIGGKTQYF,p65,CMV,I,,5-4*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATTPLIAGAHEQYF,p65,CMV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATTRGEWSNEQFF,p65,CMV,I,,24-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATTTEANTGELFF,p65,CMV,I,,3-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CATTTGTESSNQPQHF,p65,CMV,I,,12-5*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAVGRGATEAFF,p65,CMV,I,,27*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAVLGGLEDNSPLHF,p65,CMV,I,,6-6*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWAGPGGLREQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWARDGTYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWARITEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWDLEGGTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWDSSGTGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWDVGTGPHEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWGIGTGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWNIGGHTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWNLNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWNPANSGNTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWNTVGTSSEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWQTGVSTGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWRLNNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWRQGFSTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSAERELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEAWTRHTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEDNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEDRNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEGTGGLAEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEGTGLYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEPNRVLREKLFF,p65,CMV,I,,30*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEQGLGNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSESYNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSETLNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSEVHEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGANTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGDSFEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGDSLDTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGDSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGEGDPTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGFGSPGETYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGGGDGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGGLAGGFSYNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGGLNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGGTGNTGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGGVRDNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSGQLHYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSIERELDEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSIIQGAPMYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSISDIMNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLAGGTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLLAGAYNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLMAGGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLRDAGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLTINTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLVGLSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSLWGSLNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSMGGSAGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSPPAVSGANVLTF,p65,CMV,I,,30*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSPPGPEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSPRDRFTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSQGTSGGTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSRGGWGHNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSSGRENYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSSNRPLLSYNEQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSSQTGIYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSTGGTQPQHF,p65,CMV,I,,30*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSTLGQVNYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVDGLNPLGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVERGIIANYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGAGNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGDWETQYF,p65,CMV,I,,30*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGGAGNTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGNRGNEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGPGYTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVGTGAYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVHEWQANYGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVLFGANSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVLFGGRSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVLHSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVLTAESGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVPDIMNTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVPDTSSTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVRESDGYTF,p65,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVRGHNTGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVRQGGNTIYF,p65,CMV,I,,30*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVRQTTNEKLFF,p65,CMV,I,,30*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVSDLAKNIQYF,p65,CMV,I,,30*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVVAGGEGQFF,p65,CMV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVWDRGSGANVLTF,p65,CMV,I,,30*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVWRRESGANVLTF,p65,CMV,I,,30*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSVYTSGGDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSWAAATSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSWGQGVRELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSWGTPENIQYF,p65,CMV,I,,30*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWSYTDEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTDNTGELFF,p65,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTEAENTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTLAYFTDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTPDSDYSYEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTRSETQYF,p65,CMV,I,,30*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTSGRGAEQYF,p65,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWTTSPRGSDTQYF,p65,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CAWVPTGTGGTEAFF,p65,CMV,I,,30*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
NLVPMVATV,A02,,CSAAASGRSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAADGFSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAADRAYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAAGTSGRTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAALPYYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAAQGAGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSACLNLCHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSADGLPISSYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSADMSLENEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSADPQAQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSADREAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSADSAGGNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSADTGAPSYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAEDRDTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAERTGGGTNEKLFF,p65,CMV,I,,20-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAERTGTSGSNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAFWDRPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGDREPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGDRGVYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGDRGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGGNHYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGILTSGSSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGLAGVAISTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGQENYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGQGSDYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGRTDTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGTANYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGTGDSTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAGTGDTYIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAHLTPSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAIAPSQGADSIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAIDSLSNEKLFF,p65,CMV,I,,20-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAIEYSGPEGQIYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAIKYDTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAIPDRAGADTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAIRTGGHNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAISRDLLYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKDGISGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKDSFGPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKGRAKNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKRDRGVSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKRPSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKTDRLAYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAKTPNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALAGGPDEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALHRDSGNTIYF,p65,CMV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALPGLAGSNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALPLTNPPHGANVLTF,p65,CMV,I,,20-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALPQGAVNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALRNTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALRTDYYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALSGNQNYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSALTWGLAGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAMGWDSSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAMGYEGTADLTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAMIGVGGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAMYGVNSPDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANLGNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANPSGAYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANPSSGQYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANSLSWPGEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANTGAVMNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANTLAGYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSANWQGGQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPALGAMETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPARVSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPASGREADTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPDHRESADTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPETAEAYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPFVTGRSGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPGGGLTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPGTGLRDEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPKSWTGDETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPLTGNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPPGLAVYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPRLAGPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPRTGSNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPSGSSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPSGTSTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPTPTRGGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPTSGFYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAPVGVTAGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAQAGTSETGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAQDRDKEDTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAQEGRGDTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAQLQLGNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAQTGGRAETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAAGGQDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAARLAGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAGDTDNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAGGDGETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAGQAGSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAIQREGFSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARAKDVAGVDEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARALAGDTYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARALGLAGANTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARARAGGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARARDYSASQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARASPHTYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARASTSGDSNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARATGDLAGFTYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDASGGAGTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDDGQGQGARTYNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDDYDLGGTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDEGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDERFANYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDERVIPNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDFEITGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDFGSPYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDFRGPSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDFSGREKSQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGDRATNNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGEPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGFYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGGQGGSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGGTGVGWVDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGIESNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGLAGFSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGLAGGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGRSKDEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGTGNGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGTRDYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDGVTSGIYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDHCGVSVGETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDHGQEYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDHQGSSTSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDIEIAYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDIMNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDKRTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDKSLPTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLAAYNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLAGWNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLASSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLDRADNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLEGTAKNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLETSGGLETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLGETFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLGGLNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLGGTAKNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLGTNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLGYGLYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLIGAGANVLTF,p65,CMV,I,,20-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLKATLSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLKGSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLLAGVYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLPSGGPQQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLRGQGDNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLRLAEETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLSSNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLTGPNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLVRYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDLWGVNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDMAGFHEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDNLQARYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPDRLYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPGGRSSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPGGSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPGHLNTIYF,p65,CMV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPGLAAYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPQTGTDFYQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPRRKAHEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPSGRLWDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPSGTSNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDPTSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDQDGSLIGEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDQDISDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDQRTSLYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDRASAEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDREEANYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDRGNEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDRLAGDTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDRNHGARVLNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDRTNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDSGAGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDSSGSRLTLAETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDTALVNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDTASAYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDTREGLNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDVAGGSLKQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDVDSQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDVETKNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDVQGWNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDWASGGTDISYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDWGEETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDYFADTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDYKTGVDYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARDYLSDRLHEKLFF,p65,CMV,I,,20-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREAWRGRTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREEAGGPLTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREEAGTSGRRASYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREGGAYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREGQDKSYNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREGTDFYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARELAGPGNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARELGTANTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREPNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREQGVYTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREQRGYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARERPSSYNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARESPLARSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARETGRATNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARETSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAREVDAPGTQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARFEGGSRHTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGADFSFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGAGIGNTIYF,p65,CMV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGAGTPGDPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGAREAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGASSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGDISTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGDRSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGFQPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGGGDLYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGGGSFYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGGQVDTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGHTRSGTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGITGGTGETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLADFVDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLAGAYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLAGGPVETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLAQQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLDRIYYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLGLAGVLEYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLSDSTHQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGLSGGDYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGMATSGGPTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGPGAISYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGPSGELETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGQDIYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:28623251,4
NLVPMVATV,A02,,CSARGQGTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGRAAGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGRGIGTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGRTSAEREQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTANTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTEGEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTGTGSEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTGTSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTIDRDPNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTLGGYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTSGMGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGTSYGGRGPEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGVAGGRYEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGVGDSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGWETMNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARGYSAKNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARIGVGNTIYF,p65,CMV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARKELGADTSPTYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLADNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLAGDTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLAGRPADTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLAGTYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLDLAFGQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLGRSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLLGSGDQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARLPGGVGTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARNDRGDLQMSEKLFF,p65,CMV,I,,20-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARNIVGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARNNQGEAQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARNYQGANTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARNYRGGTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPFGTSGPSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPGLSDEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPGQGIYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPGQTYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPMTSGPYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPPALESQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPPDASGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPPGTPPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPRDRENNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPRTSGPYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPVQGINYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARPWNSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARQGDTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARQGDTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARQGGLAKNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARQGSGNTIYF,p65,CMV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARRGEYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARRLADTYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARRLAGGSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARRLEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARRLNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSAAGINYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSAPGTALGTPSTAGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSLDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSLFGPDGGSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSLPRATDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSPLTEGSSGNTIYF,p65,CMV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARSQRETNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTDRGGQSEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGDLQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGEGSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGFGGAEETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGGGDTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGGPLEEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTGRFYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTQGDTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTRTGLPNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTSGPPDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTSGRVGEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTSGTPGWEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARTSQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVADSHYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVARGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVDGVLSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVEFGTSGQLSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVEFGTSRQLSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVEHGLAGSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVGESSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVGLAGDRNEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVGPQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVIDYLRGNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVSGTDFYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVSSASGTYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVVSGGAPYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARVYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSARYRAGASGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASALDRTGATASGRERDLEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASDGGGFNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASEGNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASEWAGATYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASFESRSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASFSDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGETLGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGFGLGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGGTSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGGVSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGHHYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGPKAGDFHYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGSYSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGTGSNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASGVRNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASLGNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASLSESSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASNPGTGDSGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPDRGNTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPGAESSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPGQGHNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPGQNSFTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPKGAIYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPPASSGQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASPTSGASPNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASRGEVGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASRPAGTTPREAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASRQGYYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASRRGVQMNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASRTDYVYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASSGALSISYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASSGAPVVGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASSPDTDSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASSSELHKSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASSSGVNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASTENTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASTGADTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASTPGEQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASTTVGTTMSDEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASYGAGESQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSASYGRGPYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATDFPNSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATDRGLSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATGAPTIDEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATGLLTYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATIEGEYYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATLGLAEYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATLGNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATLLGLWGDEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATLTTTGWEKLFF,p65,CMV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATPGGSGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATPRDSNYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATPWVGLSFSKQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATPWVGLSFSNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATQGWLTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATSGAISSSYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATSPGTGIWEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATTAGDYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATTGTGGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATTQTLDRRIRTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSATWEQSGNGETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAVAVYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAVEREVTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAVGRSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAVLDRGTGESYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAVPGLALGEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAVSDSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAWDRRLNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAWQGGTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAWTSGNNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAYDREQETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSAYTSGGDEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSDAGPLGTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSDPSCRRKSGANVLTF,p65,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSDSGGDNTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSFIPGHSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSFKREGPFANTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSFRTAMNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGAPPYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGGFEYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGGLAGGPDPYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGGQGEDTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGGRASSNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGIVLAGADNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGKQDTSWTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGKRDTSWTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGLALGGEEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGRGSGDNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGSGASTDTQYF,p65,CMV,I,,20-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGSLGETQYF,p65,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGTDYYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGTGGDDYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGTGTQDREQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGTPGQGVGTETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSGYTGTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSLRDGRNNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSPGRGQGSSYNEQFF,p65,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSPLGRKGVNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSPRPLSSYNSPLHF,p65,CMV,I,,20-1*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSRGGYEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSRTSGDNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSSLAPGATNEKLFF,p65,CMV,I,,20-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSSLWDRSSGANVLTF,p65,CMV,I,,20-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSSQEEGPGNQPQHF,p65,CMV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSSTETGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSSSYSRQWNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSTQRGGTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAAGGRGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVADGGPYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAETYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAFGRRRPEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAGGANYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAGGSGTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAGQPSGANVLTF,p65,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAGTVNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVAQYGTSGLNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVATGLDYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVATGRGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVATGYYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDEGLAGGEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDGQGNFNYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDGSLAGRSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDHLSRGVAEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDKGGPEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDLLDRYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDLRYTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDPDNDNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDPDTNYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDPGTGDGEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDPPEGSDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDPRLPGLTNNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDQGANSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDRENTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDRGSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDSAGGNYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDSGGYQETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDSGRAGYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDTDGLSGANVLTF,p65,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDWRADRGETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVDWTGDSGNTIYF,p65,CMV,I,,29-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEAGEETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEAQGGTFNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEAYATDYYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDDRYQETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDFRAEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDGAGGLWYTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDGDERGRYIQYF,p65,CMV,I,,29-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDGSENTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDLKGAEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDLSGRELNNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDQLRETDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDRGISGANVLTF,p65,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDRVAMNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDSYYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDTSTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDYGRVETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEDYSTGIISGNTIYF,p65,CMV,I,,29-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEEGDYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEEGLSFGEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEEGQGNGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEELAGDTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGAPNTYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGDGTYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGEGGSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGEGGSYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGGRGDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGGTDYENTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGGWGTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGLADLTSYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGLYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGQEGGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGQQTYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGSSEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGTGGAPLYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGVRKTNTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGVTGPANEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEGWDRSSTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEHDTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEKGATEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVELLYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVELRNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEMQSSGPYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVENQGAYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVENSRSQETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVENTFEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVERDTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVERTSIYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVESAGGYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVESETGGLNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVESGTDYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVESLDRGETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVESPMSNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVETGGYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVETGIGYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVETRSSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVETSGGVGEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVETSGNREQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEVGSNQPQHF,p65,CMV,I,,29-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEVGVVSETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEVNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEWVHEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEWVHGQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVEYPSGQPMDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGDGNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGDGNTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGFNQPQHF,p65,CMV,I,,29-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGGGGQPQHF,p65,CMV,I,,29-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGGGGVDSYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGGSGGADTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGGSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGKGDSPNEKLFF,p65,CMV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGLAGVNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGLRQGNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGPGTLANTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGPPEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGQALQETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGQGNGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGQPANYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGQTYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGRGYEGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGSLGGVGKNIQYF,p65,CMV,I,,29-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGVDYPYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVGVKNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVHTGHEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVKDGYYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLGTEKNTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLGVTSTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLIAEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLPGLVYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLRDNNNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLRGPEGDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLSMGKLFF,p65,CMV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVLTAASGAGVEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVMDSISYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVMGTINEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVNIAYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVNRWGNEKLFF,p65,CMV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVPDVSSYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVPGISYYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVPGQTNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVPTGKTYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVQGGTYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVQGPEYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVQGPSPEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVQRGQSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVQTGVSGANVLTF,p65,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVQTTRNTQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVRGPKGATNYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVRLDSSGQPQHF,p65,CMV,I,,29-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVRQANTGELFF,p65,CMV,I,,20-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVRRQGNVWNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVRTGTRSFSGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVRTYEKLFF,p65,CMV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVSGVSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVSRDSLLLEGEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTFETGHTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTFGTGGTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTGEERTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTGPDYLGQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTGTTYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTHRGGEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTNPGGVLGYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTRQASTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTSRGGTREQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVTTGAGGYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVDPPGVNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVDSKNTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVDTNTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVESYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVGGSGYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVGTINEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVGTINERFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVGTINVQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVGTSGGANEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVGVDYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVKPNTGELFF,p65,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVLDSRYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVPEGGSYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVPRGTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVRDNGNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVRGAYEQYF,p65,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVSLAEQETQYF,p65,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVVSNYGYTF,p65,CMV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVWRDNYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVWVAGENTEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVYLLEAFF,p65,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVYPGQNNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CSVYPSGDYNEQFF,p65,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTARRLASGSRDEQFF,p65,CMV,I,,7-2*03,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTNPGDPCYNEQFF,p65,CMV,I,,7-2*03,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSEDHTGFYEQYF,p65,CMV,I,,7-2*03,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSFYFTGAPYNEQFF,p65,CMV,I,,7-2*03,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSHEGSGGYTF,p65,CMV,I,,7-2*03,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSLAPGATNEKLFF,p65,CMV,I,,7-2*03,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSPGGRTDSPHTDTQYF,p65,CMV,I,,7-2*03,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSPRDRGNTGELFF,p65,CMV,I,,7-2*03,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSPVAGAPHEQYF,p65,CMV,I,,7-2*03,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSQAPFWASNQPQHF,p65,CMV,I,,7-2*03,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSQTQLWETQYF,p65,CMV,I,,7-2*03,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
NLVPMVATV,A02,,CTSSSVNEQFF,p65,CMV,I,,7-2*03,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,amplicon-seq,RNA,PMID:28423320,5
RPHERNGFTVL,B07:02,CAASIGDFGNEKLTF,,p65,CMV,I,13-1*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CAISEGDLNTEAFF,p65,CMV,I,,10-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSEGIGYNSPLHF,p65,CMV,I,,27*01,,1-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSGDPEHGYNYGYTF,p65,CMV,I,,5-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSKGAAITVGLETQYF,p65,CMV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSLASDGPQETQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPARNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPHRNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPNRNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPQRNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPQSDQNQGTQYF,p65,CMV,I,,5-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPSRNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPTRNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSPYRNTEAFF,p65,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSQGLAGGPRTDTQYF,p65,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CASSWAPNTGELFF,p65,CMV,I,,12-3*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CSARDLKAGSWVEQYF,p65,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CSARDPQGVTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CSARDSSGGAKNIQYF,p65,CMV,I,,20-1*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CSASLASTSNYGYTF,p65,CMV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CSATPARASNTEAFF,p65,CMV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
RPHERNGFTVL,B07:02,,CSGIDKPVTDTQYF,p65,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:22323539,5
TPRVTGGGAM,B07,CATEGRMDSSYKLIF,,p65,CMV,I,3*01,,12*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,CATEIRMDSSYKLIF,,p65,CMV,I,17*01,,12*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,CATRPPGAGSYQLTF,,p65,CMV,I,17*01,,28*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,CATVSRMDSSYKLIF,,p65,CMV,I,3*01,,12*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSFRDYGNYEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSHDYRGRRSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSLIGEGTGWHQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSLRDRGSYEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSLVGVGLLLNEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSNRDRGDYEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSHDREGGSSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSHDRQGASSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSHDTGGYNSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSHDYRGRRSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSRDLGEYEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSRDRGPHGQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSSRDRGSYEQYF,p65,CMV,I,,6-4*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
TPRVTGGGAM,B07,,CASSTHDIQGLGSPLHF,p65,CMV,I,,6-4*01,,1-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:17709536,4
YSEHPTFTSQY,A01:01,CVAWGGYSSASKIIF,,p65,CMV,I,12-1*01,,3*01,,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
YSEHPTFTSQY,A01:01,,CASSVVGDEQYF,p65,CMV,I,,9*01,,2-7*01,,,human,TCL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:19864595,5
VTEHDTLLY,A-A01:01,,CACRPRALYGYTF,pp50,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAGTLAGGTDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAPRGGTNTGELFF,pp50,CMV,I,,4-2*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASGLDGGPEQFF,pp50,CMV,I,,12-5*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASNWQGPYNEQFF,pp50,CMV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASRDRLVSYEQYF,pp50,CMV,I,,6-2*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VTEHDTLLY,A-A01:01,,CASREEGCQPQHF,pp50,CMV,I,,14*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASRHNTQASHEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASRKGGSDTQYF,pp50,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASRLAGGGGEQFF,pp50,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASRTSRQGIPEAFF,pp50,CMV,I,,12-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSAAGALGYTF,pp50,CMV,I,,7-3*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSADRDRGLDTGELFF,pp50,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSDLAVSYNEQFF,pp50,CMV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSEAHAVYEQYF,pp50,CMV,I,,6-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSESLLTEQFF,pp50,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSFITDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSFPVLAGLSSTDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSFRAGYNEQFF,pp50,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSGEREDNEQFF,pp50,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSGGQGPLKELTYEQYF,pp50,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSGPSNEQFF,pp50,CMV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSGTSLGGELFF,pp50,CMV,I,,6-5*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSKENNNRPYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLAGAGNEQFF,pp50,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLAPASGRRDNEQFF,pp50,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLAPDRVEGQPQHF,pp50,CMV,I,,7-2*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLAQGYEQYF,pp50,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLASTGELFF,pp50,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLAVGDSPLHF,pp50,CMV,I,,7-6*01,,1-6*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLEAGDQPQHF,pp50,CMV,I,,7-6*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLEAGGQPQHF,pp50,CMV,I,,7-3*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLEGLAAQETQYF,pp50,CMV,I,,7-2*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLEGSTDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLEREDYEQYF,pp50,CMV,I,,7-6*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLFGDNEKLFF,pp50,CMV,I,,7-8*01,,1-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLFGGNTEAFF,pp50,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLFSSGQETQYF,pp50,CMV,I,,7-7*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLGGEQFF,pp50,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLGGSGYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLGTSGSYEQYF,pp50,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLGVAGEAFF,pp50,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLGYGTEAFF,pp50,CMV,I,,7-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLHETGMNTEAFF,pp50,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLIASPADTQYF,pp50,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLLSGTSYEQYF,pp50,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLNPRQGRDEQYF,pp50,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLPAGDIQYF,pp50,CMV,I,,7-9*01,,2-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLPGPKEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLPLTDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLPSGRAYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLRGAGVFETQYF,pp50,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLRRGPDTGELFF,pp50,CMV,I,,7-9*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLRRLAGQYEQFF,pp50,CMV,I,,7-2*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLSGLGDNEQFF,pp50,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLSGSYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLSLAGIPDTQYF,pp50,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLSLAGREQFF,pp50,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLSTSEQFF,pp50,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLTDTQYF,pp50,CMV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLTGLAGTGELFF,pp50,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLVDLVHGYTF,pp50,CMV,I,,7-8*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLVEQGIEQYF,pp50,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLVRVRTSGYYEQYF,pp50,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSLVVPQLPTYEQYF,pp50,CMV,I,,7-4*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPDTGELFF,pp50,CMV,I,,4-2*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPEGAQSYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPEWGYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPGAVYEQYF,pp50,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPGPGAGYGYTF,pp50,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPGQDTDTQYF,pp50,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPGQLLTF,pp50,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPGSTDTQYF,pp50,CMV,I,,4-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPGTGTYGYTF,pp50,CMV,I,,10-2*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPIGGLEETQYF,pp50,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPPGIGGYNEQFF,pp50,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPPLGAQQFF,pp50,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPQGINTEAFF,pp50,CMV,I,,7-9*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPRSGLGPYNEQFF,pp50,CMV,I,,7-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPRTGLNTEAFF,pp50,CMV,I,,4-2*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPRTSGNEQFF,pp50,CMV,I,,7-8*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPTGGGTGELFF,pp50,CMV,I,,6-6*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPTGGNTGELFF,pp50,CMV,I,,7-3*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPTGGSSYEQYF,pp50,CMV,I,,7-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPTWSPYEQYF,pp50,CMV,I,,7-8*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPVAGGNHNEQFF,pp50,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSPVGGSYNEQFF,pp50,CMV,I,,7-6*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQAGSNYGYTF,pp50,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQAPRGWDEQYF,pp50,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDAQGGGSYNEQFF,pp50,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDFLQTFNQPQHF,pp50,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDGRAQGGEAFF,pp50,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDGTGIGGKLFF,pp50,CMV,I,,4-2*01,,1-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDIGVSYEQYF,pp50,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDISDTDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDKTRSRGSYNEQFF,pp50,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRAGLYEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRNSGYGYTF,pp50,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRQGWNEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRRGGNYEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRRRAWNEQFF,pp50,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRSLEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRTGGGGYTF,pp50,CMV,I,,4-3*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDRVGTIFYGYTF,pp50,CMV,I,,14*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDTGLGVGAYEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDTGQGVEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDTKGANTEAFF,pp50,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQDWDTQYF,pp50,CMV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQERGGKWAYEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQERGGKWAYEQYF,pp50,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQERSMNTEAFF,pp50,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQESGGGYEQFF,pp50,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQETIAKNIQYF,pp50,CMV,I,,4-1*01,,2-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGGSDTQYF,pp50,CMV,I,,4-2*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGPGQGANYGYTF,pp50,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGQVGDGYTF,pp50,CMV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGRGDTEAFF,pp50,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGRGRNTEAFF,pp50,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGSAPSYEQYF,pp50,CMV,I,,4-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGTATNSPLHF,pp50,CMV,I,,4-2*01,,1-6*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGTGGDEQYF,pp50,CMV,I,,4-2*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGTGNTEAFF,pp50,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQGTVDEQFF,pp50,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQLAGVVTQYF,pp50,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQLAGVVTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQLGQGNTGELFF,pp50,CMV,I,,4-1*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQLPGPEAFF,pp50,CMV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQMEQLEQYF,pp50,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQPGLAVEQYF,pp50,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQQGPEQFF,pp50,CMV,I,,19*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQSRSSYNEQFF,pp50,CMV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQVGTGSINEQFF,pp50,CMV,I,,4-3*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQVQGAYEQYF,pp50,CMV,I,,4-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSQVQGTDTQYF,pp50,CMV,I,,4-1*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSRAGTGGSETQYF,pp50,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSRDRGPIGEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSRRGQNTEAFF,pp50,CMV,I,,7-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSRTLNTEAFF,pp50,CMV,I,,4-3*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSRYRQYNQPQHF,pp50,CMV,I,,4-1*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSGLGGPETQYF,pp50,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSIAGPIEQFF,pp50,CMV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSIWTSGREETQYF,pp50,CMV,I,,7-8*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSLERGWETQYF,pp50,CMV,I,,4-1*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSLGTRSPLHF,pp50,CMV,I,,4-1*01,,1-6*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSNRAGELFF,pp50,CMV,I,,7-7*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSSGQVYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSSSGRTTDTQYF,pp50,CMV,I,,7-3*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSSTLGTQYF,pp50,CMV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSTEGLLSTDTQYF,pp50,CMV,I,,7-8*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSTSRSGGIDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSVGQGKTYEQYF,pp50,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSVGQGVTYEQYF,pp50,CMV,I,,9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSVRGQGNYGYTF,pp50,CMV,I,,5-4*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSWDSSYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSWSGGGARDTQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSWSGGGASATQYF,pp50,CMV,I,,7-9*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSWTGPSYEQYF,pp50,CMV,I,,5-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,antigen-specific ex vivo proliferation,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:24512815,9
VTEHDTLLY,A-A01:01,,CASSYDRGDYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSYGGGGYEQFF,pp50,CMV,I,,6-5*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSYGGPLADTQYF,pp50,CMV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSYLAGEGYEQYF,pp50,CMV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSYPSNPGGTEAFF,pp50,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSYSAGGPYEQYF,pp50,CMV,I,,7-3*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASSYYSSNYGYTF,pp50,CMV,I,,6-5*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASTHAGRPYEQYF,pp50,CMV,I,,7-2*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASTLLGGKYEQYF,pp50,CMV,I,,7-9*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CASTPGATTGELFF,pp50,CMV,I,,7-8*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CATDHGGTDEAFF,pp50,CMV,I,,7-8*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CATHRAGGFNEQFF,pp50,CMV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CATSPRGGNQPQHF,pp50,CMV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CATSSLSGRVTGELFF,pp50,CMV,I,,15*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWNKGIAGYTF,pp50,CMV,I,,30*01,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWRPEPGQEEFNAYF,pp50,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSAGVNTGELFF,pp50,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSLPASYEQYF,pp50,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSLVEGTGELFF,pp50,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSVLGGAVETQYF,pp50,CMV,I,,30*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSVYRGYEQYF,pp50,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSWSGGGTGELFF,pp50,CMV,I,,30*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWSWSSTDTQYF,pp50,CMV,I,,30*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CAWTSGGASEQYF,pp50,CMV,I,,30*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSALGGDGETQYF,pp50,CMV,I,,29-1*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSANSVSYNEQFF,pp50,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSARDLDSLSYEQYF,pp50,CMV,I,,20-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSARDRGWDEQFF,pp50,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSARDTLAGGVQETQYF,pp50,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSATGTSGRVETQYF,pp50,CMV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSGLTESPAHYSGANVLTF,pp50,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSGRLTGGNEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSHRTGLGIEAFF,pp50,CMV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSQQVNNEQFF,pp50,CMV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVEDAGGTYEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVEEGAYEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVERTGELFF,pp50,CMV,I,,29-1*01,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVGEPGQSSYEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVGGSTDTQYF,pp50,CMV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVLGGGGYEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVLTGTGYEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVNEGSDEQYF,pp50,CMV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVRPGGSYNEQFF,pp50,CMV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
VTEHDTLLY,A-A01:01,,CSVRTGGLGANVLTF,pp50,CMV,I,,29-1*01,,2-6*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",MiSeq,RNA,PMID:28636589,4
YLAMPFATPMEAELARRSLA,B35:01,,CAIGTGDSNQPQHF,NY-ESO-1f,Lung carcinomas,I,,,,1-5,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASRTGTSDHEQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-7,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSDTTTDTQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-3,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSFGQAEKLF,NY-ESO-1f,Lung carcinomas,I,,,,1-4,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSFGRLAGGPGTDTQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-3,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSGRSGANVLTF,NY-ESO-1f,Lung carcinomas,I,,,,2-6,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSGTGTLSYEQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-7,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSLDGGNTGELF,NY-ESO-1f,Lung carcinomas,I,,,,2-2,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSLDTDTQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-3,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSLLGTDRPQHF,NY-ESO-1f,Lung carcinomas,I,,,,1-5,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSLQRFRETQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-3,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSLRGNEQF,NY-ESO-1f,Lung carcinomas,I,,,,2-1,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSLVGTNIQYF,NY-ESO-1f,Lung carcinomas,I,,,,1-3,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSRSGTGFLEQYF,NY-ESO-1f,Lung carcinomas,I,,,,2-7,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CASSSTGGGGTEAF,NY-ESO-1f,Lung carcinomas,I,,,,1-1,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
YLAMPFATPMEAELARRSLA,B35:01,,CATSTNGRDLF,NY-ESO-1f,Lung carcinomas,I,,,,,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,DNA,PMID:26291626,4
ALTPVVVTL,A02:01,,CASRMNTEAF,UNC-CDK4-1,Acute myeloid leukaemia,I,,19-1,,1-1,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",HiSeq 2000,RNA,PMID:25576336,4
ALTPVVVTL,A02:01,,CASSAQGFGELF,UNC-CDK4-1,Acute myeloid leukaemia,I,,9-1,,2-2,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",HiSeq 2000,RNA,PMID:25576336,4
ALTPVVVTL,A02:01,,CASSEGRETQYF,UNC-CDK4-1,Acute myeloid leukaemia,I,,25-1,,2-5,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",HiSeq 2000,RNA,PMID:25576336,4
ALTPVVVTL,A02:01,,CASSIGQGPYEQYF,UNC-CDK4-1,Acute myeloid leukaemia,I,,19-1,,2-7,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",HiSeq 2000,RNA,PMID:25576336,4
ALTPVVVTL,A02:01,,CASSLGGRRYEQYF,UNC-CDK4-1,Acute myeloid leukaemia,I,,11-2,,2-7,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",HiSeq 2000,RNA,PMID:25576336,4
ALTPVVVTL,A02:01,,CASSLGQKEQYF,UNC-CDK4-1,Acute myeloid leukaemia,I,,11-2,,2-7,,,human,PBMC,cancer,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",HiSeq 2000,RNA,PMID:25576336,4
GLCTLVAML,A02:01,CAAGGSQGNLIF,,BMLF1,EBV,I,13-1*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAASRKPDKIIF,,BMLF1,EBV,I,13-1*01,,30*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAASTRLLGNTGKLIF,,BMLF1,EBV,I,13-1*01,,37*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,CAATDNTDKLIF,,BMLF1,EBV,I,13-1*01,,34*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CADGSGTTDSWGKLQF,,BMLF1,EBV,I,5*01,,24*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CADPIEDAGNMLTF,,BMLF1,EBV,I,8-3*01,,39*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEALRRDTGRRALTF,,BMLF1,EBV,I,5*01,,5*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEDFNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEDKDARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEDNNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEDNNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEDPLGSQGNLIF,,BMLF1,EBV,I,5*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEDPLGSRGNLIF,,BMLF1,EBV,I,5*01,,42*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEDQNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEDSNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEDSNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEDSNARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,CAEGFASSDGQKLLF,,BMLF1,EBV,I,5*01,,,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEGHDSTLTF,,BMLF1,EBV,I,5*01,,11*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEGQTDKLIF,,BMLF1,EBV,I,5*01,,34*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEHFWGYQKVTF,,BMLF1,EBV,I,5*01,,13*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAEIHARLMF,,BMLF1,EBV,I,5*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAELGQKLLF,,BMLF1,EBV,I,5*01,,,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEMAGANNLFF,,BMLF1,EBV,I,5*01,,36*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAENPSSGNTPLVF,,BMLF1,EBV,I,5*01,,29*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAENQINNDMRF,,BMLF1,EBV,I,5*01,,43*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,CAESTGKLIF,,BMLF1,EBV,I,5*01,,37*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAESTGKLIF,,BMLF1,EBV,I,5*01,,37*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEVSGTYKYIF,,BMLF1,EBV,I,5*01,,40*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAEYSSASKIIF,,BMLF1,EBV,I,5*01,,3*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAFVANAGGTSYGKLTF,,BMLF1,EBV,I,38-1*01,,52*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAGNNARLMF,,BMLF1,EBV,I,27*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAGNNARLMF,,BMLF1,EBV,I,27*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,CAGNNARLVF,,BMLF1,EBV,I,27*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAGNNARPMF,,BMLF1,EBV,I,27*01,,31*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CALDILYNQGGKLIF,,BMLF1,EBV,I,6*01,,23*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CALDSTYSSASKIIF,,BMLF1,EBV,I,6*01,,31*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CALYSNSGYALNF,,BMLF1,EBV,I,21*01,,41*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CATDAGNDMRF,,BMLF1,EBV,I,17*01,,43*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAVGASRDYKLSF,,BMLF1,EBV,I,8-3*01,,20*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CAVNPGANSKLTF,,BMLF1,EBV,I,12-2*01,,56*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAVSARANDYKLSF,,BMLF1,EBV,I,8-6*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CAYGGSQGNLIF,,BMLF1,EBV,I,25*01,,42*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,CILGSNDYKLSF,,BMLF1,EBV,I,26-2*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVGMDSSYKLIF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNDASGTYKYIF,,BMLF1,EBV,I,12-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNGASGTYKYIF,,BMLF1,EBV,I,12-1*01,,40*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNGDRDRISRLVKF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNGKDSSYKLIF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNGKDSSYKLIF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,CVVNGMDSSHKLIF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNGMDSSYKLIF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNMPDDYKLSF,,BMLF1,EBV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNRDSSYKLIF,,BMLF1,EBV,I,12-1*01,,12*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNSINDYKLSF,,BMLF1,EBV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNSPNDYKLSF,,BMLF1,EBV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,CVVNSPNDYKLSF,,BMLF1,EBV,I,12-1*01,,20*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,,CAISGEFGSGANVLTF,BMLF1,EBV,I,,10-3*01,,2-6*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASFSQRKVPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASGGGGFQETQYF,BMLF1,EBV,I,,10-2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASNPGTSNEQFF,BMLF1,EBV,I,,4-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASPGGIQYF,BMLF1,EBV,I,,14*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASRPDSDYGYTF,BMLF1,EBV,I,,18*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSASARPEQFF,BMLF1,EBV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSAWEGAEAFF,BMLF1,EBV,I,,19*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSDGQLTAGELFF,BMLF1,EBV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSEDAGLSYNEQFF,BMLF1,EBV,I,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSEGAVAPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSEGQVSPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSEVKVSPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSFSSGTTDTQYF,BMLF1,EBV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSFSSGTTDTQYF,BMLF1,EBV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSGEQLLPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSGGQLAPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSGGQLAPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,,CASSGRVLPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSGVQLLPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSKGSVAPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSLAAGLNLKNIQYF,BMLF1,EBV,I,,7-8*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSLAEQGGELFF,BMLF1,EBV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSLGTGDEQYF,BMLF1,EBV,I,,9*01,,2-7*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
GLCTLVAML,A02:01,,CASSLRIDGTDTQYF,BMLF1,EBV,I,,7-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSLRNSYEQFF,BMLF1,EBV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSLTGTFRGYTF,BMLF1,EBV,I,,27*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSLTLQRVGTGELFF,BMLF1,EBV,I,,7-2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSNADTPLQETQYF,BMLF1,EBV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSPDRLGTGELFF,BMLF1,EBV,I,,27*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSPEQGYQETQYF,BMLF1,EBV,I,,7-9*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSPGLTYPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSPLIGTPPGEQFF,BMLF1,EBV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSPPSGSGFNEQFF,BMLF1,EBV,I,,18*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSQAGLAAYNEQFF,BMLF1,EBV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSQAGTGVTEAFF,BMLF1,EBV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSQDGAGGLGEQFF,BMLF1,EBV,I,,4-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSQGDVAPGTQYF,BMLF1,EBV,I,,2*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSQGSELMTGNTIYF,BMLF1,EBV,I,,6-6*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSQNQDMGTEAFF,BMLF1,EBV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSQSPGGIAFF,BMLF1,EBV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSQSPGGIIQYF,BMLF1,EBV,I,,14*01,,2-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSQSPGGTQYF,BMLF1,EBV,I,,14*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSQSPGGTQYF,BMLF1,EBV,I,,14*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSQSPGGTQYF,BMLF1,EBV,I,,14*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSQSPGGTQYF,BMLF1,EBV,I,,14*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSQSPGGVAFF,BMLF1,EBV,I,,14*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSQSPGGYQFF,BMLF1,EBV,I,,14*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSRLGDYTF,BMLF1,EBV,I,,4-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CASSSGLLSNTGELFF,BMLF1,EBV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSSGLLTADEQFF,BMLF1,EBV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSSGQLTNTEAFF,BMLF1,EBV,I,,9*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSSGQTLPGELFF,BMLF1,EBV,I,,18*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSSGQVSNTGELFF,BMLF1,EBV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSSQRKVPGELFF,BMLF1,EBV,I,,2*01,,2-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSVAELAGGTDTQYF,BMLF1,EBV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSVAQLAGGADTQYF,BMLF1,EBV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSVEGLRVTGELFF,BMLF1,EBV,I,,9*01,,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CASSVGELAGGIDTQYF,BMLF1,EBV,I,,9*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSVGNEQFF,BMLF1,EBV,I,,9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSVISLGYGYTF,BMLF1,EBV,I,,11-2*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSYGGISSYEQYF,BMLF1,EBV,I,,6-5*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSYPEVAPSEQFF,BMLF1,EBV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSYPEVAPSEQFF,BMLF1,EBV,I,,6-2*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,,CASSYSSGKTDTQYF,BMLF1,EBV,I,,11-2*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CASSYTRVNEQFF,BMLF1,EBV,I,,6-9*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSYWVGDTDTQYF,BMLF1,EBV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CASSYWVGRRDTQYF,BMLF1,EBV,I,,6-5*01,,2-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CAVVGTGLGYTF,BMLF1,EBV,I,,9*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,,CSAMAGGLRIYNEQFF,BMLF1,EBV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSARDDGVNTEAFF,BMLF1,EBV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSARDETGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSARDGNREWLHF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSARDGTGNDYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
GLCTLVAML,A02:01,,CSARDGTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
GLCTLVAML,A02:01,,CSARDGTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARDGTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSARDPYRASNQPQHF,BMLF1,EBV,I,,20-1*01,,1-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSARDRAYGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSARDRGLGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSARDRGSGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSARDRHREWLHF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSARDRHREWLHF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,,CSARDRIGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARDRSLGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSARDRTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSARDRTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARDRTGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSARDRVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSARDSTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSAREGTGNGYTF,BMLF1,EBV,I,,20-1*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
GLCTLVAML,A02:01,,CSARGDGQGDLLQETQYF,BMLF1,EBV,I,,20-1*01,,2-5*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSARGLVESSYNEQFF,BMLF1,EBV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:11046006,4
GLCTLVAML,A02:01,,CSARIGVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARSGVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARTGVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARVGVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSARVGVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSARWGVGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSAWDREVVGTEAFF,BMLF1,EBV,I,,20-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSDDKYGNTIYF,BMLF1,EBV,I,,20-1*01,,1-3*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSGGQANTEAFF,BMLF1,EBV,I,,29-1*01,,1-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSGTGGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSPGTDLYEQYF,BMLF1,EBV,I,,29-1*01,,2-7*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSSQEGGYGYTF,BMLF1,EBV,I,,29-1*01,,1-2*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
GLCTLVAML,A02:01,,CSVEDGTGSYEQYF,BMLF1,EBV,I,,29-1*01,,2-7*01,,,human,UBC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:25801351,5
GLCTLVAML,A02:01,,CSVEGATSEQFF,BMLF1,EBV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSVGAAGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSVGAGGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSVGSEGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSVGSGGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSVGTGGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:12504586,5
GLCTLVAML,A02:01,,CSVGTGGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:27645996,4
GLCTLVAML,A02:01,,CSVGTGGTNEKLFF,BMLF1,EBV,I,,29-1*01,,1-4*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSVRGEGDTQYF,BMLF1,EBV,I,,29-1*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12504586,4
GLCTLVAML,A02:01,,CSVVGTSLYNEQFF,BMLF1,EBV,I,,29-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:11046006,5
YVLDHLIVV,A02,CALGNTGKLIF,,BRLF1,EBV,I,13-1*01,,37*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CALKAAGNKLTF,,BRLF1,EBV,I,3*01,,17*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAMREGGNFNKFYF,,BRLF1,EBV,I,14/DV4*01,,21*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAVFEGTGGFKTIF,,BRLF1,EBV,I,13-1*01,,9*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAVKDTDKLIF,,BRLF1,EBV,I,13-1*01,,34*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAVKGGADGLTF,,BRLF1,EBV,I,13-1*01,,45*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAVNDGNNRLAF,,BRLF1,EBV,I,8-1*01,,7*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAVRDILASGTYKYIF,,BRLF1,EBV,I,3*01,,40*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,CAVSNQAGTALIF,,BRLF1,EBV,I,8-4*01,,15*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CALSVWGLNYGYTF,BRLF1,EBV,I,,19*01,,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CANTGAGDRVIYNEQFF,BRLF1,EBV,I,,30*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CASRALLGSGETQYF,BRLF1,EBV,I,,27*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CASRQNTEAFF,BRLF1,EBV,I,,3-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CASSLFPSGMDHEQYF,BRLF1,EBV,I,,27*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CASSRGTAGETEAFF,BRLF1,EBV,I,,4-1*01,,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CASTGGPGYGAQYF,BRLF1,EBV,I,,19*01,,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CASTRLLGSADTQYF,BRLF1,EBV,I,,27*01,,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CATSRDLDNGRQFF,BRLF1,EBV,I,,15*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,CSAPVPPYNEQFF,BRLF1,EBV,I,,20-1*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
YVLDHLIVV,A02,,MSLLGSNQPQHF,BRLF1,EBV,I,,19*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:12555663,5
EPLPQGQLTAY,B35:01,CAAAASGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAAASSGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAMREGGGGSNYKLTF,,BZLF1,EBV,I,14/DV4*01,,53*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVAASGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVANQAGTALIF,,BZLF1,EBV,I,3*01,,15*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVHASGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVKSSGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVQASGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVQASGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVQDSGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVRASGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVRATGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVRDFLLSGGYNKLIF,,BZLF1,EBV,I,3*01,,4*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVRDLLRSGGYNKLIF,,BZLF1,EBV,I,3*01,,4*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVRDSGGSYIPTF,,BZLF1,EBV,I,1-2*01,,6*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVRGRYTDKLIF,,BZLF1,EBV,I,3*01,,34*01,,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,CAVRTSGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVSESGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVSSSGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,CAVTSSGGSYIPTF,,BZLF1,EBV,I,1-1*01,,6*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CAIGTGDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CAISTGDGNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CAISTGDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CAISTGDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CAISTGDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CAISTGDYEQYF,BZLF1,EBV,I,,10-3*01,,2-7*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CAISTGPDSYEQYF,BZLF1,EBV,I,,10-3*01,,2-7*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CANSQPGGIEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CANSQPGGIEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASAQIGPYEQYF,BZLF1,EBV,I,,28*01,,2-7*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CASAQIGPYQYF,BZLF1,EBV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASGTGDSNQPQHF,BZLF1,EBV,I,,12-5*01,,1-5*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CASGTGDSNQPQHF,BZLF1,EBV,I,,12-5*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRLPGGYNEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRPPGANVLTF,BZLF1,EBV,I,,28*01,,2-6*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRPPGGNEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRPPGGVNEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRPPGVYEQYF,BZLF1,EBV,I,,28*01,,2-7*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRQPGGVNEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASRTPGVSTEAFF,BZLF1,EBV,I,,28*01,,1-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSFYDWNTEAFF,BZLF1,EBV,I,,5-5*01,,1-1*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CASSIPAAGGRFEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSLIGRDEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CASSLIGRDEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSLISGEGQPQHF,BZLF1,EBV,I,,28*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSLPGAGGDQPQHF,BZLF1,EBV,I,,28*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSLPGGAQGYTF,BZLF1,EBV,I,,28*01,,1-2*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSLPGRDEQYF,BZLF1,EBV,I,,28*01,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSLVVAGGPMSEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CASSLVVAGGPMSEQFF,BZLF1,EBV,I,,28*01,,2-1*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CASSTGDSNQPQHF,BZLF1,EBV,I,,19*01,,1-5*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CASSTGDSNQPQHF,BZLF1,EBV,I,,19*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CATGTGDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,CTL culture,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:16148129,5
EPLPQGQLTAY,B35:01,,CATGTGDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CATGTRDSNQPQHF,BZLF1,EBV,I,,10-3*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CATSTGDSNQPQHF,BZLF1,EBV,I,,15*01,,1-5*01,,,human,CTL culture,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
EPLPQGQLTAY,B35:01,,CATSTGDSNQPQHF,BZLF1,EBV,I,,15*01,,1-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16148129,4
FLRGRAYGL,B08:01,CAVLFGNEKLTF,,EBNA3A,EBV,II,27*01,,48*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:9862375,5
FLRGRAYGL,B08:01,CILPLAGGTSYGKLTFIF,,EBNA3A,EBV,II,26-2*01,,14*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:9862375,5
FLRGRAYGL,B08:01,CILRDVFPSGSARQLTFIF,,EBNA3A,EBV,II,26-2*01,,14*01,,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:9862375,5
FLRGRAYGL,B08:01,,CASSLGQAYEQYF,EBNA3A,EBV,II,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:9862375,5
FLRGRAYGL,B08:01,,CASSSGQAYEQYF,EBNA3A,EBV,II,,6-1*01,,2-1*01,,,human,PBMC,pathogen,antigen-specific ex vivo proliferation,sanger,RNA,PMID:9862375,5
EENLLDFVRF,B44:05,CIVWGGYQKVTF,,EBNA3,EBV,I,26-1*01,,13*01,,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16326979,4
EENLLDFVRF,B44:05,,CASRYRDDSYNEQFF,EBNA3,EBV,I,,7-9*01,,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:16326979,4
AVFDRKSDAK,A11,CAVGDNFNKFYF,,EBNA4,EBV,I,8-3*01,,21*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,CAVSDITYKYIF,,EBNA4,EBV,I,3*01,,40*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CASSLASATGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CASSLTSAAGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CASSLTSATGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CASSPTSAAGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CASSRTSATGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CASSVTSATGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
AVFDRKSDAK,A11,,CATGPRANTGELFF,EBNA4,EBV,I,,28*01,,2-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CAASTNAGNNRKLIW,,EBNA4,EBV,I,13-1*01,,38*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CAGHAGNQFYF,,EBNA4,EBV,I,35*01,,49*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CAGQLRNNLFF,,EBNA4,EBV,I,35*01,,36*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CALIQGAQKLVF,,EBNA4,EBV,I,16*01,,54*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CALMVYGGSQGNLIF,,EBNA4,EBV,I,12-2*01,,42*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CAVFYSGGSNYKLTF,,EBNA4,EBV,I,1-1*01,,53*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CAVNFAGGGADGLTF,,EBNA4,EBV,I,8-1*01,,45*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,CAVSGYNAGNMLTF,,EBNA4,EBV,I,8-4*01,,39*01,,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASLSRGLLNEAFF,EBNA4,EBV,I,,27*01,,1-1*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASSESAGGYYNEQFF,EBNA4,EBV,I,,2*01,,2-1*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASSFGSGSSYGYTF,EBNA4,EBV,I,,11-1*01,,1-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASSLEPGRNEKLFF,EBNA4,EBV,I,,7-6*01,,1-4*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASSVAESPGYPPLVTEAFF,EBNA4,EBV,I,,9*01,,1-1*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASSVGDGGANTQYF,EBNA4,EBV,I,,9*01,,2-3*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASSWGGAAQFF,EBNA4,EBV,I,,25-1*01,,2-1*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CASTTGGATGYTF,EBNA4,EBV,I,,2*01,,1-2*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
IVTDFSVIK,A11,,CSASLYGRGQPQHF,EBNA4,EBV,I,,20-1*01,,1-5*01,,,human,CTL,pathogen,antigen-specific ex vivo proliferation,rna-seq,RNA,PMID:9207000,5
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAHGGGYNKLIF,,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CALQTGANNLFF,,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CALTQGGSEKLVF,,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAALNTDKLIF,CASSLVGRDTEAF,GAD65,Diabetes Type 1,II,,,,1-1,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,CASAGPGANVLTF,GAD65,Diabetes Type 1,II,,,,2-6,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,CASGQVLSSGSNPSDTQYF,GAD65,Diabetes Type 1,II,,,,2-3,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,CASKGTVYNEQF,GAD65,Diabetes Type 1,II,,,,2-1,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,CASSFTEGYTF,GAD65,Diabetes Type 1,II,,,,1-2,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,CASSLAGGEPF,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAGSGGYQKVTF,CPSPLVGGGRF,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CALQTGANNLFF,CASSGRALYNEQF,GAD65,Diabetes Type 1,II,,,,2-1,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAVNTGNQFYF,CASSLALHEQF,GAD65,Diabetes Type 1,II,,,,2-1,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CAVNTGNQFYF,CASSLLMAAGYTF,GAD65,Diabetes Type 1,II,,,,1-2,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CILRDVWSNFGNEKLTF,CASRKDSSGNTIYF,GAD65,Diabetes Type 1,II,,,,1-3,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CILRDVWSNFGNEKLTF,CFSRPITDRNEQNF,GAD65,Diabetes Type 1,II,,,,,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,CVANKILQASKLF,CASSNGQGAETQYF,GAD65,Diabetes Type 1,II,,,,2-5,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
NFIRMVISNPAAT,DRB104:01,,CASSNGQGAETQYF,GAD65,Diabetes Type 1,II,,,,2-5,,,human,PBMC,autoimmune,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:25681349,4
KRGIVEQCCTSISSL,DRB104:01,CAVGALAGTASKLTF,CSVEATRADTQYF,insulin precursor A1-15,Diabetes Type 1,II,8-3,29-1,44,2-3,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,CADAGGTSYKLF,CASSLATSGGGSDTQYF,insulin precursor A1-15,Diabetes Type 1,II,22,5-1,52,2-3,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,CAVVNMDSNYQLIW,CASSLATSGGGSDTQYF,insulin precursor A1-15,Diabetes Type 1,II,39,5-1,33,2-3,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,CIPGSEEYGNKLVF,CASSLATSGGGSDTQYF,insulin precursor A1-15,Diabetes Type 1,II,26-2,5-1,47,2-3,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,,CASRNLGLNTEAF,insulin precursor A1-15,Diabetes Type 1,II,,14,,1-1,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,,CASSFRRVTDTQYF,insulin precursor A1-15,Diabetes Type 1,II,,28,,2-3,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,,CASSLAVIRTDTQYF,insulin precursor A1-15,Diabetes Type 1,II,,7-9,,2-3,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,,CASSLGQGETEAF,insulin precursor A1-15,Diabetes Type 1,II,,5-1,,1-1,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
KRGIVEQSSTSISSL,DRB104:01,,CASSQVRLAGGGEQF,insulin precursor A1-15,Diabetes Type 1,II,,4-1,,2-1,,,human,Pancreatic Islets,autoimmune,"Multiple PCR,antigen-specific ex vivo proliferation",sanger,RNA,PMID:15889096,5
GILGFVFTL,A02:01,CAAENNNDMRF,CASSLGTSYEQYF,Matrix potein (M1),InfluenzaA,I,13-1*01,7-1,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAAETTSGTYKYIF,CASSPIAGSSYEQYF,Matrix potein (M1),InfluenzaA,I,41*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAAGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAAGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAAGGSQGNLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAAISDYKLSF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,29/DV5*01,1-1,2-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAANYGGSQGNLIF,CASSLRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAAPYSGGGADGLTF,CATSDYVSGTLQETQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,2-1,4-1,2-5*01,,,human,Bronchoalveolar,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAASAFLGGSEKLVF,CATSERGDLNFGTDTQYF,Matrix potein (M1),InfluenzaA,I,29/DV5*01,1-1,5-1,2-3*01,,,human,Bronchoalveolar,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAASAGGGSQGNLIF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,29/DV5*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAASEGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,29/DV5*01,1-1,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAASGGTGNQFYF,CASRLAGSHEQYF,Matrix potein (M1),InfluenzaA,I,29/DV5*01,1-1,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAASGSS-GNMLTF,CASRSGREAFF,Matrix potein (M1),InfluenzaA,I,29/DV5*01,1-1,3-1,1-1*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAASSNTGKLIF,CASSSRSSYEQYF,Matrix potein (M1),InfluenzaA,I,13-1*01,19*02,3-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CACNYGGSQGNLIF,CASSIRSTDTQYF,Matrix potein (M1),InfluenzaA,I,25*01,1-1,4-1,2-3*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAEEHDRMYSGGGADGLTF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,13-2*01,19*02,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAEGGSGGSQGNLIF,CASSMRSDEKLFF,Matrix potein (M1),InfluenzaA,I,5-1,1-1,4-1,1-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAEISSGGSYIPTF,CASSTIEGQGGRHTQYF,Matrix potein (M1),InfluenzaA,I,13-2*01,9-1,6-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAEIWDYGQNFVF,CASSWEGINYGYTF,Matrix potein (M1),InfluenzaA,I,13-2*01,5-1,2-1,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENEGGGSQGNLIF,CASSIRSAGRAFF,Matrix potein (M1),InfluenzaA,I,13-2*01,1-1,4-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENGGGSTLGRLYF,CASSTRSTDTQYF,Matrix potein (M1),InfluenzaA,I,13-2*01,19*02,1-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENIGGGSQGNLIF,CASSMRSGETQYF,Matrix potein (M1),InfluenzaA,I,13-2*01,1-1,4-1,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENMGGGSQGNLIF,CASSDRAGNEQFF,Matrix potein (M1),InfluenzaA,I,13-2*01,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENMGGGSQGNLIF,CASSVRAGETQYF,Matrix potein (M1),InfluenzaA,I,13-2*01,1-1,4-1,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENNGGGSQGNLIF,CASSDRSGNEQFF,Matrix potein (M1),InfluenzaA,I,13-2*01,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAENYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,13-2*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAESIGRGSQGNLIF,CASSIRSGVEQYF,Matrix potein (M1),InfluenzaA,I,5-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFL-GKSTF,CASSDAGGGMAEAFF,Matrix potein (M1),InfluenzaA,I,2-1,2-1,2-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFMIGAGGTSYGKLTF,CASSIGSYGYTF,Matrix potein (M1),InfluenzaA,I,38-1*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFMIGAGGTSYGKLTF,CASSQGAFGYTF,Matrix potein (M1),InfluenzaA,I,38-1*01,1-1,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFMLGAGGTSYGKLTF,CASSIGYYGYTF,Matrix potein (M1),InfluenzaA,I,38-1*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFMS-GGTSYGKLTF,CASSIGVYGYTF,Matrix potein (M1),InfluenzaA,I,38-1*01,1-1,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFMSSPGGTSYGKLTF,CASSIGVYGYTF,Matrix potein (M1),InfluenzaA,I,38-1*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFSMEYGNKLVF,CASSGQGGTEAFF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,9-1,4-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFSSNYQLIW,CASSLLGGAGTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAFSSNYQLIW,CASSLLGRAGTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAAGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGADGGSQGNLIF,CASSGRAAGELFF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGADGGSQGNLIF,CASSGRSAGELFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGADGGSQGNLIF,CASSGRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGADGGSQGNLIF,CASSSRSAGELFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGADGGSQGNLIF,CASSSRSANEQFF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAFGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAFGSSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAFGSSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGDGGSQGNLIF,CASSMRAGYEQYF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGDNTGKLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSFRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSGRSADTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSGRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSIRATGELFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSIRSGYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSKRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSKRSTGELFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSRRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSSRATGELFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGGGSQGNLIF,CASSSRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGQGGSQGNLIF,CASSFYSNQPQHF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGSQGNLIF,CASSSRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGSQGNLIF,CASSSRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGSQGNLIF,CASSTRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAGSQGNLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAHGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAHGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAIGSSNTGKLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGALGGSQGNLIF,CASSSRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGALGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGALT-GKSTF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,2-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGALTGYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAMGGGSQGNLIF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAMGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAPGSSNTGKLIF,CASSTRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAPRTSGTYKYIF,CASSILTGPRTEAFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAPSSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGARAGGTSYGKLTF,CSARVRGDVYGYTF,Matrix potein (M1),InfluenzaA,I,2-1,2-1,5-1,1-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGASGGGSQGNLIF,CASSGRSTDTQYF,Matrix potein (M1),InfluenzaA,I,25*01,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGASGNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGASGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGASGSSNTGKLIF,CASSIRSGWEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGASGSSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGATGGSQGNLIF,CASSIRSDYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGATGNTGKLIF,CASSTRSGYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAVGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAVGSSNTGKLIF,CASSIRSGYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAVGSSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAVGSSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGAYGGSQGNLIF,CASSIRSTGELFF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGDLVIYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGEGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGEGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGDGGSQGNLIF,CASSIRSTGELFF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGNGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CAPLKGSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CASIIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CASSIRSQVEQFF,Matrix potein (M1),InfluenzaA,I,12-2*01,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CASSIRSSYEQFF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSQGNLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGGSSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGRQTGANNLFF,CASSYLEGSETQETQYF,Matrix potein (M1),InfluenzaA,I,2-1,6-1,3-1,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGGTGGSQGNLIF,CASSIRSGYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGIDNYGQNFVF,CASSGGRNQPQHF,Matrix potein (M1),InfluenzaA,I,1-2*01,5-1,2-1,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGLSGGSYIPTF,CASSQDWGAGTQYF,Matrix potein (M1),InfluenzaA,I,8-4*01,1-1,6-1,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGNYGGSQGNLIF,CASSIRGSGEQYF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGNYGGSQGNLIF,CASSLRSTDTQYF,Matrix potein (M1),InfluenzaA,I,25*01,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGNYGGSQGNLIF,CASSSRASYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGPDGSSNTGKLIF,CASSLIFPSGEQYF,Matrix potein (M1),InfluenzaA,I,35*01,2-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGPDTYRDGGSQGNLIF,CASSPRSGNEQFF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGPEDGGSQGNLIF,CASSIRSSGPQFF,Matrix potein (M1),InfluenzaA,I,25*01,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGPEGGYSGAGSYQLTF,CASSVSGATADTQYF,Matrix potein (M1),InfluenzaA,I,2-1,9-1,2-1,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGPFGRLMF,CASSLFPGFGEQYF,Matrix potein (M1),InfluenzaA,I,2-1,2-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGPMKTSYDKVIF,CASSSANYGYTF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGQLGGGSQGNLIF,CASSIRSSETQYF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,4-1,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGRDGGSQGNLIF,CASSSRSRQYRGSSYEQYF,Matrix potein (M1),InfluenzaA,I,35*01,5-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGSDGGSQGNLIF,CASSMRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGSQNYGGSQGNLIF,CASSWVSLDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGSSGGSQGNLIF,CASSYRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGTGFQKLVF,CASSLGDRPSTDTQYF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,8-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGVDGGSQGNLIF,CASSTRSAYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGVEYGGSQGNLIF,CASSIRSSVEQFF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGVGGGSQGNLIF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGVGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGVTYGGSQGNLIF,CASSLRSSYEQYF,Matrix potein (M1),InfluenzaA,I,35*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAGVYGGSQGNLIF,CASSIRSAHEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAHGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALAGSQGNLIF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,23/DV6*01,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALDMGGGSQGNLIF,CASSARSTDTQYF,Matrix potein (M1),InfluenzaA,I,6-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALDMGGGSQGNLIF,CASSIRAADTQYF,Matrix potein (M1),InfluenzaA,I,6-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALDMGGGSQGNLIF,CASSIRSTDTQYF,Matrix potein (M1),InfluenzaA,I,6-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALHSGGYQKVTF,CASSPTRPVEQYF,Matrix potein (M1),InfluenzaA,I,14/DV4*02,2-1,13*02,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALIAGANSKLTF,CASSIAPTDTQYF,Matrix potein (M1),InfluenzaA,I,9-2*01,19*02,5-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALLYARLMF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,1-1,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALNDYKLSF,CASSEAISGAWDEQFF,Matrix potein (M1),InfluenzaA,I,3-1,6-1,2-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALRVMNRDDKIIF,CASSTKDGGTGELFF,Matrix potein (M1),InfluenzaA,I,16*01,1-1,3-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALRVMNRDDKIIF,CASSTKEGGTGELFF,Matrix potein (M1),InfluenzaA,I,16*01,1-1,3-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALRVMNRDDKIIF,CASSTKVGGTGELFF,Matrix potein (M1),InfluenzaA,I,16*01,1-1,3-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSDLNQAGTALIF,CASSYGIAGKETQYF,Matrix potein (M1),InfluenzaA,I,1-1,7-1,1-1,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSDSGGSNYKLTF,CASSIFSGGQNIQYF,Matrix potein (M1),InfluenzaA,I,1-1,19*02,5-1,2-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSEAGKTSYDKVIF,CASSQVEAFYEQYF,Matrix potein (M1),InfluenzaA,I,1-1,4-1,5-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSEAGRGGSYIPTF,CASSIFGGAEAFF,Matrix potein (M1),InfluenzaA,I,1-1,1-1,6-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSEALVTGGGNKLTF,CASSLSRRGPNYGYTF,Matrix potein (M1),InfluenzaA,I,1-1,2-1,1-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSEASG-GNMLTF,CASSSPTSGDYEQYF,Matrix potein (M1),InfluenzaA,I,1-1,2-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSEATSGTYKYIF,CASSRGQLYEQYF,Matrix potein (M1),InfluenzaA,I,1-1,7-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSGSDYKLSF,CSARGGDSVLRVGEQYF,Matrix potein (M1),InfluenzaA,I,1-1,2-1,2-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSGSSVGAAGNKLTF,CASSVVASSYNEQFF,Matrix potein (M1),InfluenzaA,I,1-1,9-1,1-1,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CALSRAGGTSYGKLTF,CASSSRQGAANEKLFF,Matrix potein (M1),InfluenzaA,I,9-2*01,1-1,5-1,1-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMNYGGSQGNLIF,CASSTRSTDTQYF,Matrix potein (M1),InfluenzaA,I,25*01,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMRDSQGGSEKLVF,CASSYGLEQFF,Matrix potein (M1),InfluenzaA,I,14/DV4*01,6-1,5-1,2-1*01,,,human,Bronchoalveolar,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMRGDAGGTSYGKLTF,CASRIDSNQPQHF,Matrix potein (M1),InfluenzaA,I,14/DV4*01,1-1,5-1,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMRGDAGGTSYGKLTF,CASSIDSNQPQHF,Matrix potein (M1),InfluenzaA,I,14/DV4*01,19*02,5-1,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMRGDPGGTSYGKLTF,CASSILSNTEAFF,Matrix potein (M1),InfluenzaA,I,14/DV4*02,19*02,5-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMSERNKARLMF,CASGAGGPLNEQFF,Matrix potein (M1),InfluenzaA,I,12-3*01,1-1,3-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMSERN-RLMF,CASGAGGPLNEQFF,Matrix potein (M1),InfluenzaA,I,12-3*01,1-1,3-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMSGDGGSQGNLIF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,12-3*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMSGEGGSQGNLIF,CASSMRSAGELFF,Matrix potein (M1),InfluenzaA,I,12-3*01,19*02,4-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAMSLYSGGGADGLTF,CASRPPPAGQKETQYF,Matrix potein (M1),InfluenzaA,I,14/DV4*01,2-1,4-1,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAQGDGGSQGNLIF,CASSGRSTDTQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CARNTGNQFYF,CASSKQTGTGNYGYTF,Matrix potein (M1),InfluenzaA,I,2-1,6-1,4-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CASGGSQGNLIF,CASSSRSAYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CASPGDGGSQGNLIF,CASSPRSTDTQYF,Matrix potein (M1),InfluenzaA,I,25*01,1-1,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CATDAIPSDMRF,CASSFRSTDTQYF,Matrix potein (M1),InfluenzaA,I,1-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CATDALGNGNEKLTF,CATQGDNTYEQYF,Matrix potein (M1),InfluenzaA,I,1-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CATDGEYAGGTSYGKLTF,CASSVRTGYTEAFF,Matrix potein (M1),InfluenzaA,I,1-1,2-1,5-1,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CATGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CATGGSQGNLIF,CASSTRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CATGGSQGNLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVDDT-GKSTF,CASSLRSTDTQYF,Matrix potein (M1),InfluenzaA,I,8-3*01,19*02,2-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVDGGGGSQGNLIF,CASSIRSSYEQFF,Matrix potein (M1),InfluenzaA,I,22*01,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVDGGGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,22*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVDGSQGNLIF,CASSPRGGMTQHF,Matrix potein (M1),InfluenzaA,I,8-6*02,1-1,4-1,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVGGDGGSQGNLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-3*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAV-GGGSQGNLIF,CASSIRASYEQYF,Matrix potein (M1),InfluenzaA,I,8-1*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-6*02,1-1,4-1,2-7*01,,,human,Bronchoalveolar,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVGGTTDSWGKLQF,CASRGSLNQPQHF,Matrix potein (M1),InfluenzaA,I,2-1,2-1,24*02,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVGGYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-6*01,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVHLSAYSGAGSYQLTF,CASSQDKGRAYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,4-1,2-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVIGEGGKLTF,CASSLLVSGVSSTDTQYF,Matrix potein (M1),InfluenzaA,I,8-1*01,2-1,5-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVINQAGTALIF,CASSLERNTYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,2-1,1-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVKPGTASKLTF,CASSQDLTSEAFF,Matrix potein (M1),InfluenzaA,I,22*01,4-1,4-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVNGGGGSQGNLIF,CASSTRAAYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVNLNEKLTF,CSARDGTRAHYEQFF,Matrix potein (M1),InfluenzaA,I,3-1,2-1,4-1,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVNNYGQNFVF,CASSVEDYGSVSYGYTF,Matrix potein (M1),InfluenzaA,I,12-2*01,9-1,2-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVNPAEYGNKLVF,CASSRVGTTYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVNPSNTGKLIF,CASSSRSSYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVPKGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-3*01,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVPNT-GKSTF,CASSSRSGNEKLFF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,2-1,1-4*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVPPDSWGKLQF,CASSQDLAGEGTDTQYF,Matrix potein (M1),InfluenzaA,I,3-1,1-1,24*02,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVPYGNKLVF,CASTTGTVNTEAFF,Matrix potein (M1),InfluenzaA,I,13-1*01,6-1,4-1,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVPYSGGGADGLTF,CATSDFPPGVRGAPQETQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,2-1,4-1,2-5*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVRANFGNEKLTF,CASSYPLLYSGANTGELFF,Matrix potein (M1),InfluenzaA,I,41*01,6-1,4-1,2-2*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVRDGTGANNLFF,CASSISSTGELFF,Matrix potein (M1),InfluenzaA,I,3-1,19*02,3-1,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVRDGTGANNLFF,CASSPPPGAVETQYF,Matrix potein (M1),InfluenzaA,I,3-1,1-1,3-1,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVRDIGEYGNKLVF,CASGGLVHEQFF,Matrix potein (M1),InfluenzaA,I,3-1,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVREVEYGNKLVF,CASSIGYYGYTF,Matrix potein (M1),InfluenzaA,I,3-1,19*02,4-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVRKFGNEKLTF,CASSIGLYGYTF,Matrix potein (M1),InfluenzaA,I,41*01,19*02,4-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVRVPDQTGANNLFF,CASSLRVSYNEQFF,Matrix potein (M1),InfluenzaA,I,1-2*01,1-1,3-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSDDNDMRF,CASSQTYEQYF,Matrix potein (M1),InfluenzaA,I,8-4*01,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSDSGTGNQFYF,CASSQMTGLNTEAFF,Matrix potein (M1),InfluenzaA,I,8-6*02,2-1,4-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSGSQGNLIF,CASSMRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-6*01,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSGSQGNLIF,CASSSRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-6*02,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSGSQGNLIF,CASSVRSSYEQYF,Matrix potein (M1),InfluenzaA,I,8-6*02,1-1,4-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSPVSNFGNEKLTF,CASSPLSLGSPYNEQFF,Matrix potein (M1),InfluenzaA,I,8-6*02,5-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSVRMDSSYKLIF,CASSQDPGYEQYF,Matrix potein (M1),InfluenzaA,I,8-6*02,4-1,1-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVSYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,3-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVTGGGSQGNLIF,CASSFRSSYEQYF,Matrix potein (M1),InfluenzaA,I,3-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVTPGGGSQGNLIF,CASSPRASLEQYF,Matrix potein (M1),InfluenzaA,I,3-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVTPSNTGKLIF,CASSIRSAYEQYF,Matrix potein (M1),InfluenzaA,I,12-2*01,19*02,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVTSNTGKLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,3-1,1-1,3-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAVVASNTGKLIF,CASSPRDGQETQYF,Matrix potein (M1),InfluenzaA,I,1-1*01,4-1,3-1,2-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAWGH-GGTSYGKLTF,CASSIGLYGYTF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYEVRDDKIIF,CASSYSGHVNTEAFF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,6-1,3-1,1-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,1-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYGGSQGNLIF,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,2-1,19*02,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYSPGAGGTSYGKLTF,CASSIGLYGYTF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYST-GGTSYGKLTF,CASSLGIYGYTF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYSV-GGTSYGKLTF,CASSIGTYGYTF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,19*02,5-1,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CAYSYGGSQGNLIF,CASSDGTGGILYEQYF,Matrix potein (M1),InfluenzaA,I,38-2/DV8*01,6-1,4-1,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CGISLGGGSQGNLIF,CASSTRSTDTQYF,Matrix potein (M1),InfluenzaA,I,3-1,19*02,4-1,2-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CIAGASFSGGYNKLIF,CSANSDRVSYNEQFF,Matrix potein (M1),InfluenzaA,I,26-1*01,2-1,4-1,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CIAHGGGGADGLTF,CATSDGLAGGWANVLTF,Matrix potein (M1),InfluenzaA,I,26-2*01,2-1,4-1,2-6*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CLVGSMDSNYQLIW,CASSSQSNQPQHF,Matrix potein (M1),InfluenzaA,I,4*01,2-1,3-1,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CVVPESGNTGKLIF,CSAAGLAGGSYEQYF,Matrix potein (M1),InfluenzaA,I,12-1*01,2-1,3-1,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CVVRDNNDMRF,CATSDFEVAGSSYNEQFF,Matrix potein (M1),InfluenzaA,I,12-1*01,2-1,4-1,2-1*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CVVSGDDTGNQFYF,CASSLTLVFEAFF,Matrix potein (M1),InfluenzaA,I,8-2*01,7-1,4-1,1-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,CVVTPGREYGNKLVF,CASSISSGSYNEQFF,Matrix potein (M1),InfluenzaA,I,1-1,1-1,4-1,2-1*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASGLVPEGLVYEQYF,Matrix potein (M1),InfluenzaA,I,,1-1,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASGLVPGGLVYEQYF,Matrix potein (M1),InfluenzaA,I,,1-1,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASGLVPGGVVYEQYF,Matrix potein (M1),InfluenzaA,I,,1-1,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASSDRATQPQHF,Matrix potein (M1),InfluenzaA,I,,1-1,,1-5*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASSIGVYGYTF,Matrix potein (M1),InfluenzaA,I,,19*02,,1-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASSIMGSGNTIYF,Matrix potein (M1),InfluenzaA,I,,19*02,,1-3*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASSIRSSYEQYF,Matrix potein (M1),InfluenzaA,I,,1-1,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASSIRSTGELFF,Matrix potein (M1),InfluenzaA,I,,19*02,,2-2*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASSPLIGEQYF,Matrix potein (M1),InfluenzaA,I,,2-1,,2-7*01,,,human,PBMC,pathogen,"Multiple PCR,selection of antigen- specific t cells using peptide-mhc multimers ",NGS,RNA,PMID:28636592,4
GILGFVFTL,A02:01,,CASTPQGAYEQYF,Matrix potein (M1),InfluenzaA,I,,6-1,,2-7*01,,,human,PBMC,pathogen,selection of antigen- specific t cells using peptide-mhc multimers ,NGS,RNA,PMID:28636592,4
PQPELPYPQPE,DQ2,CAGDSGYALNF,CATSSRMGGDTQYF,glia-a2,Celiac disease,II,35-1,15-2,41,2-3,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CALSELSIQGAQKLVF,CASSIVDRGGETQYF,glia-a2,Celiac disease,II,9-2,4-1,54,2-5,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CALSESGANSKLTF,CASSLRAWETQYF,glia-a2,Celiac disease,II,9-2,7-2,56,2-5,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CAVRDPLYNFNKF,CASSQGGDRGESEAF,glia-a2,Celiac disease,II,3-1,4-2,21,1-1,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CIEYNFNKF,CASRPVAGLPHF,glia-a2,Celiac disease,II,26-1,7-6,21,1-6,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CIVPANTGGFKTIF,CASSFRSTDTQYF,glia-a2,Celiac disease,II,26-1,7-2,9,2-3,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CIVYGGFKTIF,CASSLRSTDTQYF,glia-a2,Celiac disease,II,26-1,7-2,9,2-3,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CLVGGGADGLTF,CASSVRTLDTGELF,glia-a2,Celiac disease,II,4-1,7-2,45,2-2,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CLVGHGSSNTGKLIF,CASSLRWGDGGKLF,glia-a2,Celiac disease,II,4-1,7-2,37-2,2-2,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
PQPELPYPQPE,DQ2,CVVNSWAGNQF,CASSLGYGVSTGELF,glia-a2,Celiac disease,II,12-2,5-4,49,2-2,,,human,PBMC,autoimmune,"SMART,selection of antigen- specific t cells using peptide-mhc multimers ",sanger,RNA,PMID:26838051,4
FWIDLFETIG,DPB102:01,CIVRAYGNNF,CASSPTGQAHEQYF,Beryllium sulfate,Allergy,II,4,18,38,2-7,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,CIVRVWDAGNNF,CASSPNGQAHEQYF,Beryllium sulfate,Allergy,II,4,18,38,2-7,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLAQAGETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLAQGAETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLAQGGETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLGQAGETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLGQGGETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLNQGGYIQYF,Beryllium sulfate,Allergy,II,,5-1,,2-4,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLSQGAETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLSQGGDTQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLSQGGEKLF,Beryllium sulfate,Allergy,II,,5-1,,1-4,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSLSQGGRPMF,Beryllium sulfate,Allergy,II,,5-1,,1-4,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSMGQGGETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
FWIDLFETIG,DPB102:01,,CASSQAQGGETQYF,Beryllium sulfate,Allergy,II,,5-1,,2-5,,,human,Lung,allergy,selection of antigen- specific t cells using peptide-mhc multimers ,sanger,RNA,PMID:24719461,4
